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Thesis Abstract 
 
Objective: People with end-stage renal disease (ESRD) experience high rates of 
depression and this is associated with poorer health-related outcomes. Acceptance and 
Commitment Therapy (ACT) has shown promising results in a number of long-term 
conditions and has been translated into a variety of self-help formats. We aimed to 
determine the feasibility of a trial examining telephone-supported self-help based on ACT for 
individuals with ESRD who experience depression. A brief and extended account of the 
research is provided. This is preceded by a systematic literature review examining whether 
ACT interventions can improve quality of life in long-term physical conditions (see section for 
more information). 
 
Design: A feasibility randomised controlled trial comparing telephone-supported ACT self-
help with treatment as usual.  
 
Methods: Participants were recruited from four outpatient haemodialysis units across 
Nottinghamshire, UK. The Patient Health Questionnaire (PHQ-9), EuroQol (EQ-5D-5L) 
health-related quality of life measure, Acceptance and Action Questionnaire II (AAQ-II) and 
Valued Living Questionnaire (VLQ) were completed at baseline and 2- and 4-months post-
randomisation. Participants in the intervention arm were asked to complete an ACT self-help 
manual over six weeks with weekly telephone support. Following completion of the trial, six 
participants were interviewed to examine the acceptability of the trial procedure and 
intervention. Interview data was analysed using framework analysis.  
 
Results: In total, 99 (36.87%) of 276 screening questionnaires were returned. Of these, 30 
(30.3%) met the cut-off for depression on the PHQ-9 with nine enrolling in the trial. AAQ-II 
scores of screened participants were positively associated with scores on the PHQ-9 and 
GAD-7, indicating a positive relationship between psychological inflexibility and distress. 
Interview data indicated that the recruitment and randomisation procedure, and assessment 
methods were acceptable. Only one in four of the participants in the ACT arm of the trial 
completed all chapters of the book with health problems the main barrier to completion. 
 
Conclusion: Our findings indicate that a definitive trial examining the effectiveness of a 
telephone-supported ACT self-help intervention would not be feasible. Many aspects of the 
trial were acceptable to participants, including the main recruitment strategy, randomisation 
procedure and data collection methods. However, low recruitment numbers and poor 
adherence to the self-help manual indicate that a full-scale trial would not be viable. Factors 
that might account for low recruitment numbers are discussed and personal reflections on 
the research process are provided. 
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Abstract 
Purpose: Long-term physical health conditions can significantly affect quality of life. 
With the prevalence of long-term physical health conditions rising, there is an urgent 
need to identify effective interventions that improve quality of life for those affected. Our 
aim was to determine the effectiveness of acceptance and commitment therapy (ACT) 
at improving quality of life in long-term physical health conditions. 
 
Methods: MEDLINE, Embase, PsycINFO, Web of Science and CINAHL were 
systematically searched along with reference lists and the website of the Association 
for Contextual Behavioral Science. 
 
Results: Fifteen studies met inclusion criteria (total n=889). Health conditions included 
chronic pain, tinnitus, epilepsy, ovarian cancer and fibromyalgia. Overall these studies 
support the use of ACT in a variety of delivery formats for improving quality of life in 
some long-term conditions. 
 
Conclusions: Preliminary evidence supports the effectiveness of ACT for improving 
quality of life in cancer, epilepsy and fibromyalgia but not in tinnitus. The findings are 
mixed for chronic pain. Delivery format (e.g. individual psychotherapy, group 
psychotherapy or self-help) was not related to the effectiveness of the ACT 
intervention. Future large scale trials, which address the methodological issues 
highlighted, are needed before stronger conclusions can be drawn.  
 
Key words: Acceptance and Commitment Therapy, systematic review, methodological 
quality, evidence-base.  
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Impact and Implications Statement 
What is already known on this subject? 
 Studies have demonstrated the efficacy of Acceptance and Commitment 
Therapy (ACT) at improving outcomes in some chronic conditions however 
quality of life is often overlooked. 
 Acceptance and mindfulness-based approaches (including ACT) are effective at 
improving quality of life in chronic pain. 
 
What does this study add? 
 Preliminary evidence supports the efficacy of ACT for improving quality of life in 
cancer, epilepsy and fibromyalgia.  
 ACT not currently supported for improving quality of life in tinnitus, with mixed 
findings in chronic pain. 
 Methodological issues need to be addressed before stronger conclusions can 
be drawn. 
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Background 
A long-term condition is defined as “a condition that cannot, at present, be cured but is 
controlled by medication and/or other treatments/therapies” (pp. 3, Department of 
Health, 2012). It is a term used to describe a range of physical, mental and 
neurological disorders. In England in 2010 there were 15.4 million people experiencing 
at least one long-term condition with the cumulative cost of care estimated to be 70% 
of the total National Health Service (NHS) budget (Department of Health, 2010). As the 
population in England over the age of 65 continues to increase, the number of people 
with long-term conditions is predicted to grow, estimated to be 18 million by 2025 
(Department of Health, 2010). 
 
Long-term conditions can affect all aspects of physical and psychological well-being 
and are associated with a reduction in quality of life (Department of Health, 2010). The 
NHS Outcomes Framework 2014 to 2015 identifies enhancing the quality of life for 
people with long-term conditions as a key priority for improvement in health outcomes 
(Department of Health, 2013). This highlights the urgent need to evaluate interventions 
aimed at improving quality of life in individuals with long-term conditions.  
 
Acceptance 
Traditional Cognitive Behavioural Therapy (CBT) approaches to long-term conditions 
emphasise control-based strategies aimed at reducing or controlling symptoms 
(McCracken & Eccleston, 2005). In recent years, a number of new therapeutic 
approaches within the CBT family have been advanced, which centre on acceptance-
based strategies. One such approach, Acceptance and Commitment Therapy (ACT; 
Hayes, Strosahl & Wilson, 1999) defines acceptance as the willingness to experience 
distressing private events (thoughts, emotions, physical symptoms) without making 
attempts to change their form or frequency. In the ACT model, acceptance is 
conceptualised in opposition to experiential avoidance: a process wherein individuals 
engage in increasingly narrow and inflexible patterns of behaviour in order to avoid 
painful and distressing experiences. According to Hayes et al. (1999), these patterns of 
experiential avoidance lead to greater disability and diminished quality of life.  
 
Acceptance has been found to be positively related to psychological well-being across 
a broad spectrum of long-term conditions such as coronary artery disease (Karademas, 
Tsagaraki & Lambrou, 2009), multiple sclerosis (Harrison, Stuifbergen, Adachi & 
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Becker, 2004), diabetes (Richardson, Adner & Nordstrom, 2001) and chronic pain 
(McCracken & Zhao-O’Brien, 2010). 
 
A growing body of research has attempted to examine the effectiveness of ACT at 
improving outcomes in chronic illness especially chronic pain. ACT is now 
recommended by the American Psychological Association’s (APA) Society of Clinical 
Psychology as an evidence-based treatment for chronic pain. In a systematic review, 
Veehof, Oskam, Schreurs and Bohlmeijer (2011) examined the effectiveness of 
acceptance-based interventions for the treatment of chronic pain. Following a meta-
analysis of 14 controlled studies, the authors concluded that acceptance-based 
interventions are effective at reducing pain and depressive symptoms with small effect 
sizes (SMD=0.37 and 0.32 respectively). A moderate effect was reported on quality of 
life (SMD=0.41), although only six studies included a quality of life outcome measure.  
 
Importantly, of the 22 studies included in the review, only seven involved an ACT 
intervention. The remaining 15 involved another acceptance-based intervention, 
namely the mindfulness-based stress reduction program (Kabat-Zinn, 1990). Given that 
ACT is a unique psychotherapeutic model with its own set of processes and 
techniques, there is a need to examine its utility independently of other acceptance-
based approaches.  
 
A particular point of distinction is that in contrast to other acceptance-based 
approaches, ACT promotes acceptance as a means of bringing about values-based 
behaviour, rather than as an end in itself. In ACT, acceptance is considered useful to 
the extent that it can increase behavioural flexibility (i.e. counteract experiential 
avoidance) and enable action in accordance with personal values and long-held goals 
– despite the presence of pain or distressing thoughts and feelings. If an ACT 
intervention is successful in fostering increased acceptance and valued behaviour, we 
would expect to see this reflected in improved quality of life. 
 
Aims 
The present study aims to systematically review the effectiveness of ACT interventions 
for improving quality of life in adults with long-term physical health conditions. 
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Methods 
Inclusion and exclusion criteria 
One reviewer identified potentially eligible studies based on titles and abstracts. Full-
text articles were then examined to determine which papers met inclusion criteria. The 
following criteria were adopted: 
 
Study designs 
We considered randomised controlled trials (RCTs) as they are considered the gold 
standard for evaluating the effectiveness of interventions. Quality, based on 
methodology, was assessed for included studies. Conference abstracts and other grey 
literature were excluded along with uncontrolled trials, case studies, reviews and 
commentaries. Our decision to omit grey and other unpublished literature was based 
on findings that the methodological quality of such studies is often poorer than those 
that have been published (Egger, Juni, Bartlett, Holenstein & Sterne, 2003). Non-
English language papers were also excluded. 
 
Participants 
Studies were included if their participants experienced one or more long-term physical 
health conditions. Participants did not have to have a formal diagnosis but where 
diagnosis was not present, researchers needed to have specified how the presence of 
the condition was determined. Studies where participants were carers of patients with 
long-term conditions were excluded, unless the intervention was delivered to both the 
patient and the carer(s) and separate data were available for the analysis of patient 
outcomes. Studies involving children and adolescents were not included. 
 
Interventions and control groups 
Trials were included where there was a comparison between a standardised ACT 
intervention and a control condition featuring either another type of treatment or no 
treatment (e.g. waiting list). All ACT interventions were included regardless of the 
delivery format or length but had to be based upon the core processes of ACT. 
 
Outcome measures 
Quality of life was defined as an individual’s perceived quality of their physical, 
psychological, social and existential functioning (Anderson, Aaronson & Wilkin, 1993). 
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Studies were considered where they included generic quality of life measures and 
health-related or illness-specific measures.  
 
Search strategy 
Five databases were searched using a comprehensive search strategy: MEDLINE 
(1946 to July 2014), Embase (1980 to July 2014), PsycINFO (1806 to July 2014), Web 
of Science (1900 to July 2014) and CINAHL (1937 to July 2014). The databases were 
searched using the following terms: “randomised”, “randomized”, “randomize”, 
“randomise”, “randomisation”, “randomization”, “randomly”, and “clinical trial” in 
combination with “acceptance and commitment therapy”, “acceptance & commitment 
therapy” “acceptance-based” and “acceptance based”. The terms were searched as 
MeSH subject headings (where available) and key words within titles and abstracts. 
Forward citation tracking was also used and reference lists of relevant papers were 
searched. 
 
Additional search strategies were also employed. The official website of the 
Association for Contextual Behavioral Science (ACBS: 
https://www.contextualscience.org) provides a list of publications relevant to ACT 
including clinical trials of ACT interventions. The “ACT Empirical” section of this list was 
searched to identify additional trials. Titles and abstracts were reviewed to identify 
studies for further screening. The ACBS website also provides an electronic mailing list 
which allows users to contact researchers and clinicians to discuss current conceptual, 
scientific, and practice developments in ACT. An email outlining the details of the 
review and requesting relevant papers was sent to the “ACT for Professionals” 
electronic mailing list. This search strategy was used as an expert consultation to 
identify additional papers.  
 
Quality assessment 
The psychotherapy outcome study methodology rating scale (Öst, 2008) was used to 
assess the methodological quality of identified studies (see Table 1). The 22-item scale 
was adapted by Öst to evaluate the general quality of outcome studies and was used in 
their review of the effectiveness of third wave behavioural therapies (including ACT). 
Each item is rated as 0 = poor, 1 = fair or 2 = good. Detailed guidance for scoring can 
be seen in Appendix A. One reviewer evaluated the studies with a proportion checked 
by a second reviewer. Disagreements between reviewers were resolved through 
discussion. 
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Figure 1  
 
Study flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
Overview of included studies 
A study flow diagram can be seen in Figure 1 and an overview of included studies can 
be seen in Table 2. Fifteen studies were identified as eligible for the review, covering 
chronic pain or whiplash associated disorders (n=8), fibromyalgia (n=2), tinnitus (n=2), 
drug-refractory epilepsy (n=2) and ovarian cancer (n=1). All included studies adopted 
an RCT design. The main reasons for excluding full-text articles were that the studies 
did not use an RCT design (n=15) or that they did not include a measure of quality of 
life (n=12). One full-text article was excluded because an English language version of 
the paper was not available. In terms of study location, nearly half were from Sweden 
(n=14) with the rest from USA (n=3), Spain (n=2), India (n=1) New Zealand (n=1) and 
South Africa (n=1).   
 
 
627 records 
identified through 
database searching 
35 records identified 
through other 
sources 
306 records after 
duplicates removed 
306 records 
screened 
43 full-text articles 
assessed for 
eligibility 
28 full-text articles excluded: 
Not RCTs n=15 
No quality of life measure n=12 
Non-English language n=1 
 
263 records excluded 
15 studies included 
in review 
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Table 1  
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W
ic
ks
e
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e
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a
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2
0
1
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i. Clarity of sample description 1 2 1 1 1 1 1 1 1 1 2 1 2 1 1 
ii. Severity/chronicity of the 
disorder 
2 0 0 1 0 1 1 1 2 0 0 1 0 1 2 
iii. Representativeness of the 
sample 
0 1 0 1 1 2 1 1 2 2 1 1 1 1 0 
iv. Reliability of the diagnosis in 
question 
0 0 0 1 0 1 1 1 1 0 0 1 0 0 0 
v. Specificity of outcome measures 2 2 1 1 1 2 1 1 1 1 2 1 2 1 1 
vi. Reliability and validity of 
outcome measures 
2 2 1 2 1 2 2 2 1 1 2 2 2 2 2 
vii. Use of blind evaluators 0 2 0 2 0 1 0 0 0 2 2 1 2 1 1 
viii. Assessor training 0 n/
a 
0 n/
a 
0 0 0 0 0 n/
a 
0 0 0 0 0 
ix. Assignment to treatment 1 1 0 2 1 1 1 1 1 1 1 1 1 1 1 
x. Design 0 1 0 2 0 2 1 2 0 2 2 2 2 0 0 
xi. Power analysis 0 1 0 0 0 2 0 0 0 1 0 1 0 0 0 
xii. Assessment points 0 0 1 2 0 1 2 2 0 2 1 2 1 0 1 
xiii. Manualised, replicable, specific 
treatment programs 
1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 
xiv. Number of therapists 0 1 1 1 0 0 1 1 0 1 1 0 1 2 2 
xv. Therapist training/experience 2 0 0 0 0 2 1 1 0 0 0 0 0 1 1 
xvi. Checks for treatment 
adherence 
0 1 0 1 2 1 1 1 1 0 1 1 1 0 1 
xvii. Checks for therapist 
competence 
0 0 0 1 0 1 1 1 0 0 1 1 1 0 1 
xviii. Control of concomitant 
treatments (e.g. medications) 
0 0 1 1 0 1 1 0 0 1 2 2 2 0 1 
xix. Handling of attrition 0 1 0 2 1 1 0 0 1 1 0 1 1 1 1 
xx. Statistical analyses and 
presentation of results 
2 2 2 2 2 2 2 2 1 2 1 2 2 2 2 
xxi. Clinical significance 0 0 0 1 2 0 0 0 0 0 0 2 0 0 0 
xxii. Equality of therapy hours (for 
non-wait-list designs only) 
n/
a 
0 n/
a 
2 n/
a 
0 2 2 2 2 2 0 2 n/
a 
n/
a 
Note: 0 = poor rating or not enough information given; 1 = fair rating; 2 = good rating; n/a = not applicable. 
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Sample characteristics 
In total, selected studies included 889 participants with sample sizes ranging from 10 to 
156. Of the 889 participants, 592 (66.59%) were female and 297 (33.41%) were male. 
The number of females was skewed by one study which included 150 females and only 
6 males (Luciano et al., 2014). Two studies included no males; one involved a sample 
of ovarian cancer patients (Rost, Wilson, Buchanan, Hildebrandt & Mutch, 2012) and 
the other chose to exclude males from the sample but gave no reason (Wicksell et al., 
2013). The average age of participants across all studies was 49.31 years, ranging 
from 18 to 91 years.  
 
Treatment and control conditions 
A summary of outcomes is presented in Table 3. Various formats were used in the 
delivery of the ACT intervention including individual psychotherapy (n=4), group 
psychotherapy (n=5), internet-based self-help (n=2), bibliotherapy with therapist 
telephone support (n=2) and combined individual and group psychotherapy (n=2). 
Several different control groups were utilised, including CBT delivered in group (n=2), 
individual (n=1) and internet-based formats (n=1); moderated online internet forum 
(n=2); combined group and individual supportive therapy (n=1); tinnitus retraining 
therapy (n=1); pharmacological treatment (n=1); applied relaxation self-help manual 
(n=1); yoga (n=1); and medical treatment as usual (TAU; n=1). Over a third of studies 
(n=6) included a wait-list control condition, two of which also included a third condition 
featuring another type of treatment, namely pharmacological treatment or internet-
delivered CBT, as mentioned above. 
 
Quality of life measures 
In almost all included studies, quality of life was a secondary outcome with primary 
outcomes tending to be related to reductions in psychological distress, increase in 
activity, reduction in sick leave or medical utilisation, or reduction in self-reported 
symptoms related to the long-term condition. ACT-specific measures such as the 
Acceptance and Action Questionnaire II (AAQ-II: Bond et al., 2011) were used in most 
of the studies. These instruments measure the therapeutic processes underlying the 
ACT model. 
 
The majority of studies used a general quality of life measure (n=10) with three studies 
using two general measures. The general measures were the Satisfaction with Life  
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Table 2  
 
Characteristics of included studies 
 
Note: Individual ACT = individually delivered ACT; Group ACT = group delivered ACT; Group + individual ACT = 
combined individual and group delivered ACT; Group + individual ST = combined individual and group delivered 
supportive therapy; Internet ACT = internet-delivered ACT; Internet CBT = internet-delivered CBT; MTAU = medical 
treatment as usual; RPT = recommended pharmacological treatment; TRT = tinnitus retraining therapy; self-help ACT = 
ACT bibliotherapy; TAU = treatment as usual. 
 
 
Scale (SWLS: Diener, Emmons, Larsen & Griffins, 1985; n=6), the Quality of Life 
Inventory (QOLI: Frisch, Cornell, Villanueva & Retzlaff, 1992; n=4), and the World 
Health Organization Quality of Life scale (WHOQOL-BREF: WHOQOL Group, 1998; 
n=2). Several studies adopted a measure of health-related quality of life including the 
Author Country Target Mean 
age 
Female Male n Treatment and control 
conditions 
 
Alonso et 
al. 2013 
 
Spain Chronic pain 85.4 8 
 
2 5 
5 
Group ACT 
Wait-list 
Buhrman et 
al. 2013 
 
Sweden Chronic pain 49.1 45  
 
31 38 
38 
Internet ACT 
Moderated online forum 
Dahl et al. 
2004 
 
Sweden Chronic pain 40 17 
 
2 11 
8 
Individual ACT + MTAU 
MTAU 
Hesser et 
al. 2012 
Sweden Tinnitus 48.5 43 
 
56 35 
32 
32 
Internet ACT 
Internet CBT 
Moderated online forum 
 
Johnston et 
al. 2010 
 
New 
Zealand 
Chronic pain 43 14 
 
10 6 
8 
Self-help ACT 
Wait-list 
Luciano et 
al. 2014 
Spain Fibromyalgia 48.31 150 
 
6 51 
52 
53 
Group ACT 
RPT 
Wait-list 
 
Lundgren 
et al. 2006 
South 
Africa 
Drug-refractory 
epilepsy 
40.68 14 
 
13 14 
13 
Group + individual ACT 
Group + individual ST 
 
Lundgren 
et al. 2008 
India Drug-refractory 
epilepsy 
23.85 6 
 
12 10 
8 
Group + individual ACT 
Yoga 
 
Rost et al. 
2012 
USA Ovarian cancer 56 47 
 
0 25 
22 
Individual ACT 
Individual CBT (TAU) 
 
Thorsell et 
al. 2011 
Sweden Chronic pain  46 58 
 
32 52 
38 
Self-help ACT 
Self-help applied 
relaxation 
 
VanBuskirk 
et al. 2014 
USA Chronic pain 56.25 48 
 
39 41 
46 
Group ACT 
Group CBT 
 
Westin et 
al. 2011 
Sweden Tinnitus 50.9 28 
 
32 21 
18 
21 
Individual ACT 
TRT 
Wait-list 
 
Wetherell 
et al. 2011 
USA Chronic pain 54.9 58 56 57 
57 
Group ACT 
Group CBT 
 
Wicksell et 
al. 2008 
Sweden Chronic pain 
and whiplash 
51.65 16 
 
6 11 
10 
Individual ACT 
Wait-list 
 
Wicksell et 
al. 2012 
Sweden Fibromyalgia 45.1 40 
 
0 23 
17 
Group ACT 
Wait-list 
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Medical Outcomes Study 12-Item Short Form Health Survey (SF-12: Ware, Kosinski & 
Keller, 1994; n=2), the 36-Item Short Form Health Survey (SF-36: Ware & Sherbourne, 
1992; n=1), and the EQ-5D visual analogue scales (EQ-5D VAS: EuroQol Group, 
1990; n=1). 
 
Two studies used illness-specific measures. The Life Satisfaction Questionnaire (LSQ: 
Carlsson, Hamrin & Lindquist, 1999) was developed to measure quality of life in 
women with breast cancer but has also been used with individuals experiencing other 
chronic physical health conditions. The LSQ was used within the Dahl, Wilson and 
Nilsson (2004) study to assess quality of life in individuals who experience chronic 
pain. The Functional Assessment of Cancer Therapy (FACT-G: Cella, 1997) is a 
cancer-specific measure of quality of life which was used within the Rost et al. (2012) 
study. An average effect size was calculated for studies where more than one quality of 
life measure was used. 
 
Chronic pain 
In total, eight studies, using a variety of delivery formats, examined ACT for chronic 
pain. Three studies used a group based format for delivering the ACT intervention 
although one (VanBuskirk, Roesch, Afari & Wetherell, 2014) was an ancillary of 
another (Wetherell et al., 2011). As the ancillary study reports no new data relating to 
quality of life, no further description is provided here. In the parent study, Wetherell et 
al. (2011) compared ACT with CBT in a randomised sample of 114 individuals with 
chronic pain. Both the ACT and CBT protocols consisted of eight 90-minute weekly 
group sessions. There were no significant improvements in mental or physical health-
related quality of life as measured by the SF-12, in either the ACT or CBT groups, at 
post treatment or six-month follow-up. Furthermore, there were no significant 
differences between the two conditions. When ACT was compared with a baseline TAU 
period, again, no significant differences were found. The methodological quality of the 
study was high, particularly in relation to the inclusiveness and size of the sample. 
 
In a cluster-RCT design, Alonso, Lopez, Losada and Gonzalez (2013) randomised two 
residential care homes to receive group ACT or wait-list control. Individual 
randomisation was not deemed necessary due to the similarity of the homes. 
Participants were 10 elderly residents with chronic pain. The ACT group received 10 
two-hour group sessions over five weeks. Scores on the SWLS did not significantly 
improve from pre- to post-treatment for individuals in the ACT condition and no follow- 
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Table 3  
 
Summary of outcomes of included studies 
 
Note: Positive values of effect-size d are in direction favouring ACT over comparator; where a single study used multiple 
measures of QOL, an average effect-size was computed. EQ-5D VAS = EQ-5D visual analogue scale; FACT-G = 
Functional Assessment of Cancer Therapy; LSQ = Life Satisfaction Questionnaire; QOL = quality of life; QOLI = Quality 
of Life Inventory; SF-12 = Medical Outcomes Study 12-Item Short Form Health Survey; SF-36 = Medical Outcomes 
Study 36-Item Short Form Health Survey; SWLS = Satisfaction with Life Scale; WHOQOL-BREF = World Health 
Organization Quality of Life. 
 
up assessment took place. No significant differences were reported between ACT and 
wait-list however post-test comparison favoured ACT, with a small to moderate effect  
Author Target QOL outcome 
measure 
 
Time of follow-
up 
Summary of QOL findings 
 
Alonso et al. 
2013  
Chronic pain SWLS No follow-up No statistical difference between ACT and 
wait-list, but small effect favouring ACT (d 
= 0.43) 
 
Buhrman et 
al. 2013 
Chronic pain QOLI No follow-up No statistical difference between ACT and 
online forum (d = 0.03) 
 
Dahl et al. 
2004 
Chronic pain LSQ 6 months No statistical difference between ACT and 
treatment as usual (d = 0.26) 
 
Hesser et 
al. 2012 
Tinnitus QOLI 
 
12 months 
(no follow-up 
data for control) 
No statistical difference between ACT and 
CBT (d = -0.03) 
Small (non-significant effect favouring ACT 
vs. online forum (d = 0.35) 
 
Johnston et 
al. 2010 
Chronic pain QOLI 
SWLS 
No follow-up ACT superior to wait-list 
(average d = 0.91) 
 
Luciano et 
al. 2014 
Fibromyalgia EQ-5D VAS 6 months ACT superior to pharmacological 
treatment (d = 0.85) – maintained at 
follow-up 
 
Lundgren et 
al. 2006 
Drug-refractory 
epilepsy 
WHOQOL-
BREF 
SWLS 
12 months ACT superior to supportive therapy 
(average d = 1.05) – maintained at follow-
up 
 
Lundgren et 
al. 2008 
Drug-refractory 
epilepsy 
WHOQOL-
BREF 
SWLS 
12 months ACT superior to yoga (average d = 0.36) – 
maintained at follow-up 
 
Rost et al. 
2012 
Ovarian cancer FACT-G No follow-up ACT superior to CBT (d = 1.35) 
Thorsell et 
al. 2011 
Chronic pain  SWLS 12 months ACT superior to applied relaxation (d = 
3.01) – maintained at follow-up 
 
VanBuskirk 
et al. 2014 
 
Chronic pain SF-12 6 months Ancillary study – see Wetherell et al. 2011 
Westin et al. 
2011 
Tinnitus QOLI 18 months (no 
follow-up for 
control) 
No statistical difference between ACT and 
tinnitus retraining therapy (d = 0.08) or 
wait-list (d = 0.12) 
 
Wetherell et 
al. 2011 
Chronic pain SF-12 6 months No statistical difference between ACT and 
CBT (d = -0.06) 
 
Wicksell et 
al. 2008 
Chronic pain 
and whiplash 
SWLS 6 months (no 
follow-up for 
control) 
 
ACT superior to wait-list (d = 1.12) – 
maintained at follow-up 
Wicksell et 
al. 2012 
Fibromyalgia SF-36 3-4 months ACT superior to wait-list for mental health-
related QOL (d = 0.84) but not physical 
health-related QOL (d = 0.19) 
 
 17 
size (d=0.43). The main limitation of this study is its extremely small sample size. As 
there was only one ACT group administered by one therapist, the effect of therapist on 
outcome is likely to be a confounding factor. 
 
Two studies delivered ACT in an individual psychotherapy format. Dahl et al. (2004) 
randomly allocated 19 public health sector workers with chronic pain to two conditions. 
In the ACT condition, participants underwent four 1-hour weekly sessions of individual 
psychotherapy alongside medical TAU while the control group only received medical 
TAU. At post-intervention and six-month follow-up there were no significant 
improvements in LSQ scores in either condition and no significant differences between 
groups. However, the generalisability of the results is questionable given the small 
sample size and that participants were drawn from a highly specific working 
environment. In addition to this, no attempts were made to assess therapist adherence 
or competence. This is particularly problematic as one of the two therapists was a 
nurse without formal psychotherapy training. 
 
In another study of ACT in an individual psychotherapy format, Wicksell, Ahlqvist, 
Bring, Melin and Olsson (2008) found significant differences in rates of improvement on 
the SWLS between individuals receiving ACT and wait-list controls. A longer treatment 
protocol was used consisting of 10 one-hour sessions administered over eight weeks. 
Participants were 22 patients with chronic pain or whiplash associated disorders. In 
comparing the groups, the authors report a large effect size in favour of ACT (d=1.12). 
Although only two therapists were involved in administering the intervention, analysis 
indicated that there was no difference in outcome between therapists. Again, the small 
sample size makes it difficult to draw strong conclusions about the effectiveness of 
ACT with this population. 
 
Three studies evaluated ACT self-help interventions for chronic pain. In a sample of 76 
individuals with chronic pain, Buhrman et al. (2013) compared an internet-delivered 
ACT intervention against a moderated online forum. Participants in the ACT group 
completed one of seven modules each week and were required to complete 
assignments in order to move onto the next module. They also received two phone 
calls at set points in the treatment to support and encourage participation. The results 
showed no significant effects of ACT on quality of life from pre- to post-intervention. 
One major limitation of the study is that no follow-up data was gathered for the control 
group meaning that that no longer-term comparison can be made between the groups.  
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Johnston, Foster, Shennan, Starkey and Johnson (2010) randomised 24 participants 
with chronic pain to either a wait-list control group or an ACT group who received a 
self-help workbook. The workbook was completed over six weeks with 30 minutes of 
weekly telephone support. Post-intervention, the ACT group showed significantly 
improved QOLI scores compared with wait-list controls. The average effect size 
between the QOLI and SWLS was large (d=0.91). Follow-up data were not collected 
therefore the long-term effects of ACT cannot be established. The methodological 
quality of this study is questionable particularly in relation to the randomisation 
procedure. The first participant was randomised by the primary researcher, after which 
participants were allocated alternately to each group in the order that they were 
contacted. This enhances the possibility of allocation bias. 
 
In a later study, Thorsell et al. (2011) used a Swedish translation of the self-help 
materials used by Johnston et al. (2010). They randomised 90 participants to receive 
ACT self-help or applied relaxation, also provided in a self-help format. Along with 
weekly telephone support, participants received a 90-minute face-to-face session, at 
the beginning and end of the intervention. The applied relaxation protocol matched the 
ACT group in terms of therapist time. In the ACT group, SWLS scores were found to 
significantly improve relative to scores in the applied relaxation group – with a large 
effect-size (d=3.01) which was maintained at 12-month follow-up (d=2.3). 
 
The main strengths of this study are its large sample size and longer follow-up period. 
However, as with the previous trial by Johnston et al., there was a high rate of attrition 
(37% in the ACT condition) which the authors attribute to the amount of reading 
required. This meant that the statistical power and precision of effect estimation were 
weakened. 
 
Fibromyalgia 
Two studies examined ACT for fibromyalgia. Luciano et al. (2014) randomised 156 
patients with fibromyalgia to one of three conditions: group delivered ACT, 
pharmacological treatment, or wait-list. Those in the ACT condition received eight 2.5-
hour group sessions with group size varying from 10 to 15 participants. 
Pharmacological treatment included an anti-convulsant, analgesics, benzodiazepines, 
hypnotics, and where indicated, an anti-depressant. ACT was found to be superior to 
pharmacological treatment at improving quality of life post-intervention and this was 
maintained at 6-month follow-up with a large effect size (d=0.85). However, it could be 
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argued that a better test for the superiority of ACT would have been a comparison to 
another efficacy-established psychotherapeutic treatment such as CBT, as this would 
be more equivalent to the ACT protocol in terms of therapy time and context of 
intervention. 
 
Wicksell et al. (2013) randomised 40 individuals with fibromyalgia to an ACT condition 
or a wait-list condition. The ACT condition comprised 12 90-minute group sessions, 
with six participants in each group. A selection of recorded sessions was systematically 
evaluated for treatment adherence and competence. A significant effect in favour of 
ACT was reported in mental health-related quality of life with a large effect size 
(d=0.84) that was maintained at 6 months (d =1.06). No such difference was found in 
physical-health related quality of life.  
 
The generalisability of findings from both of these studies is limited due to the lack of 
male participants, with males excluded by Wicksell et al. (2012) and only six included 
by Luciano et al. (2014). 
 
Drug-refractory epilepsy 
Two studies examined ACT for drug-refractory epilepsy with both adopting an ACT 
protocol combining individual and group therapy sessions. In the Lundgren, Dahl, Yardi 
and Melin (2008) study, the ACT protocol comprised two 1.5-hour individual sessions 
and two 3-hour group sessions administered over five weeks. Two 1.5-hour booster 
sessions after six and 12 months were also provided. Eighteen participants with 
epilepsy were randomised to receive either ACT or yoga. The yoga protocol was 
designed to match the ACT protocol in terms of session duration and the number of 
individual and group sessions. At 12-month follow-up, the quality of life of individuals in 
the ACT condition had improved significantly from baseline according to the WHOQOL-
BREF (d = 0.81) but not according to the SWLS. The average effect size across both 
measures was small to medium (d=0.36), favouring ACT. This effect was maintained at 
12-month follow-up. 
 
Similarly, Lundgren, Dahl, Melin and Kies (2006) compared the above ACT protocol 
(n=14) with supportive therapy (n=13). Again, the comparison group treatment protocol 
was identical to the ACT protocol in session number, format (group and individual), and 
duration, providing a strong test for ACT. The supportive therapy treatment provided 
participants with a space to reflect on their experiences of having epilepsy. At post-
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intervention and at 12-month follow-up, there were significant between group 
differences favouring ACT, on both the WHOQOL-BREF and SWLS, with large effect 
sizes (average d=1.05).  
 
Tinnitus 
Two studies examined ACT as a treatment for tinnitus although the format of treatment 
differed between the two trials. Hesser et al. (2012) randomised 99 patients with 
tinnitus to one of three groups. Two groups received an internet-delivered guided self-
help intervention, one based on ACT and the other on CBT. The third group acted as a 
control with participants encouraged to use an online discussion forum. Both self-help 
interventions involved text and picture based material and each participant was 
allocated a therapist to provide online support via a message board. When ACT was 
compared to the CBT or control conditions there were no significant differences in 
quality of life according to the QOLI.  
 
In an earlier trial, Westin et al. (2011) randomised 64 normal hearing participants with 
tinnitus into one of three conditions. One condition received 10 one-hour individual 
sessions of ACT. Sessions were weekly and lasted 60 minutes. A second condition 
received tinnitus retraining therapy where participants were allocated a wearable sound 
generator which they were asked to use for a minimum of eight hours daily for 18 
months. They also received an initial 150-minute training session with a 30-minute 
follow-up. A wait-list control comprised the third condition with participants waiting to 
receive CBT in individual, self-help, or group format. The authors report no significant 
changes in QOLI scores in either active treatment at post-intervention or follow-up. No 
follow-up data were collected for the wait-list condition meaning that comparisons with 
the active treatment conditions at follow-up could not be conducted. Another limitation 
of this study is that adherence and therapist competence was not assessed for the 
tinnitus retraining intervention so the quality of this, as a comparison for ACT, cannot 
be established. 
 
Ovarian cancer 
One study examined ACT for ovarian cancer. Rost et al. (2009) randomised 47 women 
diagnosed with Stage III or IV ovarian cancer to a TAU control group or an ACT group. 
Both conditions received twelve individual face-to-face meetings with a therapist. The 
TAU intervention was based upon a protocol comprising common CBT techniques. The 
analyses indicated that while there was a statistically significant improvement from 
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baseline in quality of life for individuals in the ACT condition, no such improvement was 
found for the TAU condition. When compared, ACT was statistically superior to CBT 
(TAU) at improving quality of life, according to FACT-G scores, with a large effect size 
(d=1.35). Although this study provides initial support for individually delivered ACT for 
improving quality of life in ovarian cancer patients, there is some question over the 
generalisability of the results. Both treatment conditions were administered by the 
same therapist and no attempt was made to assess adherence to the protocols or the 
competence of delivery.   
 
Discussion 
In total, 15 studies (including one ancillary study) met inclusion criteria for the present 
review. The studies covered a range of long-term physical health conditions and 
adopted a variety of formats for delivering ACT. Of the 14 original studies, 8 found ACT 
to be superior to control on at least one quality of life measure. It is worth noting that for 
the majority of studies, ACT was superior in terms of improvements in primary outcome 
measures, however, a full summary and discussion of these results is beyond the 
scope of this review.  
 
Given that just over half of the studies included in the review found that ACT benefitted 
quality of life while the remaining trials did not, it is difficult to draw strong overall 
conclusions about the effectiveness of ACT across physical health conditions. 
However, some tentative conclusions can be drawn. Both epilepsy studies found ACT 
to be superior to the comparison group. Given the efforts made to ensure that the 
comparison groups (yoga and supportive therapy) matched ACT in therapy time and 
delivery format, this provides strong preliminary evidence for a combined ACT protocol 
to improve quality of life for people with epilepsy. Future trials with larger samples are 
needed to further support this position. 
 
Conversely, neither of the tinnitus studies found ACT to be superior to control at 
improving quality of life even when compared to largely inactive control groups. 
Although tinnitus can be extremely disabling (Moller, 2000), it might be that quality of 
life is less impaired than in other long-term conditions. This was certainly true in the 
Westin et al. (2011) study where mean QOLI scores at baseline were similar to those 
of a healthy population. This leaves little room for improvement, suggesting that quality 
of life may not be a suitable outcome measure in this instance. As the ACT protocols 
differed substantially (one was internet-based and the other individual therapy), it is 
 22 
perhaps premature to conclude about the impact of ACT on quality of life in this 
population. 
 
Although the APA support ACT as an evidence-based treatment for chronic pain, four 
of the seven original chronic pain studies did not find ACT superior at improving quality 
of life. It is unclear why this may have been the case although one possibility is that the 
selection of studies was not representative, as several chronic pain studies were 
excluded on the grounds that they did not include quality of life measures. In order to 
effectively evaluate whether ACT can improve quality of life in individuals with long-
term conditions, future research must include such measures. 
 
As discussed, the format for delivering the ACT intervention varied across studies. 
However, this did not appear to be related to whether ACT was effective at improving 
quality of life. Across all formats the number of studies that found ACT to be superior 
was equal to the number of studies which found no difference between ACT and 
control. To elaborate further, two of the four ACT self-help studies, two of the four 
individual ACT studies, and two of the four group ACT studies found ACT to be 
superior to their respective comparison groups. The studies which used a combined 
protocol both found ACT to be superior. Given these findings, there is some support for 
all delivery formats although more research is needed to confirm their effectiveness. 
NHS mental health services in England adopt a stepped care model where the least 
intrusive treatment is offered first. Therefore, there is a need to develop interventions at 
all levels of intensity from self-help to individual psychotherapy. ACT outcome research 
is beginning to address this need. 
 
Methodological quality varied greatly between trials although there were some common 
methodological threats which should be addressed in future research. While some 
studies were careful to design active comparison treatments matching the ACT 
protocol in terms of therapy time, several studies adopted a wait-list control group. It is 
perhaps unsurprising that ACT was superior in three of the four trials that only used a 
wait-list control group. Effect sizes are often larger when active treatments are 
compared with inactive control groups. It is difficult therefore to determine the true 
effectiveness of ACT under these conditions. 
 
Another common problem was that many studies failed to carry out checks to ensure 
therapist adherence and competence. Furthermore, there were often few therapists 
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administering interventions without any form of analysis to examine the effect of 
therapist on outcome. These methods introduce significant sources of bias. 
 
Another major limitation in several included trials was the method of analysis of the 
outcomes. Bland and Altman (2011) have found that rather than comparing 
randomised groups directly, some researchers conduct a significance test comparing a 
baseline with a final measurement separately in each group. Through simulations, they 
demonstrate how the results from such findings can be biased, invalid and misleading. 
This was method was used in several of the included trials. Furthermore, in 2 out of 15 
trials, longer-term outcome data was not collected for the control groups. Future trials 
need to ensure that comparisons are made between the groups on pre-specified 
outcomes.  
 
The point at which the outcomes were assessed was another issue with some of the 
included trials. Only 10 out of 15 trials had any longer-term (>6-months) outcomes 
assessed. As such, we cannot determine whether any treatment effects found 
immediately post-intervention are maintained over time.  
 
Before concluding, we acknowledge some methodological limitations of our review. In 
another review in which quality was assessed by three reviewers, the authors were 
unable to gain acceptable kappa ratings on nearly half of the items in Öst’s tool 
(Smout, Hayes, Atkins, Klausen & Duguid, 2012). This suggests that the Öst evaluation 
tool may be unreliable. A further limitation is that the heterogeneity of studies (e.g., 
variability in clinical population, comparison condition and intervention characteristics) 
precluded meaningful use of formal meta-analysis; we computed effect size estimates 
for individual studies to allow for descriptive comparisons. 
 
Conclusion 
ACT aims to be a transdiagnostic model with wide application across the full spectrum 
of mental and physical health conditions. Despite this, 8 of the 15 studies included in 
this review examined the effectiveness of ACT for people with chronic pain. This 
continues to be the area of physical healthcare for which the most ACT outcome 
research exists. Therefore, there continues to be a dearth of research evaluating ACT 
for other chronic physical health conditions. Although tentative support is offered for 
ACT at improving quality of life in conditions such as epilepsy and ovarian cancer, the 
methodological quality of some studies is poor, and the findings need to be treated with 
 24 
caution. Therefore, large-scale and methodologically robust trials are needed to 
continue to explore the application of ACT for other long-term conditions. 
 
References 
Alonso, M.A., Lopez, A., Losada, A., & Gonzalez, J.L. (2013). Acceptance and 
commitment therapy and selective optimization with compensation for older 
people with chronic pain: A pilot study. Behavioral Psychology, 21(1), 59-79. 
doi:10.1111/pme.12885 
Anderson, R.T., Aaronson, N.K., & Wilkin, D. (1993). Critical review of the international 
assessments of health-related quality of life. Quality of Life Research, 2(6), 269-
395. doi:10.1007/BF00422215 
Bond, F.W., Hayes, S.C., Baer, R.A., Carpenter, K.M., Guenole, N., Orcutt, H.K., 
…Zettle, R.D. (2011). Preliminary psychometric properties of the acceptance 
and action Questionnaire–II: A revised measure of psychological inflexibility and 
experiential avoidance. Behavior Therapy, 42(4), 676-688. 
doi:10.1016/j.beth.2011.03.007 
Bland, J.M., & Altman, D.G. (2011). Comparisons against baseline within randomised 
groups are often used and can be highly misleading. Trials, 12(264), 1-7. 
doi:10.1186/1745-6215-12-264 
Bruce, B., Lorig, K., Laurent, D., & Ritter, P. (2005). The impact of a moderated e-mail 
discussion group on use of complementary and alternative therapies in subjects 
with recurrent back pain. Patient Education & Counseling, 58(3), 305-311. 
doi:10.1016/j.pec.2004.08.012 
Buhrman, M., Skoglund, A., Husell, J., Bergström, K., Gordh, T., Hursti, T., 
...Andersson, G. (2013). Guided internet-delivered acceptance and commitment 
therapy for chronic pain patients: A randomized controlled trial. Behaviour 
Research & Therapy, 51(6), 307-315. doi:10.1016/j.brat.2013.02.010 
 25 
Carlsson, M., Hamrin, E., & Lindquist, R. (1999). Psychometric assessment of the Life 
Satisfaction Questionnaire (LSQ) and a comparison of a randomised sample of 
Swedish women and those suffering from breast cancer. Quality of Life 
Research, 8(3), 245-253. doi:10.1023/A:1008875306645 
Cella, D.F. (1997). Facit manual: Manual of the functional assessment of chronic illness 
therapy measurement system. Chicago, IL: Center on Outcomes, Research & 
Education, Evanston Northwest Healthcare & Northwestern University.  
Dahl, J., Wilson, K.G., & Nilsson, A. (2004). Acceptance and commitment therapy and 
the treatment of persons at risk of long-term disability resulting from stress and 
pain symptoms: A preliminary randomized trial. Behavior Therapy, 35(4), 785-
801. doi:10.1016/S0005-7894(04)80020-0 
Department of Health (2010). Improving the health and well-being of people with long-
term conditions. World class services for people with long-term conditions: 
Information tool for commissioners. Retrieved from 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsand
statistics/Publications/PublicationsPolicyAndGuidance/DH_111122 
Department of Health (2012). Long term conditions compendium of information: Third 
edition. Retrieved from https://www.gov.uk/government/publications/long-term-
conditions-compendium-of-information-third-edition 
Department of Health (2013). The NHS outcomes framework. Retrieved from 
https://www.gov.uk/government/publications/nhs-outcomes-framework-2014-to-
2015 
Diener, E., Emmons, R.A., Larsen, R.J., & Griffin, S. (1985). The satisfaction with life 
scale. Journal of Personality & Social Psychology, 49, 71-75. 
doi:10.1037/t01069-000 
Egger, M., Juni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003). How important are 
comprehensive literature searches and the assessment of trial quality in 
 26 
systematic reviews? Empirical study. Health Technology Assessment, 7(1), 1-
76. 
EuroQol Group (1990). EuroQol - a new facility for the measurement of health-related 
quality of life. Health Policy, 16(3), 199-208. doi:10.1016/0168-8510(90)90421-9  
Frisch, M.B., Cornell, J., Villanueva, M., & Retzlaff, P.J. (1992). Clinical validation of the 
quality of life inventory: A measure of life satisfaction for use in treatment 
planning and outcome assessment. Psychological Assessment, 4(1), 92-101. 
doi:10.1037/1040-3590.4.1.92 
Harrison, T., Stuifbergen, A., Adachi, E., & Becker, H. (2004). Marriage, impairment, 
and acceptance in persons with multiple sclerosis. Western Journal of Nursing 
Research, 26(3), 266-285. doi:10.1177/0193945903260188 
Hayes, S.C., Strosahl, K., & Wilson, K.G. (1999). Acceptance and commitment therapy: 
An experiential approach to behavior change. New York, NY: Guilford Press. 
Hesser, H., Gustafsson, T., Lunden, C., Henrikson, O., Fattahi, K., Johnsson, E., 
...Andersson, G. (2012). A randomised controlled trial of internet-delivered 
cognitive behavior therapy and acceptance and commitment therapy in the 
treatment of tinnitus. Journal of Consulting & Clinical Psychology, 80(4), 649-
661. doi:10.1037/a0027021 
Johnston, M., Foster, M., Shennan, J., Starkey, N.J., & Johnson, A. (2010). The 
effectiveness of an acceptance and commitment therapy self-help intervention 
chronic pain. Clinical Journal of Pain, 26(5), 393-402. 
doi:10.1097/AJP.0b013e3181cf59ce 
Kabat-Zinn, J. (1990). Full catastrophe living: using the wisdom of your body and mind 
to face stress, pain and illness. New York, NY: Delacorte. 
Karademas, E.C., Tsaqaraki, A., & Lambrou, N. (2009). Illness acceptance, 
hospitalization stress and subjective health in a sample of chronic patients 
admitted to hospital. Journal of Health Psychology, 14(8), 1243-1250. 
doi:10.1177/1359105309345169 
 27 
Luciano, J.V., Guallar, J.A., Aquado, J., Lopez-Del-Hoyo, Y., Olivan, B., Magallon, R., 
…Garcia-Campayo, J. (2014). Effectiveness of group acceptance and 
commitment therapy for fibromyalgia: A 6-month randomized controlled trial. 
Pain, 155(4), 693-702. doi:10.1016/j.pain.2013.12.029 
Lundgren, T., Dahl, J., Melin, L., & Kies, B. (2006). Evaluation of acceptance and 
commitment therapy for drug refractory epilepsy: A randomized controlled trial 
in South Africa - A pilot study. Epilepsia, 47(12), 2173-2179. doi:10.1111/j.1528-
1167.2006.00892.x 
Lundgren, T., Dahl, J., Yardi, N., & Melin, L. (2008). Acceptance and commitment 
therapy and yoga for drug refractory epilepsy: A randomized controlled trial. 
Epilepsy & Behavior, 13(1), 102-108. doi:10.1016/j.yebeh.2008.02.009 
McCracken, L.M., & Eccleston, C. (2005). A prospective study of acceptance of pain 
and patient functioning with chronic pain. Pain, 118(1), 164-169. 
doi:10.1016/j.pain.2005.08.015 
McCracken, L.M., & Zhao-O’Brien, J. (2010). General psychological acceptance and 
chronic pain: There is more to accept than the pain itself. European Journal of 
Pain, 14(2), 170-175. doi:10.1016/j.ejpain.2009.03.004 
Moller, A.R. (2000). Similarities between severe tinnitus and chronic pain. Journal of 
the American Academy of Audiology, 11(3), 115-124. 
Öst, L.G. (2008). Efficacy of the third wave of behavioral therapies: A systematic review 
and meta-analysis. Behaviour Research & Therapy, 46(3), 296-
321. doi:10.1016/j.brat.2007.12.005 
Richardson, A., Adner, N., & Nordstrom, G. (2001). Persons with insulin-dependent 
diabetes mellitus: Acceptance and coping ability. Journal of Advanced Nursing, 
33(6), 758-763. doi:10.1046/j.1365-2648.2001.01717.x  
Rost, A.D., Wilson, K., Buchanan, E., Hildebrandt, M.J., & Mutch, D. (2012). Improving 
psychological adjustment among late-stage ovarian cancer patients: Examining 
 28 
the role of avoidance in treatment. Cognitive & Behavioral Practice, 19(4), 508-
517. doi:10.1016/j.cbpra.2012.01.003 
Smout, M.F., Hayes, L., Atkins, P.W., Klausen, J., & Duguid, J.E. (2012). The 
empirically supported status of acceptance and commitment therapy: An 
update. Clinical Psychologist, 16(3), 97-109. doi:10.1111/j.1742-
9552.2012.00051.x 
Thorsell, J., Finnes, A., Dahl, J., Lundgren, T., Gybrant, M., Gordh, T., & Buhrman, M. 
(2011). A comparative study of 2 manual-based self-help interventions, 
acceptance and commitment therapy and applied relaxation, for persons with 
chronic pain. Clinical Journal of Pain, 27(8), 716-723. 
doi:10.1097/AJP.0b013e318219a933 
VanBuskirk, K., Roesch, S., Afari, N., & Wetherell, J.L. (2014). Physical activity of 
patients with chronic pain receiving acceptance and commitment therapy and 
cognitive behavioural therapy. Behaviour Change, 31(2), 131-143. 
doi:10.1017/bec.2014.6 
Veehof, M.M., Oskam, M.J., Schreurs, K.M., & Bohlmeijer, E.T. (2011). Acceptance-
based interventions for the treatment of chronic pain: A systematic review and 
meta-analysis. Pain, 152(3), 533-542. doi:10.1016/j.pain.2010.11.002 
Ware, J.E., & Sherbourne, C.D. (1992). The MOS 36-item short-form health survey 
(SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473-
483. doi:10.1007/bf03260127  
Ware, J.E., Kosinski, M.A., & Keller, S.D. (1994). A 12-item short form health survey: 
Construction of scales and preliminary tests of reliability and validity. Medical 
Care, 34(3), 220-233. doi:10.1097/00005650-199603000-00003  
Westin, V.Z., Schulin, M., Hesser, H., Karlsson, M., Noe, R.Z., Olofsson, U., 
…Andersson, G. (2011). Acceptance and commitment therapy versus tinnitus 
retraining therapy in the treatment of tinnitus: A randomised controlled trial. 
 29 
Behaviour Research & Therapy, 49(11), 737-747. 
doi:10.1016/j.brat.2011.08.001 
Wetherell, J.L., Afari, N., Rutledge, T., Sorrell, J.T., Stoddard, J.A., Petkus, A. J., 
...Atkinson, J.H. (2011). A randomized, controlled trial of acceptance and 
commitment therapy and cognitive-behavioral therapy for chronic pain. Pain, 
152(9), 2098-2107. doi:10.1016/j.pain.2011.05.016 
WHOQOL Group (1998). Development of the World Health Organization WHOQOL-
BREF quality of life assessment. Psychological Medicine, 28(5), 551-558. 
doi:10.1017/s0033291798006667  
Wicksell, R.K., Ahlqvist, J., Bring, A., Melin, L., & Olsson, G.L. (2008). Can exposure 
and acceptance strategies improve functioning and life satisfaction in people 
with chronic pain and whiplash-associated disorders (WAD)? A randomized 
controlled trial. Cognitive Behaviour Therapy, 37(7), 169-182. 
doi:10.1080/16506070802078970 
Wicksell, R.K., Kemani, M., Jensen, K., Kosek, E., Kadetoff, D., Sorjonen, K., 
…Olsson, G.L. (2013). Acceptance and commitment therapy for fibromyalgia: A 
randomized controlled trial. European Journal of Pain, 17(4), 599-611. 
doi:10.1002/j.1532-2149.2012.00224.x 
  
 30 
 
 
 
 
 
 
 
Journal Paper 
  
 31 
 
 
Running head: Self-help for haemodialysis patients with depression 
 
 
 
Acceptance and Commitment Therapy self-
help intervention for depression in 
haemodialysis patients: A feasibility 
randomised controlled trial 
 
 
William Vogt1, Roshan das Nair2, 3, Nima Moghaddam1, 
Barnaby Proctor1 and Emma Coyne3 
 
 
1Trent Doctorate in Clinical Psychology, University of 
Lincoln 
2Trent Doctorate in Clinical Psychology and Division of 
Ageing & Rehabilitation, University of Nottingham 
3Department of Clinical Psychology & Neuropsychology, 
Nottingham University Hospitals NHS Trust 
  
 32 
Abstract 
Objective: People with end-stage renal disease (ESRD) experience high rates of 
depression and this is associated with poorer health-related outcomes. Acceptance 
and Commitment Therapy (ACT) has shown promising results in a number of long-term 
conditions and has been translated into a variety of self-help formats. We aimed to 
determine the feasibility of a trial examining telephone-supported self-help based on 
ACT for individuals with ESRD who experience depression. 
 
Design: A feasibility randomised controlled trial comparing telephone-supported ACT 
self-help with treatment as usual.  
 
Methods: Participants were recruited from four outpatient haemodialysis units across 
Nottinghamshire, UK. The Patient Health Questionnaire (PHQ-9), EuroQol (EQ-5D-5L) 
health-related quality of life measure, Acceptance and Action Questionnaire II (AAQ-II) 
and Valued Living Questionnaire (VLQ) were completed at baseline and 2- and 4-
months post-randomisation. Participants in the intervention arm were asked to 
complete an ACT self-help manual over six weeks with weekly telephone support. 
Following completion of the trial, six participants were interviewed to examine the 
acceptability of the trial procedure and intervention. Interview data was analysed using 
framework analysis.  
 
Results: In total, 99 (36.87%) of 276 screening questionnaires were returned. Of 
these, 30 (30.3%) met the cut-off for depression on the PHQ-9 with nine enrolling in the 
trial. AAQ-II scores of screened participants were positively associated with scores on 
the PHQ-9 and GAD-7, indicating a positive relationship between psychological 
inflexibility and distress. Interview data indicated that the recruitment and 
randomisation procedure, and assessment methods were acceptable. Only one in four 
of the participants in the ACT arm of the trial completed all chapters of the book with 
health problems the main barrier to completion. 
 
Conclusion: Our findings indicate that a definitive trial examining the effectiveness of a 
telephone-supported ACT self-help intervention would not be feasible. Many aspects of 
the trial were acceptable to participants, including the main recruitment strategy, 
randomisation procedure and data collection methods. However, low recruitment 
numbers and poor adherence to the self-help manual indicate that a full-scale trial 
would not be viable.  
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Impact and Implications Statement 
What is already known on this subject? 
 Depression is highly prevalent in ESRD and is related to a number of negative 
health-related outcomes. 
 ACT has been used successfully as a treatment for depression. 
 There are no trials of ACT in ESRD. 
 
What does this study add? 
 A full trial of telephone-supported self-help based on Acceptance and 
Commitment Therapy (ACT) is not feasible. 
 Self-help interventions may not be appealing to ESRD patients identified as 
experiencing depression. 
 Health problems may make it difficult for ESRD patients to commit to and 
engage with supported self-help interventions. 
 ACT processes may be related to psychological distress in ESRD. 
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Introduction 
End-Stage Renal Disease 
Chronic Kidney Disease (CKD) is a long-term condition in which the function of the 
kidneys – to filter out waste products from the blood – slowly declines (Lewis, 2013). 
When renal function becomes sufficiently low it is described as End Stage Renal 
Disease (ESRD) and renal replacement therapy is likely to be needed to prolong life. 
This includes haemodialysis, peritoneal dialysis and kidney transplantation1.  
 
ESRD is an irreversible life-threatening condition with 58,968 adult patients undergoing 
renal replacement therapy in the UK in 2014, an increase of 4 per cent since 2013 
(MacNeill, Casula, Shaw & Castledine, 2016). The annual rate of growth in the 
numbers of patients undergoing renal replacement therapy has remained moderately 
consistent over the last 10-15 years, indicating a growing demand for services. 
 
Depression 
The prevalence of depression in ESRD is high with estimates ranging from 10 to 45% 
(Kimmel, 2001). Depression is related to poorer outcomes in ESRD including increased 
morbidity (Cukor et al., 2012) and mortality (Chilcot, Davenport, Wellsted, Firth & 
Farrington, 2011), and reduced quality of life (Drayer et al., 2006). This is in addition to 
poorer adherence to haemodialysis and increased health-care utilisation (Hedayati et 
al., 2005)2.  
 
Correlations have been found between behavioural disengagement, a form of avoidant 
coping, and depression in ESRD (Ibrahim, Chiew-thong, Desa, Razali, 2013; Keskin & 
Engin, 2011). Similarly, the suppression of distressing emotions by ESRD patients, 
another form of avoidance, is related to higher levels of depression (Gillanders, Wild, 
Deighan & Gillanders, 2008). Although, more research is needed to fully understand 
the aetiology of depression in ESRD, these findings suggest that avoidant coping may 
be a factor. 
 
An alternative to avoidance is acceptance, the active embrace of private experiences 
(e.g. thoughts, feelings and sensations) without making attempts to change their form 
or frequency (Hayes, Strosahl & Wilson, 1999). As an important aspect of 
                                               
1 See Extended Introduction 1.1 for further information on renal replacement therapy 
2 See Extended Introduction 1.3 for further information on depression in ESRD 
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accommodative coping, acceptance has been found to be a key factor in adjustment to 
kidney disease (Wright & Kirby, 1999) and has also be shown to have a direct effect on 
mental health (Poppe, Crombez, Hanoulle, Vogelaers & Petrovic, 2013). In light of 
these findings, Chan (2013) argues that kidney patients should be offered interventions 
that specifically aim to increase acceptance3. 
 
The high prevalence of depression in ESRD and its relationship with various aspects of 
the course of the disease highlight the need to develop effective treatments for 
depression with this population and to make such treatments more available as part of 
the standard care provided for these patients (Zalai, Szeifert & Novak 2012). The 
National Institute for Health and Care Excellence (NICE) recommend the use of 
pharmacological interventions, as well as individual and group psychotherapy, for the 
treatment of depression in adults with chronic physical health problems (NICE, 2009a). 
However, evidence supporting the use of pharmacological interventions for depression 
in ESRD remains sparse. A recent systematic review concluded that there is 
insufficient evidence on the efficacy of anti-depressants for depression in ESRD 
(Nagler, Webster, Vanholder & Zoccali, 2012). Furthermore, some studies suggest 
that, for individuals with ESRD, dosage adjustments may be needed (Baghdady, Banik, 
Swartz & McIntyre, 2009) and that the side effects associated with anti-depressants 
may not be tolerated by ESRD patients (see Kimmel, Weihs & Peterson, 1993 for a 
review)4.  
 
Given the lack of evidence for pharmacological interventions for depression in ESRD, 
coupled with the potential complications associated with these interventions, some 
have highlighted the pressing need to evaluate non-pharmacological treatments in this 
population (Christensen & Ehlers, 2002), however a 2005 Cochrane review reported 
insufficient data to conclude about the effectiveness of psychosocial interventions for 
depression in haemodialysis (Rabindranath et al., 2005)5. 
 
Acceptance and Commitment Therapy 
Acceptance and Commitment Therapy (ACT: Hayes et al., 1999) is an acceptance and 
mindfulness based psychotherapeutic modality which is part of the third wave in 
cognitive and behavioural therapies (Hayes, 2004). ACT posits a trans-diagnostic  
                                               
3 See Extended Introduction 1.4.9 for further information on acceptance in CKD 
4 See Extended Introduction 1.2.1 for further information on psychopharmacological treatments 
5 See Extended Introduction 1.2.2 for further information on psychotherapeutic treatment 
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Figure 2  
 
Flow of participants through the trial 
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& Lillis, 2006). Psychological inflexibility is characterised by experiential avoidance, 
attempts to change unwanted private experiences even when doing so leads to 
additional suffering (Hayes, Pistorello & Levin, 2012). ACT teaches acceptance and 
mindfulness skills as a counter to experiential avoidance, encouraging clients to 
engage in value-guided action while accepting and embracing, rather than avoiding, 
unwanted private events (Hayes et al., 1999). Acceptance is not an end in itself but a 
way of fostering valued action6. 
 
No trials have examined the effectiveness of ACT in ESRD however ACT has shown 
promise in a variety of other long-term conditions (Montgomery, Kim & Franklin, 2011) 
and has been shown to be superior to placebo or treatment as usual for depression (A-
Tjak et al., 2015). These findings offer a credible rationale for preliminary research 
examining the effectiveness of ACT for ESRD patients. 
 
Self-help 
Given the prevalence of depression in ESRD and the high cost of one-to-one therapy, 
there is a strong argument for developing alternative models for delivering 
psychological interventions to this client group. Furthermore, NICE guidelines for the 
treatment of depression recommend a stepped care model in which the least intrusive, 
most effective treatment is offered first (NICE, 2009b). As such there is a need to 
develop low-intensity interventions for this population. 
 
Self-help interventions provide the opportunity to offer standardised psychotherapeutic 
interventions to large numbers of people with minimal input from the therapist (Watkins 
& Clum, 2007). Such interventions are available for a wide variety of mental health 
conditions (Kazdin & Blase, 2011) and an increasing number are evidence based 
treatments with effect sizes comparable with one-to-one therapy (Cuijpers, Donker, van 
Straten & Andersson, 2010). A number of ACT self-help manuals have been developed 
with preliminary data suggesting that they can produce psychological benefits in 
conditions such as chronic pain (Johnston, Foster, Shennan, Starkey & Johnson, 2010) 
and depression (Fledderus, Bohlmeijer, Pieterse & Schreurs, 2012)7. 
 
No trials have examined the suitability of a telephone-supported self-help intervention 
for haemodialysis patients experiencing depression. The primary aim of the present 
                                               
6 See Extended Introduction 1.4 for further information on ACT 
7 See Extended Introduction 1.5 for further information on self-help interventions 
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study was to determine the feasibility of such a trial, in terms of recruitment, 
assessment, adherence, attrition and the acceptability of the intervention materials and 
format. A secondary aim was to generate some provisional data about the potential 
efficacy of the intervention by conducting individual level analysis comparing pre- and 
post-intervention outcomes. A final aim was to examine the relationship between 
psychological flexibility and distress in haemodialysis patients to test the rationale for 
using ACT with this client group. 
 
Method 
Design 
A mixed-methods, between-within design was used. All participants continued to 
receive medical treatment as usual from the renal service and were randomly assigned 
to the control condition (treatment as usual) or the intervention condition (ACT self-help 
manual with weekly telephone support + treatment as usual).  
 
Participants 
Participants were recruited from four outpatient haemodialysis units across 
Nottinghamshire, UK8. Of these, two are located at a large metropolitan hospital with 
the other two serving as satellite units in smaller urban areas. All potential participants 
had a diagnosis of ESRD and were receiving haemodialysis treatment at one of the 
recruitment sites.  
 
For inclusion in the trial, participants needed to be aged 18 years or above, receiving 
haemodialysis for at least 6-months, have adequate English reading ability, and meet 
the cut-off for depression on the Patient Health Questionnaire (PHQ-9; Kroenke, 
Spitzer & Williams, 2001). A cut-off of ≥10 was applied as this has been identified as a 
validated cut-off for depression in dialysis patients (Watnick, Wang, Demadura, & 
Ganzini, 2005). Reading ability was deemed adequate if participants were able to 
complete the screening measures independently. This was checked prior to gaining 
consent. 
 
Individuals were excluded from the trial if they were receiving concurrent psychological 
treatment at the time of recruitment or in the previous 6-months. Participants were 
advised to inform the research team if they started psychological treatment during the 
                                               
8 See Extended Methods 2.1 for further information on recruitment 
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trial. Those with visual or hearing impairments that were not otherwise corrected for 
(e.g. with eyeglasses or hearing aid), and that would make engagement with the 
intervention difficult, were also excluded. 
 
Procedure 
To examine the feasibility of recruitment methods, two recruitment strategies were 
utilised. In the first strategy, a designated member of staff was identified to approach 
participants at one of the satellite units. The chief investigator (WV) was on hand to 
speak to patients who expressed an interest or wanted more information. In the second 
strategy, dialysis unit staff distributed screening measures to haemodialysis patients at 
all four units when they attended for routine dialysis treatment. Staff were advised to 
distribute to all patients unless there were significant cognitive or language barriers. 
Returned measures were scored by WV. Those eligible were approached by WV at the 
unit and provided with a participant information sheet and a brief verbal account of the 
research. Patients were given at least 24 hours to review the information. Those 
interested were then interviewed to check eligibility criteria and complete consent 
forms. 
 
Once consented, participants completed baseline measures and were randomised (1:1 
allocation ratio) using a computer-generated random number sequence9. Participants 
were notified of their allocation in person or by telephone. Individuals allocated to the 
intervention condition were given a copy of the self-help manual along with guidance 
on which chapters to read each week. A time was also arranged for the first support 
call to take place. Subsequent calls were arranged on a week-by-week basis with all 
calls audio-recorded. 
 
Participants were asked to repeat the measures two- and four-months post-
randomisation. Measures were provided by staff on the unit or by post depending on 
preference. Six participants were interviewed by telephone, at the end of the trial, to 
examine aspects of feasibility. Interviews were conducted by a trainee clinical 
psychologist (BP) who was familiar with the design and intervention materials used, but 
not otherwise involved in the trial. 
 
 
 
                                               
9 See Extended Methods 2.4 for further information on the randomisation process 
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Table 4  
 
Screening and outcome measures 
 
Measure 
 
Screening Baseline 2-month follow-
up 
4-month follow-
up 
 
PHQ-9 ✓ ✓ ✓ ✓ 
GAD-7 ✓    
ET and problem list ✓    
AAQ-II ✓ ✓ ✓ ✓ 
EQ-5L-5D  ✓ ✓ ✓ 
VLQ 
 
 ✓ ✓ ✓ 
PHQ-9: Patient Health Questionnaire; GAD-7: Generalised Anxiety Disorder; ET: Emotion Thermometer; AAQ-II: 
Acceptance and Action Questionnaire; EQ-5D-5L: EuroQol health-related quality of life measure; VLQ: Valued Living 
Questionnaire  
 
 
Intervention 
Participants in the intervention condition received a copy of the self-help manual Get 
out of your mind and into your life: the new Acceptance and Commitment Therapy 
(Hayes & Smith, 2005). Permission to use the book was provided by the author. 
Individuals were provided with guidance on which chapters to complete each week 
over a period of six-weeks. A weekly telephone call from WV, lasting up to 30 minutes, 
offered support to participants to understand the materials and encourage adherence10. 
 
Measures 
Table 4 shows which measures were used as part of the screening procedure and 
which were used as outcome measures11. A description of each measure is provided 
below. 
  
Depression and anxiety 
The PHQ-9 is a nine item scale with each item representing one of the nine depression 
diagnostic criteria of the Diagnostic and Statistical Manual-IV (DSM-IV; American 
Psychiatric Association, 1994). We used it as a screening and outcome measure. 
Using a cut-off of ≥10, the PHQ-9 has 88% sensitivity and specificity with good internal 
consistency (Cronbach’s α =.86-.89; Spitzer et al., 2001). Respondents rate on a four 
point Likert scale (0 is not at all to 3 is nearly every day) how often they were bothered 
by the problems listed in the previous two weeks. A severity score is calculated by 
                                               
10 See Extended Methods 2.5 for further information on the self-help manual 
11 See Extended Methods 2.3 for further information on the measures used 
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summing the scores for all items with higher scores representing more severe 
depression. Reductions in depressive symptoms are not the target of ACT, which aims 
to allow patients to accept distressing private events. However, it is possible that 
symptoms may reduce as a secondary effect of increased valued action. 
 
The Generalised Anxiety Disorder 7-item (GAD-7; Spitzer, Kroenke, Williams & Löwe, 
2006) scale assesses symptoms of generalised anxiety. We used the GAD-7 to 
examine the relationship between psychological flexibility and distress, and to examine 
rates of distress across the units. Both the PHQ-9 and GAD-7 have been used in renal 
populations (e.g. Watnick et al., 2005; Trigka, Douzdampanis, Aggelakou-Vaitsi, Vaitsis 
& Fourtounas, 2013). The GAD-7 has excellent internal consistency (Cronbach’s α 
=.92) and good test-retest reliability (intraclass correlation =.83; Spitzer et al., 2006). 
 
The Emotion Thermometer (ET; Mitchell, Baker-Glenn, Granger & Symonds, 2010) 
comprises eight visual analogue scales in the form of four emotion domains (distress, 
anxiety, depression and anger) and four impact domains (pain, burden, need help and 
overall health). Each domain is indicated using a 10 point Likert scale in a colour coded 
visual thermometer format. A problem list is also provided with respondents asked to 
tick which of the problems they have been effected by over the previous two weeks. 
We administered the ET to examine which distress measure is most acceptable for this 
population. The ET has excellent internal consistency (Cronbach’s α =.91; Mitchell & 
Symonds, 2010). 
 
Acceptance 
The Acceptance and Action Questionnaire II (AAQ-II: Bond et al., 2011) is a seven item 
measure of psychological inflexibility (or experiential avoidance). It was used to provide 
provisional analysis of the underlying processes of the ACT model and to determine 
whether the intervention cultivates acceptance. The AAQ-II has good internal reliability 
(Cronbach's α =.84). 
 
Health-related quality of life 
The EQ-5D-5L (EuroQol Group, 1990) is a five-dimension measure of health-related 
quality of life with good psychometric properties (Janssen et al., 2012). It was included 
to assess the feasibility of collecting cost-effectiveness outcome measures in a 
definitive trial. Test-retest reliability for the EQ-5D-5L is acceptable (intraclass 
correlation =.69; Janssen, Birnie, Haagsma & Bonsel, 2008). 
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Valued living 
The Valued Living Questionnaire (VLQ: Wilson, Sandoz, Kitchens & Roberts, 2010) is 
a 20-item scale consisting of two parts. In Part 1, participants rate the importance of ten 
life domains using a 10-point Likert scale (1 is not at all important and 10 is extremely 
important). In Part 2, participants rate, using the same scale, how consistently they 
have lived within the valued behavioural pattern of each domain over the previous 
week. A composite score taking into consideration the importance placed on each 
domain and the extent to which an individual is living consistently within that domain is 
calculated. The VLQ has good internal consistency (Cronbach’s α =.7) and test-retest 
reliability (intraclass correlation =.75). 
 
Socio-demographic characteristics 
Socio-demographic characteristics were gathered from patient medical records. 
Residence postcodes were converted into an index of multiple deprivation rank (IMDR), 
based on a UK government qualitative study examining patterns of social and 
economic deprivation across England (Department of Communities and Local 
Government, 2015). It delineates seven domains of deprivation: income, employment, 
education, skills and training, health deprivation and disability, crime, barriers to 
housing and services, and living environment. The study divides England into 32,844 
neighbourhood areas and ranks them in order of deprivation with a score of 1 being the 
most deprived. Clinical information was collected from participants’ medical records. 
 
Data analysis  
Descriptive statistics were used to provide an overview of screened and enrolled 
patients. To examine the feasibility of recruitment, between group analyses explored 
differences between those who completed the screening questionnaire and those who 
did not. Differences in age and IMDR were examined using Mann-Whitney U analyses 
as parametric assumptions were violated. A mixture of parametric and non-parametric 
tests were used to examine differences between participants allocated to the ACT and 
control conditions of the trial (see Table 6). 
 
To examine the overall feasibility of the trial, interview data were transcribed verbatim 
and analysed using framework analysis (Ritchie & Spencer, 1994). Pre-defined codes 
relating to different aspects of the research question were applied to each transcript 
and these were combined to generate a framework (Gale, Heath, Cameron, Rashid &  
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Table 5  
 
Baseline characteristics of screened patients 
 
Characteristic Completers Non-completers 
 
Participants, n 99 177 
Age, mean (SD) 69.7 (16.1) 66.5 (14.2) 
Female % 49.5 45.8 
Index of Multiple Deprivation, median 10,431 9,283 
PHQ-9, mean (SD) 7.5 (6.9) -- 
GAD-7, mean (SD) 5.1 (6.0) -- 
AAQ-II, mean (SD) 16.0 (11.0) -- 
ET distress, mean (SD) 2.7 (3.1) -- 
ET anxiety, mean (SD) 2.5 (3.1) -- 
ET depression, mean (SD) 2.7 (3.2) -- 
ET anger, mean (SD) 2.5 (3.3) -- 
ET pain, mean (SD) 4.0 (3.4) -- 
ET burden, mean (SD) 4.0 (3.6) -- 
ET need help, mean (SD) 3.0 (3.3) -- 
ET overall health, mean (SD) 4.8 (3.0) -- 
 
PHQ-9: Patient Health Questionnaire; GAD-7: Generalised Anxiety Disorder; AAQ-II: Acceptance and Action 
Questionnaire; ET: Emotion Thermometer 
 
 
Redwood, 2013). Pre-defined codes were recruitment, randomisation, measures, 
support calls, self-help manual and treatment as usual. A deductive, manifest level 
approach was taken when interpreting the data. To examine the credibility of the 
intervention, Pearson’s product- moment correlations were used to determine the 
relationship between psychological flexibility (AAQ-II) and distress (PHQ-9 and GAD-
7). The Leeds Reliable Change Indicator software (Agostinis, Morley & Dowzer, 2008) 
was used to examine individual level change over time12. 
 
Results 
To provide a cohesive account of the findings, where applicable, quantitative and 
qualitative data have been collated under the sub-headings below. 
 
Sample 
In total, 99 (36.9%) of 276 screening questionnaires were returned13. Table 5 shows 
the demographic characteristics of screening questionnaire completers and non-
completers. Of those who completed the questionnaire, 30 (30.3%) met the cut-off for 
depression, 17 of whom declined to participate. Six people were excluded: four were  
                                               
12 See Extended Methods 2.7 for further information on the individual level analysis 
13 See Extended Results 3.1 for further information on the screening  
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Table 6 
 
Baseline characteristics of enrolled participants 
 
 ACT Control p value 
 
Participants, n 4 5 -- 
Attrition, n 1 0 -- 
Age, mean (SD) 65.3 (16.0) 49.2 (19.8) 0.23a 
Female % 75 60 0.6b 
Years dialysing, mean (SD) 9.5 (13.7) 7.6 (5.7) 0.56c 
PHQ-9, mean (SD) 13.8 (2.2) 16.6 (2.5) 0.12a 
EQ-5D index value, mean (SD) 0.4 (19.1) 0.4 (0.3) 0.42a 
EQ-VAS 41.25 (19.3) 44 (8.9) 0.9c 
AAQ-II, mean (SD) 25.5 (11.6) 28.2 (13.9) 0.7a 
VLQ, mean (SD 47.3 (11.2) 51.2 (13.9) 0.66a 
 
PHQ-9: Patient Health Questionnaire; EQ-5D index value: EuroQol health-related quality of life measure; EQ-VAS: 
EuroQol visual analogue scale; AAQ-II: Acceptance and Action Questionnaire 
a = Independent t-test; b = Fisher’s exact test; c = Mann-Whitney U 
 
 
receiving concurrent psychological treatment and two had significant hearing 
impairment that would prevent engagement in the telephone support aspect of the 
intervention. This left seven participants who consented to the trial. Two further 
participants enrolled through the first recruitment strategy described above, giving a 
total number of nine participants. 
 
Analysis showed a statistically significant difference in age between screening 
completers (Mdn = 74) and non-completers (Mdn = 69), U = 7417.5, z = -2.11, p = .04. 
No differences were found IMDR between screening questionnaire completers (Mdn = 
10,431) and non-completers (Mdn = 9283), U = 8,391, z = -.58, p = .5614.  
 
Feasibility  
In all, six participants were interviewed about their experiences of the trial, four from the 
control arm and two from the ACT arm. While all participants were asked the same 
questions, not all of them made comments relating to the pre-defined codes. 
 
Recruitment 
Of 276 screening questionnaires distributed, 99 (36.9%) were returned. All participants 
interviewed thought that the recruitment procedure was appropriate, with five stating 
that it was not too intrusive to be approached on the dialysis unit and the sixth making 
                                               
14 See Extended Results 3.3 for further information on assumption testing 
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no comment about this. All participants interviewed indicated that the information 
provided was clear. To ensure that the psychological needs of patients were 
addressed, those who met the cut-off for depression but declined to participate in the 
trial were subsequently asked whether they would like any other form of psychological 
support. Patients were told that the questionnaire indicated that they may be struggling 
with low mood and they were asked if they would like to speak to someone about this. 
All 17 patients who declined to participate also declined other psychological support.  
 
Randomisation 
Four participants indicated that they thought the randomisation procedure was a fair 
way to allocate participants although one of these participants also thought that it might 
deprive individuals of the care that they need. One participant stated that they did not 
think the allocation procedure was fair as they also felt that some people might not get 
the necessary help. Another participant made no comment about the randomisation 
procedure. 
 
Acceptability of measures 
Table 7 shows the percentage of items not completed for each screening measure. 
The highest percentage of missing data points were on the ET, while all participants 
completed all items on the PHQ-9 and GAD-7. The ET was placed at the end of the 
questionnaire and participants may have lost motivation before completing the full 
battery. Alternatively, participants may have found the ET confusing or difficult to 
complete. Five of the participants interviewed were happy with the time taken to 
complete the measures with the other participant not commenting on this aspect of the 
procedure. Four participants stated that the questionnaire items were appropriate while 
one thought that it was unclear why some of the questions were being asked, in 
particular items on the VLQ. Another participant was confused by the scales used on 
some of the measures and specifically made reference to the pain scale on the ET. 
Interestingly, there was no missing data for participants enrolled in the actual trial. 
 
Attrition 
Only one participant (11%), an individual allocated to the ACT condition, dropped out of 
the trial. This participant withdrew due to ill health before starting the self-help manual. 
The remaining participants remained in the trial although one passed away before 
follow-up measures were completed. 
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Table 7  
 
Percentage of missing data points per measure at screening 
 
Measure Missing data points  
 
PHQ-9, % 0 
GAD-7, % 0 
AAQ-II, % 0.4 
ET, % 9.3 
Problem list, % 
 
3.5 
PHQ-9: Patient Health Questionnaire; GAD-7: Generalised Anxiety Disorder; AAQ-II: Acceptance and Action 
Questionnaire; ET: Emotion Thermometer 
 
 
Support calls 
One participant interviewed from the ACT arm described the calls as being 
appropriately scheduled in terms of timing, frequency and duration. The other 
participant felt that the calls were helpful to provide clarity and understanding on the 
content of the book. Both participants thought that the support call aspect of the 
intervention could be off-putting for dialysis patients because of the time taken, the 
difficulties hearing calls while on the dialysis unit or because some patients might not 
feel comfortable talking on the phone. All but three support calls (8%) took place at the 
agreed time. 
 
Acceptability of self-help manual 
Only one of the four participants in the ACT condition completed all sections of the self-
help manual. Health problems were a barrier to completion for all other participants 
who received the manual. One participant read five pages of the introductory chapter 
before having a series of health problems. They did not want to withdraw but found it 
difficult to continue with the manual. Another participant completed four chapters during 
the first week but was unable to continue thereafter, when the participant was admitted 
to hospital for a routine surgical procedure, not planned at the time of recruitment, and 
two separate family bereavements. As described above, a fourth participant withdrew 
due to health complaints, prior to starting the manual. 
 
Only two participants in the intervention arm were interviewed and thus there is only a 
small amount of data pertaining to the helpfulness and acceptability of the self-help 
manual. In terms of the content of the book, one participant thought that the language 
and examples used were more relevant to an American population. They also felt that  
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Table 8  
 
Individual level analysis comparing pre- and post-intervention outcomes 
 
Participant ID 
 
Time PHQ-9 AAQ-II EQ-5D-5L 
Treatment as usual 
2 Pre 18 35 -0.1 
 Post  15 40 0.22MID↑ 
 Follow-up 15 38 0.22M 
4 Pre 18 24 0.4 
 Post 22 42R↓C↓ -0.13MID↓ 
 Follow-up 21 39M -0.13M 
6 Pre 13 7 0.68 
 Post 16 7 0.57MID↓ 
 Follow-up LTF LTF LTF 
7 Pre 19 44 0.66 
 Post 17 40 0.66 
 Follow-up 17 41 0.68 
8 Pre 15 31 0.53 
 Post 6 C↑ 18 R↑ 0.53 
 Follow-up 7 M 24 0.54 
Supported self-help 
3 Pre 13 38 0.29 
 Post 6C↑ 24R↑ C↑ 0.68 R↑MID↑ 
 Follow-up 7M 28M 0.59 
5 Pre 13 27 0.57 
 Post 19 35C↓ 0.23R↓MID↓ 
 Follow-up 17 28 0.3M 
9 Pre 12 11 0.38 
 Post 10 10 0.23MID↓ 
 Follow-up 13 15 0.17M 
R denotes Reliable Change at p<.05; C denotes Clinically Significant Change (from clinical to non-clinical range); MID 
denotes a minimally important (clinical) difference; ↑ indicates an improvement and ↓ indicates a deterioration; M 
denotes changes maintained at 4-month follow-up; LTF denotes lost to follow-up 
 
 
some of the language used was too difficult and this made them feel inadequate. The 
participant who completed all chapters of the book, reported that he had found the 
book helpful and was only dissatisfied with one part, a values clarification exercise in 
which readers are asked to think about their funeral. He found it uncomfortable thinking 
about his death. He also felt that it would have been better if he had had longer to read 
the book as he found it hard to read it all in the allotted 6-weeks. 
  
Process-outcome relationship 
Pearson correlation showed a strong positive relationship between psychological 
inflexibility and depression, r (95) = .83, p < .001. A second Pearson’s correlation 
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showed a similarly strong positive relationship between psychological inflexibility and 
general anxiety, r (96) = .86, p < .001.  
 
Individual level analysis 
Table 8 provides a summary of individual level analyses comparing pre- and post-
intervention outcomes and denotes incidences of clinically significant and reliable 
change. Incidents of minimally important differences are also provided for the EQ-5D-
5L as no clinical cut-offs are available. Two participants, one from each condition, 
exhibited clinically significant changes in PHQ-9 scores, which were maintained at 
follow-up. One participant from the ACT condition showed reliable improvement, while 
two in the control condition showed reliable deterioration, on the AAQ-II. Two 
individuals from each condition experienced minimally important deteriorations in EQ-
5D-5L scores and one in the control group experienced a minimally important 
improvement. This is perhaps indicative of the high symptom burden and dynamic 
health state experienced by haemodialysis patients. It is also consistent with the finding 
that health problems may occur frequently for this client group and may be a significant 
barrier to engagement in self-help materials. 
 
Discussion 
Main findings 
Our findings indicate that a definitive trial examining the effectiveness of a telephone-
supported ACT self-help intervention would not be feasible. Many aspects of the trial 
were acceptable to participants, including the main recruitment strategy, randomisation 
procedure and data collection methods. However, low recruitment numbers and poor 
adherence to the self-help manual indicate that a full-scale trial would not be viable.  
 
Recruitment15 
Our screening indicated a 30.3% prevalence of depression amongst those who 
returned the questionnaire, a rate that falls within the range of prevalence estimates 
previously identified in the literature (Chilcot, Wellsted & Farrington, 2010) and 
consistent with other studies that have used a PHQ-9 cut-off of 10 (e.g. Weisbord et al., 
2013). Seventeen of those who met the cut-off did not want to participate in the trial 
and declined the offer of individual psychological support outside of the trial. A further 
four people were already receiving psychological treatment.  
                                               
15 See Extended Discussion 4.1 for further information on recruitment 
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A combination of factors may have contributed to our low recruitment numbers 
primarily relating to cohort characteristics. The mean age of screened patients was 
69.7, consistent with the national average for haemodialysis patients (MacNeill et al., 
2016). The challenges of recruiting older adults into clinical trials are well documented 
(Piantadosi et al., 2015) and may be especially difficult in trials examining late-life 
depression (Thompson, Heller & Rody, 1994).  
 
Older adults are less likely to recognise symptoms of depression and are more likely to 
attribute them to physical illness or aging (Rodda, Walker & Carter, 2011). This is 
perhaps doubly relevant here given the cross-over between symptoms of ESRD and 
the somatic symptoms of depression. This misattribution of symptoms has been 
highlighted as a barrier to treatment-seeking (Sarkisian, Lee-Henderson & Mangione, 
2003). Older adults may also deny symptoms of depression due to the perceived 
stigma both of depression itself and of needing help for a mental health problem 
(Evans & Mottram, 2000). 
 
As well as a misattribution of symptoms, the symptomatology of depression and ESRD 
may themselves act as a barrier to recruitment. Self-help requires motivation, 
concentration and a time commitment. Fatigue is common in ESRD and was reported 
by more than half of the participants who completed our screening measure. Similarly, 
low motivation and concentration are characteristic of depression. 
 
A further consideration may relate to the treatment burden already experienced by 
haemodialysis patients. As well as the dialysis regimen itself, patients have to manage 
a high pill burden and strict fluid and dietary restrictions. Bearing in mind the co-
morbidities and age of the cohort, it is likely that they will have multiple healthcare 
appointments in addition to those related to kidney care. Given these commitments, 
haemodialysis patients may lack the time and motivation to engage in an additional 
self-driven treatment for a problem that they may not perceive to be psychological in 
nature. 
 
Adherence 
Our conclusions about adherence are based on an extremely small number of 
participants and must therefore be considered with caution. Only one of the four 
participants who received the ACT intervention completed all sections of the manual, 
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with two completing less than one quarter and another dropping-out prior to starting. 
For all non-completers of the manual, health problems were reported as the main 
barrier. This is perhaps unsurprising given the high symptom burden of people with 
ESRD. Furthermore, depression in ESRD is associated with a range of negative 
health-related outcomes and it may be that those most in need of an intervention of this 
kind are also most likely to disengage due to health problems. Past research suggests 
that older adults with poorer physical health are more likely to drop-out of longitudinal 
depression trials (Sharma, Tobin & Brant, 1989). 
 
Individuals with ESRD are more likely than the general population to experience a 
dynamic health state which may impact their ability to engage in psychotherapeutic 
treatment. It is important that clinicians offering psychotherapeutic interventions, 
including guided self-help, deliver them flexibly and in response to patient need. In the 
present trial, the standardised nature of the intervention did not allow sufficient flexibility 
to those patients whose health problems prevented full and immediate engagement 
with the materials.  
 
Implications for service delivery 
The Improving Access to Psychological Therapies (IAPT) programme has 
demonstrated that low-intensity interventions, including guided self-help, can be 
effective for treating mild to moderate anxiety and depression in a primary care setting 
(Department of Health, 2012) and there are now plans to extend the IAPT programme 
to the treatment of people with long-term physical conditions (Department of Health, 
2011). The present research brings some important considerations to light.  
 
Matcham et al. (2014) carried out a review of self-help interventions for people with 
long-term physical conditions. After removing studies with a high risk of bias from the 
analysis, no significant differences in drop-out rates between self-help and control 
groups were found. The authors took this as evidence that self-help interventions are 
acceptable to patients with long-term conditions. Our findings indicate that there may 
be some resistance to self-help interventions in ESRD and that there needs to be 
further consideration on how services promote these types of treatments to patients, 
bearing in mind the multiple barriers that might discourage treatment acceptance. 
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ACT model 
Our findings show that self-reported symptoms of depression and anxiety are highly 
correlated with psychological flexibility. This provides support for the ACT model in 
ESRD and may indicate the possible utility of an ACT-based intervention. In light of our 
other findings, a non-self-help format (e.g. individual or group psychotherapy) may be 
more suitable. Outcome studies are needed to examine whether ACT interventions 
delivered in other formats are acceptable and effective in the ESRD population. 
 
While the need for more research into ACT in ESRD is warranted, our findings offer 
only limited support for the ACT model. Observational correlational evidence of 
process-outcome relationships is weaker than proof of principle evidence showing that 
manipulation of one or more ACT processes is followed by a change in desired 
outcomes. Furthermore, although depression is the presenting clinical problem, the 
ACT model does not target or make hypotheses about symptom reduction. As such, 
we would not necessarily expect increased psychological flexibility to lead to a 
reduction in depression. Measures indicating increased valued action or quality of life 
may be a better demonstration of proof of principle. 
 
Our conclusions about process-outcome relationships assume that the AAQ-II is a 
good proxy measure for psychological flexibility. Using exploratory factor analysis, 
Wolgast (2014) demonstrated that items on the AAQ-II were more strongly associated 
with items measuring distress than those measuring experiential avoidance. He 
concluded that the AAQ-II failed to adequately discriminate between constructs and 
that this may have led to an overestimation of the relationship between ACT processes 
and distress. We defend its use here as it remains the most widely used and 
researched measure of psychological flexibility, however it is important to consider the 
limitations of the AAQ-II before drawing strong conclusions about the ACT model. 
 
Strengths and limitations16 
The main limitation of the trial is that low recruitment numbers and poor adherence 
prevented us from drawing conclusions about which aspects of the self-help manual 
might be most helpful for ESRD patients and precluded further proof of principle 
exploration of the ACT model. However, the mixed methods approach strengthened 
                                               
16 See Extended Discussion 4.4 and 4.5 for further information on strengths and limitations 
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the design by providing a more detailed account of the practicalities of conducting the 
research. 
 
Conclusion 
Our trial procedures were largely acceptable however low recruitment rates and poor 
adherence suggest that the intervention was inappropriate for treating depression in 
ESRD. A combination of factors may account for our low recruitment including the high 
treatment burden already experienced by dialysis patients, stigmatisation, denial or 
misattribution of depressive symptoms, disorder specific factors and high morbidity. 
Supported self-help based on ACT may have a utility in this population but more 
research is needed to examine where this utility might lie.  
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1. Extended Introduction 
This section of the extended paper provides further details on renal replacement 
therapy and the epidemiology of depression in ESRD. A review of the evidence base 
for pharmacological and psychotherapeutic interventions for depression in ESRD is 
provided. This is followed by a more detailed account of the ACT model and the current 
evidence base, as well as a review of self-help interventions more generally. The 
section will conclude with a look at the aims and epistemological position of the 
research.  
 
1.1 Renal replacement therapy 
Unless otherwise states, figures included in this section are taken from the UK Renal 
Registry 18th Annual Report and relate to the 2014 calendar year (MacNeill, Casula, 
Shaw & Castledine, 2016). The most common form of renal replacement therapy in the 
UK is kidney transplantation, accounting for 53% of all treatment. The second most 
common treatment is haemodialysis, in which a vascular connection is made between 
the patient and an artificial kidney. Patients typically have three, four-hour 
haemodialysis session per week. Haemodialysis accounts for 41% of all renal 
replacement with the vast majority of patients receiving haemodialysis at a satellite 
clinic (50.7%) or main hospital site (40.4%), while a smaller number facilitate their own 
treatment at home (4.9%). A third option for treatment is peritoneal dialysis in which 
blood is filtered through the patient’s peritoneum, a thin membrane which lines the 
abdomen. Dialysate solution is passed into the peritoneal cavity at the start of dialysis 
and drained out after 4-8 hours. Only 6.1% of renal replacement therapy patients 
receive peritoneal dialysis.  
 
In the UK, the median age of haemodialysis patients (67.2 years) is higher than that of 
peritoneal dialysis patients (64.2 years) and substantially higher than transplant 
patients (53.3 years). Sixteen per cent of all renal replacement therapy patients are 
over the age of 75. ESRD patients experience a high symptom burden. A systematic 
review found the most common symptoms to be fatigue (71%), pruritus (severe itching; 
55%), constipation 53%, anorexia (49%), pain (47%), sleep disturbance (44%), anxiety 
(38%), dyspnea (trouble breathing; 35%) nausea (33%), restless legs 30%, and 
depression (27%; Murtagh, Addington-Hall & Higginson, 2007). 
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1.2 Depression in ESRD 
The incidence of depression is perhaps unsurprising given the high number of 
stressors often experienced by ESRD patients including changes in social, family and 
occupational role, loss of physical, sexual and cognitive functioning and considerable 
treatment burden (Bohra & Novak, 2015). There continues to be wide variation 
regarding the extent of depression in ESRD with estimates ranging from 10 to 47% 
(Craven, Rodin & Littlfeld, 1988; Kimmel, 2001; Kimmel et al., 1995; Kimmel et al., 
1998; Kimmel et al., 1996; Lopes et al., 2004; Smith, Hong & Robson, 1985; Watnick, 
Kirwin, Mahnensith & Concato, 2003). This variation is largely explained by the variety 
of assessment methods used, with higher estimates generally found when using self-
report methods and lower rates using diagnostic interview (Cohen, Norris, Acquaviva, 
Peterson & Kimmel, 2007). The prevalence of depression may vary by country with the 
highest rates in the United States and the lowest rates in Japan (Lopes et al., 2004). 
 
Rates of depression seem to vary depending on the mode of renal replacement 
therapy patients receive with the highest rates found in haemodialysis patients (Martin, 
Tweed & Metcalfe, 2004). Irrespective of the mode of treatment, the prevalence of 
depression in ESRD is significantly higher than in the general population where lifetime 
prevalence estimates for England range from four to ten per cent (McManus, Meltzer, 
Brugha, Bebbington & Jenkins, 2009), an estimate that is consistent across other 
European countries (Alonso et al., 2004). Furthermore, rates of depression are greater 
in ESRD when compared with other chronic physical health problems such as 
congestive heart failure (Jiang et al., 2001) and diabetes (Anderson, Freedland, Clouse 
& Lustman, 2001). This has been supported by a large US study in which one-year 
prevalence rates of depression were three times higher than the general population for 
ESRD patients compared with two times higher in patients with coronary artery 
disease, hypertension, heart failure, and diabetes (Egede, 2007). 
 
Although depression appears common in ESRD, diagnostic difficulties arise due to the 
overlap between the symptoms of depression and those of ESRD, including sleep 
problems, fatigue, appetite disturbance and cognitive difficulties (Chilcot, Wellsted & 
Farrington, 2010; Drayer et al., 2006). To diagnose depression in ESRD, it has been 
argued that attention should be paid to the psychological symptoms of depression, 
such as hopelessness, low mood and suicidal thinking (Kimmel, 2001). However, 
research suggests that under-diagnosis is more likely when the physical symptoms of 
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depression are omitted from assessment and that a more inclusive approach leads to 
greater consistency in prevalence rates (O’Donnell & Chung, 1997). 
 
As previously discussed, there is a well-established link between depression and a 
variety of negative health-related outcomes with several mechanisms implicated. 
These include poor compliance with medication and dialysis (Kaveh & Kimmel, 2001; 
Kimmel, 2001; Kimmel, 2002), poor nutritional status (Cohen & Kimmel, 2007), and 
altered immune system functioning (Kimmel, 2001; Miller, Cohen & Herbert, 1999). 
 
1.2.1 Psychopharmacological Treatments 
Few studies, and only one randomised controlled trial (RCT), have examined the 
effectiveness of pharmacological treatments for depression in ESRD. In a double-
blinded placebo controlled trial (n=14), Fluoxetine was found to be an effective 
treatment for depression in patients receiving dialysis, although significant differences 
in self-reported depressive symptoms did not occur until four weeks into the trial and 
were not maintained at eight weeks (Blumenfield et al., 1997). The findings of this 
study are limited by the small sample size and short duration of the trial. The protocol 
for a high-quality, double blind placebo-controlled pilot RCT examining the 
effectiveness of Sertraline for haemodialysis patients with depression, was published 
last year, with the aim of filling this gap in the literature (Friedl et al., 2015). Of greater 
relevance to the present research is the ASCEND trial, the first large-scale, multi-
centre RCT comparing individual chair-side CBT with Sertraline (for the protocol, see 
Hedayati et al., 2016). At the time of writing, this study is in the recruitment phase and 
has an estimated completion date of August 2017 
(https://clinicaltrials.gov/ct2/show/NCT02358343). 
 
1.2.2 Psychotherapeutic Treatments 
Only a handful of studies have examined the effectiveness of psychotherapeutic 
interventions for treating depression in ESRD and fewer still have specifically targeted 
haemodialysis patients. A 2005 Cochrane review identified no RCTs of psychosocial 
interventions for depression in dialysis patients and was therefore unable to draw 
conclusions about the effectiveness of such interventions (Rabindranath et al., 2005). 
Since then, some trials have been conducted with favourable findings. Given the 
limited number of trials in ESRD overall, an overview of all known trials, regardless of 
the type of renal replacement therapy (RRT) received by participants, is provided.  
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CBT is the most widely researched therapeutic model for the treatment of depression in 
ESRD. In a recent randomised crossover trial (Cukor et al., 2014), 59 haemodialysis 
patients were allocated to either individual CBT or waiting-list control. All patients met 
relevant cut-offs for depression on the Beck Depression Inventory (BDI-II; Beck, Steer, 
Ball & Ranieri, 1996) and Hamilton Depressive Rating Scale (HDRS; Hamilton, 1960). 
Patients in the intervention group received individual chair-side CBT during dialysis, 
administered weekly for three months. Scores on the BDI-II and HDRS significantly 
improved in the intervention group compared with controls and this was sustained at 3-
month follow-up. An uncontrolled pilot study which preceded this trial also found 
significant and sustained improvements in BDI-II scores for all 16 ESRD patients 
receiving chairside CBT (Cukor, 2007). 
 
In a Brazilian trial, 85 haemodialysis patients with a diagnosis of major depression were 
randomised to receive group CBT or standard care (Duarte, Miyazaki, Blay & Sesso, 
2009). Depression diagnosis was determined using the Mini International 
Neuropsychiatric Interview. Those who were randomised to the treatment condition 
received 12 weekly sessions of group CBT, each lasting 1 hour 30 minutes. The 
number of patients in each therapy group is not clear. Improvements in BDI-II scores 
were found in both the control and CBT arms however greater gains in depression and 
quality of life scores were found for CBT which were maintained at 9-months. Further 
support for group-delivered CBT as a treatment for depression in ESRD has been 
reported in a case study of five haemodialysis patients who received two sessions of 
group therapy (Kaniarz, 1998). These findings however, are extremely limited due to 
the lack of rigour associated with the case study methodology, in particular the 
extremely small sample size and lack of control group for comparison.  
 
In an Israeli study, 15 medical centres were randomised to receive supportive 
psychotherapy, CBT or no-treatment (Hener, Weisenberg & Har-Even, 1996). 
Participants were individuals adjusting to home peritoneal dialysis and their partners. 
Couples in the supportive psychotherapy and CBT groups received eight, 80-minute 
sessions of therapy in their homes. A diagnosis of depression was not required for 
inclusion in the trial. Interestingly, supportive psychotherapy emphasised acceptance of 
the illness and encouraged emotional expression, aspects that would be consistent 
with the ACT model. Significant improvements in depression and anxiety were found 
for both treatment groups compared with no-treatment controls, although no longer-
term follow-up data was collected. There were no significant differences in outcomes 
between the two types of therapy. 
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In another randomised trial, individual and group psychotherapy treatments were 
compared against a non-treatment control group for individuals who had received a 
kidney transplant (n=126; Baines, Joseph & Jindal, 2004). The same therapeutic 
model, Systemic Integrative Psychotherapy, was delivered in both the individual and 
group therapy conditions over twelve weekly sessions. The authors report significant 
improvements in depression in both conditions when compared with the non-treatment 
group, although differences appeared more significant in the individual therapy group. 
Improvements were sustained at twelve-month follow-up however, as effect sizes were 
not reported, it is not possible to deduce the magnitude of the change. 
 
The recent publication of the iDiD trial protocol, detailing a feasibility study examining a 
telephone-supported computerised CBT intervention for psychological distress in 
haemodialysis patients (Hudson et al., 2016), demonstrates further recognition for the 
need to develop low-intensity psychotherapeutic interventions in ESRD. Results from 
this trial, combined with our own findings, may help to establish the most appropriate 
format for delivering self-help treatments to haemodialysis patients.  
 
In summary, while the number of methodologically robust trials remains small, those 
which are available provide some support for both group and individual psychotherapy 
for treating depression in ESRD. In haemodialysis, both RCTs conducted to date 
support the use of CBT, although as single-centre trials they lack greater 
generalisability. The ASCEND trial described above, may go some way to addressing 
this issue. 
 
1.3 Provision of psychological services in UK renal care 
A number of national care guidelines have acknowledged the importance of 
psychological support in renal care. NHS service specifications for in-centre 
haemodialysis recommend that patients have access to psychological services (NHS 
England, 2016). Similar recommendations are given by the Kidney Health Advisory 
Group (Loud & Gallagher, 2013) and NICE quality standards for treating adults with 
CKD (NICE, 2011), both of which recommend timely access to psychological support 
for all patients with advanced kidney disease. However, there are no recent figures on 
the availability of psychological services across UK renal units. The most recent data, 
now 14 years old, indicates a considerable dearth of counsellors and clinical 
psychologists in renal care (British Renal Society, 2002). Although official figures are 
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unavailable, most units employ or have access to a clinical psychologist and a network 
of renal clinical psychologists meet quarterly (E. Coyne, Consultant Clinical 
Psychologist, personal communication, January 13th 2016). 
 
The National Renal Workforce Planning Group propose a tiered framework for 
providing psychological support in renal care (British Renal Society, 2002). The 
framework comprises of three levels covering increasing severity of psychological 
difficulties, with the bottom level provided by all staff, comprising general support such 
as information, advice and empathy. The next level, provided by nursing, medical and 
other qualified members of the multi-disciplinary team, involves supportive counselling 
with a focus on the emotional consequences of receiving illness- and treatment-related 
information. The final level is psychological assessment and intervention in relation to 
mental health needs, adjustment, adaptation, coping and the impact of ESRD on the 
family system. This level should be provided by specialist psychological practitioners 
including clinical psychologists, counsellors and psychotherapists. Consistent with this 
tiered approach to psychological support, NICE guidelines for the treatment of 
depression in chronic physical health problems recommend a stepped-care model in 
which the least intrusive and most effective treatment is provided first (NICE, 2009). 
They propose four steps of care with patients receiving increasingly invasive 
treatments according to need, or as lower steps prove ineffective. Although the tiered 
framework proposed by the British Renal Society does not correspond with the steps 
proposed in the NICE stepped-care model, there is recognition from both organisations 
that both low- and high-intensity psychological interventions are needed within the 
renal context.  
 
1.4 Acceptance and Commitment Therapy (ACT) 
ACT is considered part of the third-wave of behavioural therapies where traditional 
behavioural therapy is the first wave and CBT is the second wave (Hayes, 2004). It is 
based on a philosophy of science called functional contextualism, where truth is held to 
be successful working (Hayes, 1993). The epistemological basis of functional 
contextualism is discussed in greater depth below.  
 
Fundamentally, ACT is based on the contextual behavioural principles of Skinner 
(1938; 1948), a full account of which is beyond the scope of this paper but a brief 
explanation may provide some context for understanding the ACT model. To 
understand human behaviour from a contextual behavioural perspective we must 
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consider not only the behaviour itself, but the context in which the behaviour is 
performed, as well as the consequences of performing it (Törneke & Romero, 2008). 
As such, a behavioural understanding consists of a three term contingency where A is 
the antecedent, B is the behaviour and C is the consequences (Törneke, Luciano & 
Valdivia, 2008). Certain consequences increase the likelihood of a behaviour being 
performed in a similar context in the future (reinforcement) and other consequences 
decrease this likelihood (punishment). In this way, behaviour is governed by its 
consequences and this is known as operant conditioning. As a straightforward 
example, in the presence of an anxiety-provoking meeting (A), leaving the meeting 
early (B) leads to a reduction in anxiety (C). This behaviour has been reinforced by its 
consequences and is more likely to be performed again in similar circumstances in the 
future. 
 
The ACT model augments the principles of behavioural theory by incorporating a 
behavioural account of human language and cognition called Relational Frame Theory 
(RFT; Hayes, Barnes-Holmes & Roche, 2001). Again, a full account of the assumptions 
and theory of RFT is beyond the scope of this paper but a brief account is provided. 
According to RFT, language and cognition is based on the learned ability to arbitrarily 
relate events. Through multiple exemplar training in early childhood, humans learn to 
relate stimuli that have no relation in their learning history, even when the stimuli have 
no formal properties in common (Törneke, 2010). This is known as derived relational 
responding. This ability to relate is reinforced through the operant processes described 
above and generalises to other stimuli (Healy, Barnes-Holmes & Smeets, 2000). These 
arbitrarily established relations result in a transformation of stimulus functions (the 
response evoked by a stimulus) whereby the function of one stimulus acquires the 
function of the other by virtue of this arbitrary relationship. To explain this premise, 
Törneke et al. (2008) use the example of being told that a number of local people have 
contracted typhoid, a disease spread through badly prepared chicken. As a result, 
eating chicken is placed in a relational frame of coordination with feeling sick and its 
stimulus functions are transformed (i.e. chicken elicits a sick feeling). RFT specifies a 
number of ways in which the functions of language lead to psychological distress and it 
is these processes that are targeted in ACT. A review of the empirical basis for RFT 
found 62 empirical studies and concluded that there was a growing evidence base 
supporting the main assumptions of RFT (Dymond, May, Munnelly & Hoon, 2010). 
 
At the heart of ACT is the concept of destructive normality wherein psychological pain 
is universal and the product of normal processes of human language and cognition, as 
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specified in RFT (Hayes, Strosahl & Wilson, 1999). The verbal processes implicated in 
psychological distress are some of the same processes that are involved in verbal 
reasoning and problem solving and so attempts to eliminate these processes will be 
inherently problematic (Hayes, Luoma, Bond, Masuda & Lillis, 2006). The assumption 
of destructive normality separates ACT from other therapeutic traditions, including 
CBT, where the central assumption is one of healthy normality. By this account, 
humans naturally function in a state of good psychological health, characterised by 
happiness and contentedness. Psychological pain is a deviation from this normal state 
and is driven by abnormal, pathological processes inside the client (e.g. maladaptive 
cognitive patterns). While CBT and other psychotherapies aim to eliminate or reduce 
psychological pain, ACT asserts that attempts to control or avoid pain may lead to 
additional suffering and that the elimination of pain is not necessary to live a valued 
and meaningful life. ACT theorists cite the high prevalence rates of common mental 
health problems as convincing evidence to support the destructive normality 
hypothesis. This is perhaps especially relevant in populations such as ESRD patients, 
where there are particularly high rates of psychological distress. With prevalence rates 
of depression ranging from 20 to 40% in the ESRD population (e.g. Chilcott et al., 
2010) it is difficult to argue that psychological pain represents a deviation from 
normality. 
 
1.4.1 ACT model 
Underlying the ACT model is the concept of psychological flexibility, the ability to 
consciously connect with the present moment and respond flexibly in the service of 
one’s values (Hayes et al., 1999). The aim in ACT is to increase psychological flexibility 
by targeting six core repertoire-expanding processes, each of which corresponds with a 
repertoire-narrowing process. The latter set of processes arises from characteristics of 
human language and cognition (Hayes et al., 1999).  
 
1.4.2 Acceptance vs. experiential avoidance 
Acceptance involves increasing an individual’s willingness to accept private events 
such as thoughts, memories, emotions and bodily sensations, even when they are 
distressing or aversive (Hayes et al., 1999). It is not a resigned, passive acceptance of 
these experiences but an active, curious and deliberate exploration of them (Hayes, 
Pistorello & Levin, 2012). The repertoire-narrowing counter to acceptance, experiential 
avoidance, involves attempts to alter the form or frequency of unwanted private 
experiences (Hayes, Wilson, Gifford, Follette & Strosahl, 1996). Such attempts often 
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result in a narrowing of the individual’s behavioural repertoire as they struggle to avoid 
these private events. In part, experiential avoidance is problematic due to the extension 
of relational networks. While non-humans can avoid situations that illicit pain and 
distress, the functions of language are such that humans can experience pain at any 
time, wherever they are (Törneke & Ramnero, 2008).  
 
The aim of acceptance is to increase one’s ability to respond flexibly to private 
experiences. A relationship has been found between experiential avoidance and a 
number of negative mental health outcomes, including depression and anxiety (Hayes 
et al., 2006). In order to foster acceptance, the therapist helps the client to see the 
futility and counter-productiveness of control and avoidance strategies. To achieve this, 
the therapist helps to produce a sense of creative hopelessness in which the cost of 
control and avoidance strategies, increased suffering and a failure to move towards 
identified values and goals, is highlighted. The client is then encouraged to abandon 
these strategies and accept private experiences in the pursuit of their values. 
Acceptance is not a goal in itself but a means of bringing about value-guided action 
(Hayes et al., 2012).  
 
1.4.3 Cognitive defusion vs. cognitive fusion 
Cognitive fusion is a process which occurs when thoughts take on a literal quality, 
acquiring the stimulus functions of what they refer to (Hayes et al., 2006). Individuals 
will respond to these cognitions in a way that is similar to how they would respond if the 
tangible properties of the event represented in the cognition were present. For 
example, an individual who is having thoughts about a medical procedure going wrong 
may experience fear or anxiety even though they are not having a medical procedure 
at the present moment. In ACT, this process is targeted through cognitive defusion 
which centres on changing the way individuals interact with their thoughts and other 
private experiences (Hayes et al., 2012). Rather than attempting to change the form or 
frequency of these experiences, defusion strategies aim to alter their undesirable 
functions by creating a context in which these functions are diminished (Hayes et al., 
2006). When fused with thoughts, they play an excessive role in regulating behaviour, 
leading to inflexible patterns of responding. The role of defusion is to help clients to see 
their thoughts, not as literal truths, but psychological events that can be responded to 
flexibly (Hayes et al., 2006). A wide variety of techniques have been developed to help 
clients to defuse from their thoughts, including encouraging them to visualise their 
thoughts floating past on a cloud, speaking their thoughts repeatedly or in an amusing 
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voice, or labelling the thought as a thought (e.g. “I am having the thought that…”; 
Hayes & Strosahl, 2005). 
 
1.4.4 Contact with the present moment vs. domination of the past or future 
To use cognitive defusion effectively, a degree of present moment awareness is 
needed as this allows the process of thinking to become more evident (Hayes et al., 
2012). This present moment awareness, known as mindfulness, allows individuals to 
make contact with psychological and environmental events as they occur, viewing them 
with curiosity and without judgement (Hayes et al., 1999). Mindfulness is also an 
essential part of acceptance as one must have an open awareness of events in the 
present moment, in order to accept them. By taking notice of internal and external 
events in the present moment, the individual is able to respond flexibly and in a way 
that is more consistent with their values. Mindfulness aims to reduce a rigid attention to 
past and future experiences (Hayes et al., 2012). For example, one might dwell on past 
losses or worry about future demands, while ignoring what is occurring in the present. 
This again is a function of language (Törneke & Ramnero, 2008). Mindfulness is 
developed through activities and techniques which encourage an ongoing description 
of private events. This might involve paying attention to different parts of the body in 
turn, attending to the breath or simply noticing the sounds in the room. The therapist 
also encourages the client to notice what thoughts, memories, emotions and 
sensations arise within the therapeutic relationship (Wilson & Dufrene, 2009). 
 
1.4.5 Self as context vs. self as content 
A product of relational framing is that certain frames lead us to experience ourselves as 
if we are our thoughts, memories, emotions and sensations, rather than an observer of 
these experiences (Hayes et al., 2006). We typically describe ourselves as if we are 
these psychological events and this creates a self-narrative or conceptualised self, 
which can limit behavioural flexibility (Hayes et al, 2012). This reduced response 
flexibility occurs because individuals are reluctant to engage in behaviour that deviates 
from the conceptualised self and this leads to increased experiential avoidance 
(Mendolia & Baker, 2008). In ACT, this is known as self as content. The therapeutic 
process aimed at targeting this is called self as context and involves helping individuals 
to see the distinction between the thinking self (self as content) and the observing self 
(self as context; Harris, 2009). Mindfulness is often central to this process as it 
encourages individuals to experience private events as an observer without being 
caught up in judgements or attempts to alter them. Self as context helps to foster 
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acceptance and defusion as it gives individuals a safe space to notice their 
experiences without attachment (Hayes et al., 2006). Self as context interventions also 
involve metaphors such as the chess board metaphor (Hayes et al., 1999). In this 
metaphor, self as content equates to viewing oneself as the chess pieces moving 
around the board, while self as context equates to viewing oneself as the chessboard 
upon which private events (the chess pieces) occur.  
 
1.4.6 Values clarification vs. unclear and avoidant motives 
As previously described, the ultimate aim of ACT is to increase value-consistent 
behaviour. Unlike goals, values cannot be obtained or reached; instead they are 
qualities of purposive action (Hayes et al., 1999). For example, looking after one’s 
health is not an outcome that can be achieved, but a continuous process that may 
extend throughout the lifespan. Often, attempts to avoid or control unwanted private 
experiences result in moving the individual away from what they most value. By 
supporting individuals to clarify what is most important to them, it is possible to link 
values with behaviour change while highlighting the cost of continued avoidance, in 
terms of distancing the individual from their values. From an RFT perspective, values 
are verbally constructed contingencies which create an intrinsic reinforcement for 
patterns of behaviour which are consistent with identified values (Wilson, Sandoz, 
Kitchens & Roberts, 2010). Values clarification is achieved through metaphor, 
experiential processes and writing exercises (Hayes et al., 2006). 
 
1.4.7 Committed action vs. unworkable solutions 
Closely linked with values clarification is the process of committed action where the aim 
is to create an ever increasing behavioural repertoire linked to chosen values (Hayes et 
al., 2006). Consistent with first- and second-wave behavioural therapies, committed 
action usually involves a graded approach to behavioural change guided by short, 
medium and long-term goals (Hayes et al., 2012). In ACT, these goals are informed by 
the individual’s values but unlike values, they are obtainable behavioural outcomes. 
Acceptance, mindfulness and defusion skills allow the individual to manage the 
psychological barriers which inevitably arise during attempts at value-guided action 
(Hayes et al., 2006). Committed action stands in contrast to the unworkable solutions 
that arise through experiential avoidance.  
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1.4.8 ACT evidence base 
A number of meta-analyses and narrative reviews of the ACT evidence base have now 
been conducted. Most recently, a meta-analysis examining ACT interventions for 
depression, anxiety, addiction and somatic health problems found ACT to be superior 
to psychological placebo, wait-list and treatment as usual on primary (Hedge’s g = .57), 
secondary (g = .30) and process outcome measures (g = .56), while no significant 
differences between ACT and CBT, the established treatment, were found (A-Tjak, et 
al., 2015). Contrary to this, an earlier meta-analysis found mean effect sizes favouring 
ACT over CBT for depression (Hedge’s g = .27) and quality of life (g = .25) post-
treatment (Ruiz, 2012). The author carried out a further analysis of nine studies that 
had conducted mediational analyses examining processes of change, reporting that 
while ACT operated through its proposed processes, CBT did not.  
 
In another meta-analysis, ACT outperformed control conditions (psychological placebo, 
treatment as usual and wait-list) for target problems overall at post-treatment and 
follow-up, but failed to outperform established treatments (Powers, Zum Vörde Sive 
Vörding & Emmelkamp, 2009). Contesting these findings, Levin and Hayes (2009) re-
analysed studies in the previous authors’ database and found an effect size favouring 
ACT over established treatments (Hedge’s g = .27). Two narrative reviews also report 
broad support for ACT in a variety of clinical problems (Hayes et al., 2006; Smout, 
Hayes, Atkins, Klausen & Duguid, 2012).  
 
A less favourable review examining ACT for a range of clinical problems found a small 
overall effect size (r = .42) and concluded that ACT failed to fulfil the criteria for an 
empirically supported treatment, although the best evidence was for chronic pain and 
tinnitus (Öst, 2014). This was consistent with an earlier review by the same author 
(Öst, 2008). In both reviews, the methodological quality of ACT RCTs was inferior to 
those examining CBT, although the procedure for matching ACT and CBT trials in 
order to examine their respective methodological quality has been questioned 
(Gaudiano, 2009). The areas of methodological quality in which ACT was consistently 
inferior to CBT trials were: representativeness of the sample, reliability of the diagnosis, 
reliability and validity of outcome measures, assignment to treatments, number of 
therapists administering the interventions, therapist training and experience, checks for 
treatment adherence, control of concomitant treatments, statistical analyses and 
presentation of data, clinical significance, and equality of therapy hours between 
conditions (Öst, 2008). 
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Alongside outcome research, a number of studies have examined the therapeutic 
processes underpinning the ACT model. Much of this research involves correlational 
analyses examining the relationship between experiential avoidance and psychological 
distress. Typically, experiential avoidance is measured using the AAQ-II or its 
predecessor, the AAQ (Hayes et al., 2004). Some problem specific adaptations of this 
measure, such as the Chronic Pain Acceptance Questionnaire (CPAQ; McCracken, 
Vowles & Eccleston, 2004), have also been developed. A review of the correlational 
data found a strong weighted correlation between depressive symptoms and 
experiential avoidance (r = .55), based on 22 correlations (Ruiz, 2010). A similarly 
strong weighted correlation was found between anxiety symptoms and experiential 
avoidance (r = .52), based on 14 correlations. A meta-analysis by Hayes et al. (2006) 
reported similar positive correlations between experiential avoidance and the majority 
of psychological symptoms while negative correlations were found between 
experiential avoidance and quality of life. The authors also found that experiential 
avoidance, as measured by the AAQ, explained 16 to 28% of the variance in health-
related outcomes. 
 
If one assumes that measures such as the AAQ-II are good proxy measures for 
experiential avoidance, then these reviews provide strong support for the ACT model of 
psychopathology and treatment. However, both the AAQ and AAQ-II have received 
criticism, the former for its lack of comprehensibility and reliability (Bond et al., 2011) 
and the latter for its inability to discriminate between constructs. Wolgast (2014) used 
exploratory factor analysis to investigate the extent to which the AAQ-II could 
discriminate between experiential avoidance and psychological wellbeing, finding that 
items on the AAQ-II were more strongly associated with items measuring distress than 
those measuring experiential avoidance. These findings indicate that there may be an 
overestimation of the association between experiential avoidance and distress, 
particularly in light of the wide proliferation of the AAQ-II. However, at present it 
remains the most widely used and researched ACT process measure 
 
Overall, there is a mixed picture of the ACT evidence base although in general, ACT 
was equivalent to established treatments and better than placebo conditions for a 
range of mental health problems. Where researchers have argued that the evidence 
does not support ACT as an empirically supported treatment, this is largely due to 
unsatisfactory research methodology and clearly there is a need for more large-scale, 
high-quality RCTs. It appears that the theoretical orientation of the researchers is a 
factor when considering the efficacy of ACT with the most favourable reviews having 
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been conducted by proponents of the ACT model. Correlational data supports the ACT 
model of psychopathology although better measures of ACT processes may need to be 
developed to draw stronger conclusions.  
 
1.4.9 Acceptance in CKD 
While there remains a dearth of research examining the potential benefits of 
psychotherapeutic interventions in ESRD, the impact of psychosocial factors has 
garnered significant attention. A small proportion of this attention has been on the 
concept of acceptance with some authors recommending the provision of treatments 
that foster acceptance in CKD patients in order to bring about positive health outcomes 
(Chan, 2013; Chiang, Livneh, Guo, Yen & Tsai, 2015). This section of the extended 
paper will give an overview of the concept of acceptance and its potential significance 
in the course of CKD.  
 
Acceptance was first conceptualised as the final stage in a five-stage model of grief, 
where denial, anger, bargaining and depression make up the preceding stages (Kubler-
Ross, 1969). Within this framework, acceptance is viewed as an adaptive state which 
allows individuals to acknowledge and be at peace with the reality of their situation. 
Over-reliance on denial strategies and failure to achieve acceptance is seen as 
pathological. Initially derived from work with terminally ill patients and later applied to 
people with Acquired Immune Deficiency Syndrome (AIDS; Kubler-Ross, 1987), the 
model has since been used as a general framework for considering adaptation to 
chronic illness. However, despite its wide application, the model has received 
considerable criticism, mainly for its prescriptive account of grief and the adaptational 
process (e.g. Corr, 1993).  
 
It has been argued that there may be two distinguishable types of acceptance in 
chronic illness and that these may lead to different health outcomes (Nakamura & Orth, 
2005). Resigned acceptance involves a recognition and awareness of the negative 
experiences associated with one’s illness, accompanied by passive behaviour and 
stoical tolerance. This type of acceptance is related to poorer outcomes in a variety of 
chronic illnesses including breast cancer (Greer, Morris, Pettingale & Haybittle, 1990; 
Pettingale, Morris, Greer & Haybittle, 1985) and AIDS (Reed, Kemeny & Taylor, 1994). 
Conversely, active acceptance comprises two processes; the recognition of negative 
experiences without engaging in self-defeating behaviours intended to control said 
experiences; and the assimilation of the illness into one’s life while pursuing values and 
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goals (Chan, 2013). Active acceptance has been shown to be positively associated 
with psychological well-being in an array of chronic health problems including coronary 
artery disease and cancer (Karademas, Tsagaraki & Lambrou, 2009), chronic pain 
(McCracken & Zhao-Obrien, 2010), diabetes (Richardson, Adner & Nordstrom, 2001), 
chronic fatigue syndrome (Van Damme, Crombez, Van Houdenhove, Mariman & 
Michielsen, 2006), and rheumatoid arthritis (Persson, Berglund & Sahlberg, 1996). The 
concept of active acceptance is consistent with the ACT conceptualisation of 
acceptance. 
 
Given the prominence of acceptance in the grief literature, it is perhaps unsurprising 
that many studies have adopted the loss-oriented Acceptance of Disability Scale (ADS; 
Lindowski, 1971) or its successor, the Acceptance of Disability Scale – Revised (ADS-
R; Groomes & Linkowski, 2007), in order to examine acceptance in chronic conditions. 
Acceptance of disability is seen as a coping task that is central to psychosocial 
adjustment to chronic illness (Groomes & Linkowski, 2007). Individuals must 
acknowledge and actively accept the impact and chronic nature of the disease before 
they are able to perform adaptive behaviours (Chan, 2013). The relationship between 
acceptance of disability and positive health outcomes has been demonstrated in CKD. 
In a three-year prospective cohort study of 262 CKD patients, acceptance of disability 
was negatively related to an increased risk of poor clinical outcomes with those who 
scored lower on the AOD-R more likely to have progressed to dialysis or died at follow-
up (Chiang et al., 2015).  
 
Further evidence has highlighted the clinical significance of acceptance in CKD. In a 
qualitative study using semi-structured interviews and Grounded Theory, Wright and 
Kirby (1999) explored patients', partners' and professionals' conceptualisations of 
adjustment to ESRD. They identified acceptance, consisting of cognitive, behavioural 
and affective components, as the key factor in psychosocial adjustment to the disease. 
More recently, a cross-sectional study examined the direct and mediating effects of 
acceptance and personality characteristics on health-related quality of life in patients 
with CKD (Poppe, Crombez, Hanoulle, Vogelaers & Petrovic, 2013). The authors report 
a small direct effect of acceptance on physical health (r² = .18) and a medium direct 
effect on mental health (r² = .31). They conclude by recommending that future research 
is needed to examine which psychological interventions can foster acceptance in 
patients with ESRD. 
 
 77 
1.5 Self-help treatments 
Self-help is defined as a self-administered treatment which utilises manuals or books 
which are based on an evidence-based intervention (NICE, 2004). Self-help 
interventions can be both guided and unguided. Guidance typically involves supporting 
individuals to move from a position of passivity to one of therapeutic engagement, while 
helping them to actively engage with and understand the self-help materials.  
 
An increasing number of studies have demonstrated the efficacy of self-help 
interventions for treating common mental health problems with some studies finding 
effect sizes comparable with face-to-face therapy. For example, in one meta-analysis, 
there was no significant difference in effect size between guided self-help and face-to-
face therapy for anxiety and depression, post-intervention or at follow-up (Cuijpers, 
Donker, van Straten & Andersson, 2010). Self-help has also been used successfully in 
the treatment of psychological distress for people with long-term physical health 
problems. A meta-analysis which included 25 studies found a small but significant 
effect favouring written self-help over control conditions for reducing symptoms of 
depression in individuals with physical illness (SMD = -0.13; Matcham et al., 2014). No 
significant differences were found between self-help and control conditions for anxiety 
or psychological distress. The analysis included both guided and unguided self-help 
interventions but only eight were based on a therapeutic model. Effect sizes were 
larger when studies with interventions not based on therapeutic models were excluded 
(SMD = -0.37). This suggests that self-help treatments are most effective in physical 
conditions when they are derived from an evidence-based therapeutic approach. 
 
To date, there have been no trials examining the efficacy of self-help interventions in 
ESRD however ACT self-help has received some attention. A meta-analysis examining 
the efficacy of acceptance and mindfulness-based self-help interventions, which 
included seven ACT studies, found significant increases in mindfulness and 
acceptance, and reductions in anxiety and depression, when compared with control 
conditions (Cavanagh, Strauss, Forder & Jones, 2014). Small to medium effect sizes 
were reported. The majority of studies included self-help interventions with some form 
of guidance although this varied considerably in terms of format and time with some 
protocols only providing email-based guidance.  
 
Meta-analytic studies have shown that self-help treatments are ineffective at treating 
depression and anxiety when no additional therapeutic guidance is provided (Gellatly et 
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al, 2007; Hirai & Clum, 2006) although others meta-analyses have been more 
favourable (e.g. Cuijpers et al., 2010). This suggests that self-help materials may need 
to be supplemented with guidance from a practitioner in order for them to produce 
meaningful outcomes. The importance of guidance in self-help interventions may be 
related to the therapeutic alliance. Bordin’s (1979) widely recognised conceptualisation 
of the therapeutic alliance comprises three essential elements. The first element 
regards the mutually agreed goals of therapy. The second element, the therapeutic 
bond, refers to the positive affective connection between client and practitioner, and the 
third element, the therapeutic tasks, refers to the mutually agreed means of achieving 
the therapeutic goals.  
 
The powerful effect of the therapeutic alliance on treatment outcomes is well-
established in psychotherapy research (Ardito & Rabillino, 2011) with some evidence to 
suggest that it may be the most significant mechanism of change across therapeutic 
orientations (e.g. Fluckiger Del Re, Wampold, Symonds & Horvath, 2012). Strong 
positive correlations have been reported between therapeutic alliance and outcome 
regardless of the therapeutic model, assessment tool used or time of assessment (e.g. 
Horvath, Del Re, Fluckiger & Symonds, 2011). The role of the therapeutic alliance in 
guided self-help interventions has been examined in both quantitative and qualitative 
research. Coull and Morris (2011) found that the therapeutic alliance predicted 
improvements in mental health for individuals who completed a CBT-based guided self-
help intervention for depression and anxiety. Furthermore, in a meta-synthesis of nine 
qualitative studies examining guided self-help, Khan, Bower and Rogers (2007) found 
that an effective therapeutic alliance positively impacted on individuals’ use of self-help. 
These studies highlight the potential importance of the therapeutic alliance in terms of 
self-help utilisation and outcomes. 
 
1.5.1 Rationale for ACT self-help in renal services 
There is a strong rationale for providing an ACT-based self-help intervention to 
haemodialysis patients experiencing depression. This rationale is based on the 
following:  
 
1. Self-help allows increased access and availability of an evidence-based 
intervention for a population where there is a high prevalence of psychological 
distress and where access to psychological interventions may be limited. 
2. Self-help has the potential to extend the provision of evidence-based 
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psychotherapeutic interventions to individuals who might not access traditional 
face-to-face psychological therapy (e.g. due to stigma). 
3. The provision of low-intensity interventions is consistent with a stepped model 
of care as recommended in NICE guidance for the treatment of depression in 
long-term conditions (NICE, 2009). 
4. Guided self-help may be a cost-effective means of providing an evidence-based 
intervention to large numbers of people with minimal practitioner input. 
5. Supporting the self-management of health-care needs is recommended in NICE 
guidance for the assessment and management of CKD. Self-help is consistent 
with a self-management model of care and might help to foster a sense of 
empowerment, self-efficacy and autonomy. 
6. The self-help materials remain in the possession of the client allowing them to 
update or renew their treatment as often as they require. 
7. Haemodialysis patients endure a considerable treatment burden. Self-help 
allows individuals to access an evidence-based intervention with flexibility and 
convenience without additional healthcare appointments. 
8. There is promising evidence for the efficacy of ACT-based self-help treatments 
for depression and other conditions, as well as some evidence linking ACT 
processes to positive mental and physical health-related outcomes. 
9. Self-help has been used effectively to treat depression in other long-term 
physical health problems. 
 
1.6 Feasibility randomised controlled trials 
The Medical Research Council (MRC) recommends the use of feasibility and pilot 
studies as an essential preparatory stage in the development and evaluation of 
complex interventions (Craig et al., 2008). The purpose of feasibility and pilot studies is 
to allow potential problems to be identified before carrying out a definitive trial. The 
MRC cite common problems that arise in evaluation studies relating to acceptability, 
compliance, intervention delivery, recruitment and retention. The National Institute of 
Health Research (NIHR) Evaluation, Trials and Studies Coordinating Centre (NETSCC) 
provide clear definitions to help researchers differentiate between feasibility and pilot 
studies (http://www.nets.nihr.ac.uk/glossary). Feasibility trials are used to determine 
important parameters that are needed to design a definitive trial. These parameters 
may include: number of eligible patients, response rates, follow-up rates, adherence 
rates and willingness of facilitating clinicians to recruit participants. Pilot studies  
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Table 9 
  
Feasibility parameters  
 
Parameter Operationalisation Assessed 
 
Screening questionnaire 
response rate 
 
Proportion of screening 
questionnaires returned 
Frequency and 
percentage 
Rate of depression Proportion of screened 
patients who meet cut-off on 
PHQ-9 
 
Frequency and 
percentage 
Eligibility rate Proportion of screened 
patients who meet all eligibility 
criteria 
 
Frequency and 
percentage 
Recruitment rate Proportion of eligible patients 
randomised to trial 
 
Frequency and 
percentage 
Retention Proportion of participants who 
remain in the trial at follow-up 
 
Frequency and 
percentage 
Adherence to self-help 
book 
Proportion of participants who 
complete all chapters of the 
book and number of chapters 
completed per participant 
 
Frequency and 
percentage (weekly 
adherence recorded 
during telephone support 
calls) 
Adherence to telephone 
support 
Proportion of telephone calls 
taking place 
 
Frequency and 
percentage 
Acceptability of recruitment 
procedure 
Participants perceptions of the 
recruitment procedure 
 
Framework analysis 
Acceptability of 
assessment methods 
Participants perceptions of the 
assessment methods and 
proportion of items completed 
per questionnaire 
 
Framework analysis 
Percentage of completed 
items/missing data per 
questionnaire 
Acceptability of 
randomisation procedure 
Participants perceptions of the 
randomisation procedure 
 
Framework analysis 
Acceptability of self-help 
book 
Participants perceptions of the 
self-help book 
 
Framework analysis 
Acceptability of telephone 
support 
Participants perceptions of the 
telephone support 
 
Framework analysis 
 
 
however, are designed to be smaller versions of the definitive trial and aim to 
determine whether all aspects of the procedure work together. Table 9 shows the 
parameters of interest for the present trial, with details of how each of these 
parameters is operationalised and assessed. 
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There is a good rationale for evaluating a telephone-supported ACT self-help 
intervention for haemodialysis patients who experience depression. As such, a 
feasibility trial is needed in order to estimate relevant parameters for a full-scale trial 
and to determine whether such a trial is warranted. 
 
1.7 Aims 
As a feasibility trial, the present study aimed to determine the acceptability of our 
recruitment methods, randomisation procedure, assessment methods, self-help 
materials and telephone support. We also aimed to provide estimates on the number of 
eligible patients and rates of recruitment, retention and adherence. Two secondary 
aims were not related to aspects of feasibility. Firstly, we aimed to use individual level 
analyses to provide provisional data on the potential efficacy of a telephone-supported 
ACT self-help intervention with this client group. Secondly, we aimed to examine the 
relationship between experiential avoidance and psychological distress to examine the 
rationale for using the ACT model with this population. 
 
1.8 Epistemological position 
In carrying out the present research we adopted a post-positivist stance. Post-
positivism is an extension of positivism, the belief that an objective reality exists 
independent of human perception, which can be observed, measured and understood 
through empirical methods (Everest, 2014). While maintaining the central premise that 
an objective reality exists, post-positivism acknowledges that the researcher cannot be 
entirely independent of the research and therefore only an approximate understanding 
of reality can be achieved, based upon the subjective observations and interpretations 
of the researcher (Denzin & Lincoln, 2000). By this account, truth equates to a 
correspondence between theory and reality, as much as this is possible, given the 
limitations created by researcher bias. 
 
As previously described, ACT is embedded in a pragmatic philosophy of science called 
functional contextualism. In pragmatism, all knowledge is relative and so an absolute 
truth does not exist (James, 1907). Knowledge refers to the “act in context”, or in other 
words, behavioural relations as a function of their current and historical setting (Hayes, 
1993). An evaluation of truth is itself an act in context and thus, one can never step 
outside of the behavioural stream to make an objective observation of it (Morris, 1988). 
By this contextualist account, the criterion of truth is one of successful working rather 
than correspondence between a model and ontological reality (Hayes et al., 2012).  
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Post-positivism and functional contextualism both embrace experimental methodology 
but with different objectives in mind. While post-positivism aims to model reality through 
experimental procedures (while acknowledging the impact of researcher bias), 
functional contextualism uses these procedures as a means of realising the goals of 
the researcher, namely to predict and influence events (Vilardaga, Hayes & Schelin, 
2007). The justification for our post-positivist stance is that it remains the dominant 
paradigm for research examining best practice in psychotherapy (Field, 2012). In 
accordance with this position, attempts were made throughout the research to ensure 
researcher bias was reduced as much as was practicable. 
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2. Extended Methods 
This section provides further details on the recruitment procedure, the assessment 
measures used, the target sample size and the randomisation process. Details of the 
individual level analysis are also provided as well as a break-down of the self-help 
manual. Finally, an account of the ethics committee application process is described.  
 
2.1 Recruitment 
Four dialysis units, all coordinated by the same NHS Trust, were selected for 
recruitment. It was hoped that by recruiting from multiple dialysis units this would 
provide a large enough population from which to identify eligible and interested 
participants. This also gave us a more representative sample than if recruiting from one 
unit alone and allowed us to determine the variability in screening questionnaire return 
rates between different facilitating staff teams. 
 
We utilised two recruitment procedures allowing us to evaluate different approaches to 
recruitment. In the first procedure, a designated member of staff at each unit was 
identified to approach participants, provide them with a participant information sheet 
and determine their interest in participating in the trial. WV was on hand to speak to 
patients who expressed an interest or wanted more information. This recruitment 
method was trialled at one dialysis unit but proved extremely time consuming, 
identifying only two participants who were willing and eligible to participate in the trial. 
As a result, it was agreed that an alternative recruitment procedure should be pursued 
in which all haemodialysis patients were screened. WV was then able to approach 
those who met the cut-off on the PHQ-9 to determine their interest and eligibility. This 
second recruitment procedure also allowed us to determine the number of patients who 
met the PHQ-9 cut-off and compare this with previous population estimates for 
depression. 
 
2.2 Sample Size 
For pilot and feasibility trials, a sample size of 24 (12 per arm) has been recommended 
(Julious, 2005). The rationale for this guidance is based upon recruitment feasibility 
and precision about the mean and variance of each group. Based upon this guidance 
and the time-constraints of the research, there was a target sample size of 30 (15 per 
group) allowing for 25% attrition. Although this attrition rate appears high, in an RCT of 
a telephone-supported ACT self-help intervention for chronic pain, similar to the 
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present trial in terms of length, participant burden and intervention, 42% attrition was 
reported (Johnston, Foster, Shennan, Starkey & Johnson, 2010). However, this high 
level of attrition appears quite rare with one review finding that in 71 trials only 18% 
reported a drop-out rate of 20% or more (Wood, White & Thompson, 2004).  
 
2.3 Measures 
This section provides additional details on the screening and outcome measures used 
within the study. As previously described, the Generalised Anxiety Disorder 7-item 
(GAD-7: Spitzer, Kroenke, Williams & Löwe 2006) scale was included alongside the 
Patient Health Questionnaire (PHQ-9: Kroenke, Spitzer & Williams, 2001) to examine 
correlations between psychological flexibility and anxiety at screening. As with the 
PHQ-9, respondents indicate, using a four-point Likert scale (0 is not at all to 3 is nearly 
every day) how often they have been bothered by a series of anxiety symptoms over 
the previous two weeks. The total score is the sum of all items. The GAD-7 is 
recommended by NICE (2011) and was selected for the present study based on its 
brevity and excellent reliability (Cronbach’s α = .92; Spitzer et al., 2006). 
 
The use of the Emotion Thermometer (ET: Mitchell, Baker-Glenn, Granger & Symonds, 
2010) at screening allowed us to examine the acceptability of a second distress 
measure as part of our feasibility analysis. The ET offers a rapid completion time and 
simplicity. To complete the ET, respondents rate how much emotional upset they have 
experienced on each domain and the degree to which this has impacted upon them 
over the previous two weeks. Permission to use this measure was granted by the 
author. The ET has been validated for use in cancer (e.g. Schubart, Mitchell, Dietrich & 
Gusani, 2015), epilepsy (Rampling et al., 2012) and cardiovascular disease (Mitchell et 
al., 2012), although it has yet to be validated with a haemodialysis population. In a 
sample of cancer patients, the ET showed excellent internal consistency (Cronbach’s α 
= .91; Mitchell & Symonds, 2010). 
 
The EQ-5D-5L (EuroQol Group, 1990) assesses five dimensions (mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression) representing different aspects 
of the respondents' health state. For each dimension respondents indicate by ticking a 
box, which of five statements best describes their health today. Each statement 
represents a different level of perceived problem and corresponds with a number from 
1 (no problem) to 5 (extreme problem). These numbers have no arithmetic properties, 
instead they are combined to create a 5-digit code describing the respondent’s overall 
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health state. A total of 3125 health states are possible. Health states can be converted 
into a country-specific index value allowing for the calculation of quality-adjusted life 
years (QALY), a measure of disease burden which is used to determine the cost-utility 
of an intervention. Scores range from -1 to 1. The EQ-5D-5L has shown acceptable 
test-retest reliability (intraclass correlation =.69; Janssen et al., 2012) 
 
The Acceptance and Action Questionnaire (AAQ-II: Bond et al., 2011) was also 
administered as part of the screening procedure to enable inferences to be drawn 
about those who wish to participate and those who do not, and to examine the 
relationship between psychological flexibility and distress. Respondents rate how much 
they agree with seven statements using a seven point Likert scale where 1 is never 
true and 7 is always true. The measure is scored by totalling the answers, with possible 
scores ranging from 7 to 49. High scores indicate greater psychological inflexibility. 
Internal reliability of the AAQ-II is good (Cronbach's α =.84). 
 
The Valued Living Questionnaire (VLQ: Wilson et al., 2010) was used as a functional 
measure to provide preliminary analysis of whether the intervention fosters valued 
action. For each domain the importance score and consistency score are summed and 
the mean is calculated. The mean scores for all domains are then summed to provide a 
valued-living composite score. Preliminary analysis indicates that the VLQ composite 
score has good internal consistency (Cronbach's α =.7) and test re-test reliability 
(intraclass correlation =.75).  
 
2.4 Randomisation and blinding 
An account of the randomisation procedure can be seen in the journal paper above. 
Given the nature of the trial, blinding was not possible. It was necessary to inform 
participants of their allocation in order for those allocated to the intervention arm to be 
provided with the self-help manual. WV was aware of allocation as he informed 
participants which group they had been allocated to and provided telephone support to 
those allocated to the self-help arm of the trial. WV was not aware of the computer-
generated random number sequence used in the randomisation procedure. The 
interviewer (BP) was also aware of allocation as participants in the intervention arm 
were given more questions to answer than those in the treatment as usual arm.  
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Table 10 
 
Overview of weekly reading, chapter titles and contents in Hayes and Smith (2005) 
 
Week 
 
Chapter title Content of chapters and processes targeted 
1 
 
Introduction 
 
General introduction to ACT model and processes. 
Chapter 1: 
Human suffering 
 
Introduces notion of destructive normality and the process of 
experiential avoidance. Exercises help readers generate a 
suffering inventory and consider how their life would be different if 
they were not struggling with pain. These exercises lay the 
groundwork for creative hopelessness. 
 
Chapter 2: Why 
language leads 
to suffering 
 
Introduces RFT principles using exercises and a series of figures 
depicting how a relational network with two trained relationships 
expands to six relationships with no further training (i.e. four 
relationships are derived). Creative hopelessness is built using an 
exercise in which readers identify their coping strategies and rate 
the long and short-term success of these strategies. Exercises 
and metaphor are used to demonstrate ineffectiveness of 
avoidance. The relationship between language and experiential 
avoidance is explained. A metaphor is used to introduce the 
difference between cognitive fusion and defusion. 
 
2 Chapter 3: The 
pull of avoidance 
 
Uses several metaphors and an example to explain the 
ineffectiveness and futility of the control/avoidance agenda. 
Discusses various reasons why we have learnt to pursue this 
agenda. An exercise is used to help readers evaluate the 
workability of their control strategies over a number of days. 
Another exercise acts as a primer for mindfulness by asking 
readers to record present moment thoughts and feelings. 
 
Chapter 4: 
Letting go 
 
Introduces acceptance as an alternative to experiential avoidance. 
Several metaphors are used to exemplify this. Research is cited to 
emphasise the importance of acceptance in different clinical 
problems. Exercises are used to show the advantages of 
acceptance. 
 
Chapter 5: The 
trouble with 
thoughts 
 
Discusses thought production, cognitive fusion and the 
relationship between cognitive fusion and experiential avoidance. 
Exercises are used to help readers to reflect on their thoughts and 
to determine which thoughts are most related to their struggle with 
pain. An exercise is also used to demonstrate the difference 
between fusion and defusion. 
 
3 Chapter 6: 
Having a thought 
versus buying a 
thought 
 
Discusses the ineffectiveness of thought challenging. Cognitive 
defusion is explained using RFT principles. A wide range of 
defusion exercises are provided along with details of when to use 
defusion and how to develop one’s own defusion techniques. 
 
Chapter 7: If I'm 
not my thought 
then who am I? 
 
Introduces concepts of self as context and self as content. An 
exercise is used to show the arbitrary nature of self-
conceptualisations. Self as content is linked to cognitive fusion to 
demonstrate its role in limiting behaviour. The chess board 
metaphor is provided to explain self as context. Exercises are 
used to demonstrate self as context and mindfulness. 
 
Continued 
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Table 10  
 
Continued 
 
Week 
 
Chapter title Content of chapters and processes targeted 
4 
 
Chapter 8: 
Mindfulness 
 
Introduces mindfulness, what it is not and how to practice it. A 
wide range of mindfulness exercises are provided to demonstrate 
the concept.  
 
Chapter 9: What 
willingness is and 
is not 
 
Provides a more detailed account of acceptance and what it is 
not. An exercise helps readers identify what experiences they 
need to accept. A figure depicting a head full of painful 
experiences is used as a physical metaphor to represent 
acceptance. 
 
5 Chapter 10: 
Willingness: 
learning how to 
jump 
 
Works through first steps towards acceptance using exercises. 
Chapter 11: What 
are values? 
 
Introduces values as chosen life directions and differentiates them 
from goals, feelings and outcomes using exercises and metaphor. 
6 Chapter 12: 
Choosing your 
values 
 
Uses exercises to help readers identify their values in different life 
areas and rate them in terms of importance and the degree to 
which they are living consistently with each value. 
Chapter 13: 
Committing to 
doing it 
 
Introduces committed action and uses exercises to help readers 
to set goals, identify actions that they can take towards achieving 
their goals and consider expected barriers. Guidance on building 
patterns of effective action are provided with charts that can be 
used to track valued living over time. 
 
Conclusion: The 
choice to live is 
vital 
 
Provides a summary of the material covered and reminds readers 
that valued living is a choice. 
 
 
2.5 Intervention 
Table 10 provides an overview of the recommended weekly reading from Get Out of 
Your Mind and into Your Life with a brief description of the topics and processes 
covered (Hayes & Smith, 2005). The book is 198 pages in total (excluding appendix 
and reference section), equating to an average of 33 pages (including figures and 
exercises) per week. Each chapter comprises information about the ACT model and 
includes examples, exercises and metaphors. Some exercises are experiential in 
nature (e.g. mindfulness or defusion techniques) while others involve writing or keeping 
a diary. The duration of the intervention and amount of weekly reading was discussed 
and agreed with the Clinical Psychologist within the service. In qualitative studies, 
dialysis patients have described their dialysis regimen as being characterised by 
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boredom and waiting (e.g. Moran, Scott & Darbyshire, 2009) with a typical 
haemodialysis patient requiring three four-hour sessions of dialysis each week. As 
such, participants would have at least 12 hours each week to undertake their reading. 
The protocol for a trial of computerised CBT self-help also proposes supplying self-help 
materials for patients to complete during in-centre haemodialysis (Hudson et al., 2016). 
 
As described above, the guided aspect of the intervention comprised six weekly 
telephone calls lasting up to 30 minutes and conducted by WV. The content of the calls 
was structured around a series of questions which can be seen below. 
 
1. Have you read chapters X and Y? 
2. If so, how did you find it? If not, what got in the way? 
3. Was there anything you would like to clarify with me (e.g. concepts, exercises)? 
4. What did you like/not like about the chapter? 
5. What did you find helpful/unhelpful in the chapter? 
6. Did you do all the exercises? If so, how did you find them? If not, what got in the 
way? 
7. Is there anything you would like to discuss in relation to chapter X? 
8. Do you have any questions about the chapter? 
9. Do you have any questions relating to your participation in the study? 
 
After initial introductions and a check to ensure that the time was appropriate, 
participants were reminded that they would be asked a number of questions. They 
were advised that it would be helpful to have the manual in front of them during the call. 
 
Common factor strategies (aspects of psychotherapy which are common across 
therapeutic modalities) such as active listening, warmth, empathy, summarising, 
reflections and questioning skills, were used to develop and maintain a therapeutic 
alliance with each participant. We did not assess the strength of the therapeutic 
alliance, however, as this was beyond the scope of the study. 
 
There were several functions to the calls. Participants were asked whether they had 
read each of the prescribed chapters and completed all of the exercises therein. This 
allowed us to determine to what extent participants had adhered to the intervention, 
with follow-up questions examining barriers to adherence. Providing encouragement 
was another core function of the calls. When participants had not completed the 
chapters, they were given reassurance and encouraged to continue with the manual. 
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When participants had completed the chapters they were given praise to reinforce their 
efforts. Several questions gave participants the opportunity to discuss and clarify 
information. This served to support their understanding of the written material, 
exercises, therapeutic model and techniques, and provided time to troubleshoot any 
difficulties. 
 
Although risk was not assessed explicitly during each call, in the event that a 
participant’s responses or demeanour gave cause for concern, a risk assessment 
would be carried out. Ultimately, no risk issues arose during these calls. At the end of 
the call, participants were given the opportunity to ask any remaining questions relating 
to the intervention or trial procedure and a time for the next call was arranged. A 
reminder of which chapters to read over the subsequent week was also provided. 
 
2.6 Framework analysis 
As described above, framework analysis (Ritchie & Spencer, 1994) was used in the 
analysis of interview data. Like thematic analysis and qualitative content analysis, the 
framework approach allows the researcher to identify similarities, differences and 
relationships between different parts of the data before drawing descriptive or 
explanatory conclusions based on themes (Gale, Heath, Cameron, Rashid & Redwood, 
2013). The output of the framework analysis, and a defining characteristic of the 
approach, is a matrix which allows the data to be analysed according to code or case 
(e.g. interviewee). 
 
In selecting this method, there were two primary considerations: the research question 
and the epistemological position of the researchers. As a feasibility trial, we had pre-
defined areas of interest relating to specific aspects of the trial procedure and 
intervention. Unlike thematic analysis, which focuses on themes emerging from the 
data, framework analysis emphasises a priori issues and as such allows the 
investigation of specific pre-defined themes. Furthermore, unlike some qualitative 
approaches, framework analysis is not tied to a particular epistemological or theoretical 
position and is therefore flexible to the approach of the researcher. This strengthens 
the rationale for its use here. 
 
There is published guidance for conducting framework analysis in healthcare (Gale et 
al., 2013) and psychological research (Parkinson, Eatough, Holmes, Stapley & 
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Midgley, 2016). The analysis was carried out by WV based on this guidance. A brief, 
stage-by-stage account of our approach is provided below: 
 
Stage 1: Transcription 
Audio recordings were transcribed by a paid transcription service for time saving 
purposes. Given that the content is of primary interest in framework analysis, other 
conventions of dialogue, such as pauses, were not required.  
 
Stage 2: Familiarisation 
An initial read through of the transcripts allowed familiarisation with the data prior to 
coding. It is not necessary to review all of the data in framework analysis (Srivastava & 
Thomson, 2009), however, as there was relatively little data and as the transcription 
had been carried out externally, all of the data was reviewed. 
 
Stage 3. Coding 
Following familiarisation with the data, the transcripts were re-read and codes were 
applied to each line. These codes are essentially labels describing the content of the 
line. As an entirely deductive study, codes were pre-defined based on different aspects 
of the trial procedure and intervention (recruitment, randomisation, measures, support 
calls and self-help manual). There was an additional code labelled “treatment as usual” 
as the interview also investigated participants’ past experiences of treatment (i.e. 
whether they had previously accessed individual or group therapy, used 
psychopharmacological treatments or read self-help books). Data that did not fit into 
any of these codes were given the code “other”. 
 
Stage 4. Charting data into a framework matrix 
For each transcript, the data was summarised for each code, reducing the data while 
maintaining the original meaning of the content. Using a spreadsheet, the summarised 
data was charted into a matrix with each column heading representing an individual 
participant and each row heading representing a code.  
 
Stage 5. Mapping and interpretation 
For each code, similarities and differences between the data were identified providing a 
description of participants’ individual and collective perceptions of each aspect of the 
trial.  
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2.7 Individual level analysis 
RCTs typically use between-group comparisons of measures of central-tendency using 
inferential statistical analyses. Such analyses were precluded by our small sample size, 
however, individual level analyses provide an account of how individual participants 
respond to interventions by comparing pre- and post-intervention outcomes. The Leeds 
Reliable Change Indicator software (Agostinis, Morley & Dowzer, 2008) can be used to 
examine whether individual changes in outcome scores are reliable and/or clinically 
significant.  
 
Reliable change refers to instances when the change in an outcome score is 
sufficiently large that it is unlikely to be due to measurement unreliability (Jacobson, 
Follette & Revenstorf, 1984). To determine whether reliable change has occurred, the 
software calculates measurement variability, known as the reliable change index (RCI), 
by dividing the change in the individual client’s score by the standard error of the 
difference for the outcome measure being used. If the RCI is greater than or equal to 
1.96, then the change is statistically significant and there is a 95% certainty that reliable 
change has occurred. Such changes may represent both improvement in functioning 
and deterioration.  
 
Clinically significant change refers to instances when the client’s level of functioning 
following treatment improves to the extent that it falls outside the range of the 
dysfunctional population (Jacobson & Truax, 1991). Where a measure has an 
externally determined clinical cut-off score, this can be used to determine clinically 
significant change (e.g. on measures where high scores indicate poorer functioning, 
those falling below the designated cut-off have moved outside the range of the 
dysfunctional population). In the present trial, we used a cut-off of 10 for the PHQ-9 so 
clinically significant change refers to scores that fall under this cut-off, post-intervention. 
No clinical cut-offs are published for the EQ-5D-5L but an increase or decrease of 0.07 
is considered a minimally important difference (Walters & Brazier, 2005). For the AAQ-
II, no externally determined cut-offs are provided. In these instances, Jacobson et al. 
(1984) propose the use of one of three statistical criteria: 
 
a. If normative data for a non-clinical reference group (e.g. general population) is 
not available, to designate an outcome as clinically significant the post-
intervention score should fall outside the range of functioning for the clinical 
population (e.g. 1.96 standard deviations). 
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b. When normative data for a non-clinical reference group is available and scores 
from the non-clinical and clinical groups overlap, clinically significant change is 
indicated by the post-intervention score falling within the range of the non-
clinical population (e.g. 1.96 standard deviations from the non-clinical 
population mean). 
c. When normative data for a non-clinical reference group is available and scores 
from the non-clinical and clinical groups do not overlap, clinically significant 
change is indicated by the post-intervention score falling closer to the non-
clinical population mean than the clinical population mean. 
 
In accordance with this guidance, criteria b was adopted to determine clinically 
significant change on the AAQ-II.  
 
2.8 Ethical approval 
The research protocol and supporting documents were submitted to the National 
Research Ethics Service Committee (NRES), North West, who granted ethical approval 
for the trial (see Appendix B for approval letter). To recruit from Nottingham University 
Hospital NHS Trust sites, ethical approval was sought and granted from the trust 
Research and Innovation department (see Appendix C for approval letter). Ethical 
approval was also granted from the University of Lincoln, School of Psychology 
Research Ethics Committee (SOPREC).  
 
Our second recruitment procedure, which involved distributing screening 
questionnaires to all patients, was not part of our original protocol. As such, this 
required the submission of a substantial amendment to the NRES Committee and 
subsequent agreement from the local Research and Innovation department. Copies of 
approval letters can be seen in Appendix D and E.  
 
2.8.1 Informed consent 
Screening questionnaires were accompanied by a letter giving a brief overview of why 
we were requesting patients’ information. Patients were advised that by completing the 
screening questionnaire they were consenting to their anonymised information being 
used in our research. This allowed us to collect data on rates of acceptance and 
psychological distress from individuals not enrolled in the trial. 
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Prospective participants were provided with a participant information sheet giving an 
overview of the study including: details of the purpose of the trial, who was eligible, how 
participants would be randomised, what was required of participants in each arm of the 
trial, what the potential benefits, risks and disadvantages were, how the research was 
funded and contact details for WV, NRES Committee, SOPREC and the local Patient 
Advice and Liaison Service (PALS). The information sheet also informed potential 
participants of their right to withdraw at any time during the trial and explained that all 
information would be treated as confidential. Prior to participation, participants were 
required to sign a consent form. Copies of the latest versions of the participant 
information sheet and consent form can be seen in Appendix F and G. To ensure that 
the participant information sheet and consent form were at an appropriate reading 
level, copies were given to two lay-persons who read through and confirmed 
readability. 
 
2.8.2 Confidentiality 
All participant information was treated as confidential and was not shared beyond those 
involved in conducting the research (see exception below). All electronic data was 
anonymised using corresponding identification numbers and stored on password 
protected computers. Hardcopy participant data was stored securely in the trial master 
file in a locked office at the University of Lincoln. 
 
The limitations and one exception to confidentiality rules were given to patients in 
advance of any assessment data being collected. In the letter accompanying the 
screening questionnaire, patients were advised that if their responses indicated that 
they were experiencing significant psychological distress, then their family doctor would 
be notified by letter. This ensured effective risk management and gave individuals the 
opportunity to seek treatment from their family doctor, as appropriate. The intention to 
share this information with family doctors was repeated in the participant information 
sheet. Similarly, prospective participants were advised that if a member of the research 
team had concerns about the well-being of a participant or anybody else, then a breach 
of confidentiality would be warranted. Where possible, consent would be gained prior to 
sharing this information outside of the research team. 
  
2.8.3 Iatrogenic effects 
The term iatrogenic effect refers to the capacity for treatments to cause harm. It is 
estimated that three to six per cent of individuals who receive psychotherapeutic 
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treatment experience deterioration in their mental health (Mohr, 1995). No attempts 
have been made to estimate iatrogenic effects in self-help interventions. However, as 
with all treatments, such effects are possible. 
 
ACT interventions encourage clients to abandon unhelpful avoidance behaviours and 
open themselves up to distressing private experiences such as thoughts, memories, 
emotions and physical sensations. In doing so, clients may experience some additional 
distress. However, there is considerable evidence that ACT interventions aimed at 
reducing experiential avoidance lead to positive benefits for clients (Hayes et al., 2006). 
The participant information sheet advised participants that discussing their problems 
could cause distress and that any concerns about their well-being would be shared with 
the Clinical Psychologist based within the renal service. This allowed participants to 
make an informed decision, bearing in mind the possible risks of participation. 
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3. Extended Results 
This section provided further details on return rates for our screening questionnaire 
across units and the self-reported prevalence of various problems identified on the ET 
problem list. There is also an account of parametric assumption testing and the 
treatment of outliers. Finally, there is an examination of data pertaining to participants’ 
past experiences of treatment, to provide an account of what patients receive as 
treatment as usual. 
 
3.1 Screening procedure 
Table 11 shows the number of screening questionnaires distributed and returned per 
unit. There was considerable variability in the return rate between units with a higher 
return rate at the satellite units when compared with the city units. The highest return 
rate was at satellite unit 2 where nearly half of the patients returned their 
questionnaires. The reason for this variability is unclear however it may relate to the 
way in which facilitating staff teams distributed and collected the questionnaires.  
 
3.2 Problem list 
Table 12 shows the frequency and percentage of screening questionnaire completers 
who reported each of the problems on the ET problem list. More than half of those who 
completed the screening questionnaire reported problems with pain, fatigue, sleep, 
getting around, and dry or itchy skin. The number of people who identified depression 
as a problem (n = 31) is consistent with the number meeting the cut-off for depression 
on the PHQ-9 (n =30). 
 
3.3 Outliers, normality testing and homogeneity of variance 
A series of between group analyses were carried out to examine: a) differences 
between screening questionnaire completers and non-completers; and b) differences 
between participants in the ACT and treatment as usual conditions at baseline. The 
independent t-test is a commonly used method for evaluating the difference between 
two unpaired groups. It requires that the dependant variable is approximately normally 
distributed in both groups and that there are no significant outliers. Homogeneity of 
variance between the groups is also required. The identification and treatment of 
outliers for each variable in each group is described below. Where a variable was not 
approximately normally distributed, non-parametric Mann-Whitney U tests were 
computed. 
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Table 11 
 
Percentage of questionnaires returned per unit 
 
 Questionnaires 
 
Unit Distributed Returned 
 
City unit 1, n (%) 100 32 (32) 
City unit 2, n (%) 49 9 (18.4) 
Satellite unit 1, n (%) 53 23 (43.4) 
Satellite unit 2, n (%) 74 35 (47.3) 
Total 276 99 (36.9) 
 
 
Boxplots were used to check for outliers in age of completers and non-completers. This 
identified five outliers amongst completers and two amongst non-completers. Outliers 
were reduced to the next highest age that was not an outlier. Normality was assessed 
using visual inspection of normality plots and z-tests using a critical z-value of 3.29 as 
recommended for a sample of this size (Kim, 2013). Age was not normally distributed 
amongst those who completed the screening questionnaire with a skewness of -.91 
(SE = .24) and kurtosis of -.11 (SE = .48). The absolute z-value for kurtosis was 3.76. A 
normal distribution in age was found amongst non-completers with a skewness of -.54 
(SE = .18) and kurtosis of .001 (SE = .36). As age was not normally distributed for 
screening questionnaire completers, a Mann-Whitney U test was conducted. 
 
Further checks for outliers, normality and homogeneity of variance were conducted 
prior to examining baseline differences between participants allocated to the ACT and 
control arms of the trial. Inspection of boxplots showed no outliers in age, years 
dialysing, PHQ-9, EQ-VAS and VLQ, however one outlier was identified for the EQ-5D-
5L index value and another for the AAQ-II. These outliers were reduced to the next 
lowest values that were not outliers.  
 
Normal distributions were found in both groups for age, PHQ-9, EQ-5D-5L index score, 
AAQ-II and VLQ, as assessed by Shapiro-Wilk’s test (p = >0.05). Shapiro-Wilk’s is 
regarded as an appropriate method for assessing normality in samples less than 50. A 
non-normal distribution was found in years dialysing for the ACT condition (p = .04) and 
EQ-VAS in the control condition. As the normality assumption was violated, Mann-
Whitney U tests were administered to examine between-group differences in years 
dialysing and EQ-VAS. Homogeneity of variance, as assessed by Levene’s test, was 
found for age (p = .94), PHQ-9 (p = .54), EQ-5D-5L index value (p = .37), AAQ-II (p =  
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Table 12  
 
Proportion of each problem on the problem list reported by screening questionnaire completers  
 
Problem n (%) 
Getting around 56 (58.3) 
Pain 55 (57.3) 
Fatigue 54 (56.8) 
Skin dry/itchy 51 (53.1) 
Sleep 50 (52.1) 
Tingling in hands/feet 44 (45.8) 
Breathing 36 (37.5) 
Worry 35 (36.8) 
Bathing/dressing 33 (34.4) 
Sadness 32 (33.7) 
Depression 31 (33) 
Feeling swollen 31 (32.3) 
Eating 27 (28.1) 
Nervousness 27 (28.4) 
Nausea 25 (26) 
Changes in urination 24 (25) 
Constipation 23 (24) 
Indigestion 22 (22.9) 
Nose dry/congested 22 (22.9) 
Fears 21 (22.1) 
Transportation 21 (22.1) 
Diarrhoea 19 (19.8) 
Dealing with partner 17 (17.9) 
Sexual 11 (11.5) 
Dealing with children 10 (10.5) 
Housing 9 (9.5) 
Fevers 7 (7.3) 
Mouth sores 6 (6.3) 
Relating to God 5 (5.3) 
Work/school 4 (4.2) 
Loss of faith 3 (3.2) 
Child care 1 (1) 
Insurance 0 (0) 
 
 
.74) and VLQ (p = .46). As each of these variables met all relevant assumptions, 
independent t-tests were conducted. 
 
To examine whether psychological inflexibility, as measured by the AAQ-II, was 
correlated with psychological distress, two Pearson’s product-moment correlations 
were computed. The first examined the relationship between psychological inflexibility 
and depression, as measured by the PHQ-9. Visual inspection of a scatter plot 
revealed one outlier which was removed prior to the analysis. The second analysis 
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examined the relationship between psychological inflexibility and general anxiety, as 
measured by the GAD-7. A scatter plot was inspected prior to analysis but in this 
instance no outliers were identified. 
 
3.4 Treatment as usual 
As a feasibility trial using a treatment as usual control arm, it was important to 
determine what treatment as usual typically looks like. Interviewees were asked about 
their experiences of previous treatments including psychopharmacological treatment, 
individual or group psychotherapy and self-help. Of the six participants interviewed, 
four had not been prescribed anti-depressant medication since being diagnosed with 
CKD. Two participants had been prescribed Citalopram although only one of these 
participants had a current prescription. Two participants had never received any 
psychological therapy since being diagnosed with CKD while three had received 
various interventions. Two participants had seen the Clinical Psychologist at the renal 
unit, another participant had received four sessions of CBT but did not complete a full 
course of treatment. Another participant had seen a Psychiatrist when she was first 
diagnosed. Five out of the six participants had never been to a therapeutic or 
meditative group while one had attended one session of art therapy. Only one 
participant had previously read a self-help book although she could not recall the title. 
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4. Extended Discussion 
This section will expand upon issues discussed in the journal paper regarding matters 
of recruitment, adherence and other aspects of feasibility. A consideration of the 
strengths and limitations of the study are provided as well as recommendations for 
future research directions.  
 
4.1 Feasibility: Recruitment 
Recruitment difficulties are not uncommon in health research. One systematic review 
found recruitment problems in 63% of the 114 RCTs included (McDonald et al., 2006). 
Recruitment problems are well documented in depression trials specifically, with 
numerous studies failing to reach their target recruitment numbers (e.g. Woodford, 
Farrand, Bessant & Williams, 2011) or failing to recruit altogether (Hunt, Shepherd & 
Andrews, 2001; Ruddell, Spencer, Hill & House, 2007). 
 
Recruitment problems have been reported in other trials of telephone-supported self-
help with one trial reporting only 1% of individuals with mild to moderate depression 
who were sent study information packs, consenting to the trial (Woodford et al., 2011). 
The intervention in this case was a computerised CBT course with minimal telephone 
support and the recruitment methods and target population were also dissimilar to 
those of the present trial. Despite the dissimilarities, this highlights that difficulties 
recruiting into self-help studies is not unique to our trial.  
 
While it has been argued that recruitment experience is unique to each trial (Baquet, 
Henderson, Commiske & Morrow, 2008), some studies have attempted to identify 
recruitment barriers that might be common across mental health research. A meta-
synthesis examining factors affecting recruitment into depression trials identified three 
emergent themes: the participant’s health state, their attitude toward research and trial 
interventions; and the communication and relationship between participants, 
gatekeepers (e.g. carers and clinicians) and the research team (Hughes-Morley, 
Young, Waheed, Small & Bower, 2014). These emergent themes provide a framework 
for considering possible reasons for our recruitment failure.  
 
4.1.1 Health state 
In their review, Hughes-Morley et al. (2014) found that certain presenting 
characteristics of depression (e.g. lack of confidence) could have a negative impact on 
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recruitment. They also found that the existence of co-morbid problems had a 
confounding effect. The impact of these aspects of health state on our recruitment is 
discussed in the journal paper above.  
 
The authors of the review also found that participation was affected by perceptions of 
the impact of participation on their health state which involved a cost-benefit analysis. 
Clearly this is speculative, but it is possible that patients who we approached about 
participation did not perceive there to be a benefit. This is especially likely if they did 
not believe they were depressed (as discussed in the journal paper) or had a poor 
understanding of the potential benefits of supported self-help. Perhaps more 
information about self-help during recruitment would have addressed this. This could 
have been achieved by inviting individuals to information sessions or by providing more 
detail in the participant information sheet. However, it seems unlikely, given their 
reluctance to enrol in the trial, that many individuals would attend an invited information 
session, if it had been available. 
 
As well as failing to perceive benefits, eligible patients may have perceived there to be 
a considerable cost to participation, primarily in terms of the time commitment involved. 
This is in light of the extensive treatment burden already experienced by haemodialysis 
patients.  
 
4.1.2 Attitude toward research 
The second factor identified by Hughes-Morley et al. (2014) relates to potential 
participants’ attitudes toward research and trial interventions. They report that 
individuals are more motivated to participate in depression trials if doing so allows them 
to access an otherwise unavailable treatment. Telephone-supported self-help is not 
available as a standardised treatment at our recruitment sites but psychological support 
is available through the renal clinical psychologist. Eligible patients who declined 
participation also declined psychological support outside of the trial indicating that, 
even if they had perceived this to be a treatment that was otherwise unavailable, this 
would not have been a motivating factor.  
 
The reviewers found that participants were more likely to decline participation if they 
had a previously negative experience of the intervention. Although self-help materials 
are widely available, our framework analysis indicated that only one of the six 
participants interviewed in our trial had previously used a self-help book. While it is 
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difficult to generalise from such a small sample, it suggests that past negative 
experiences of self-help are an unlikely cause for our low recruitment numbers as few 
eligible patients are likely to have utilised self-help previously. 
 
4.1.3 Engaging the patient 
The third major theme identified by Hughes-Morley et al. (2014) was the relationship 
between researchers, participants and gatekeepers. Of particular relevance to the 
present trial is the issue of stigma. The reviewers found that depression was viewed as 
a highly stigmatised mental health problem. Furthermore, participants did not view their 
own difficulties to be of the same clinical severity as depression.  
 
When approaching participants in the present trial, we were careful to avoid the 
potentially stigmatising diagnostic label “depression”. Potential participants were 
advised that the screening questionnaire indicated that they might be feeling down or 
low in mood. It was anticipated that the use of the word “depression” during the initial 
conversation about the research could discourage further discussion and subsequent 
participation. However, estimated prevalence rates for depression in ESRD were 
detailed in the participant information sheet. It was hoped that by demonstrating how 
common depression is within the dialysis population, it might reduce stigma and 
encourage altruistic motivations for participation (i.e. individuals might be willing to 
participate knowing that a large number of dialysis patients may be helped through the 
development of a new treatment for depression). It is possible that our use of the word 
“depression” discouraged patients from participating due to the associated stigma or 
because they did not recognise themselves as depressed. 
 
Future depression trials in ESRD might benefit from avoiding diagnostic labels 
altogether. For example, our study could have been sold as an intervention to improve 
well-being rather than as a treatment for depression. In doing so, patients would not be 
deterred by the double stigmatisation of being perceived as depressed and being 
treated for depression. 
 
4.1.4 Experiential avoidance 
The factors identified by Hughes-Morley et al. (2014) may offer a partial account for our 
recruitment difficulties however, the avoidance paradigm, central to the ACT model, 
provides further insight. The rationale for an ACT intervention in ESRD was partly 
based on research highlighting the clinical significance of experiential avoidance and 
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acceptance in the psychological well-being of ESRD patients (Gillanders, Wild, 
Deighan & Gillanders, 2008; Ibrahim, Chiew-thong, Desa, Razali, 2013; Keskin & 
Engin, 2011; Poppe et al., 2013). Indeed, although we acknowledge the limitations of 
the AAQ-II, our findings indicated strong correlations between psychological distress 
(self-reported symptoms of depression and anxiety) and psychological 
inflexibility/flexibility. If distressed haemodialysis patients are more likely to engage in 
experiential avoidance as a coping strategy, then these avoidant behaviours may also 
act as a barrier to accepting treatment.  
  
Several aspects of psychological treatment might elicit avoidance behaviour. 
Psychological treatment involves an open exploration of emotional experiences. This 
can be challenging and aversive, and may lead some individuals to avoid treatment. 
Indeed, studies of have shown that undergraduate students who have a tendency to 
avoid emotions are less likely to seek treatment, although the use of non-clinical 
samples mean that these findings lack generalisability (Ciarrochi & Deane, 2001; 
Komiya, Good, & Sherrod, 2000). Similarly, students’ expectations about the extent of 
emotional expression in treatment have been shown to predict both treatment-seeking 
attitudes and treatment-seeking behaviour (Vogel, Wester, Wei & Boysen, 2005). 
Emotional suppression, a form of avoidance, is related to greater levels of depression 
in haemodialysis patients (Gillanders et al., 2008). This highlights a propensity amongst 
depressed dialysis patients to avoid emotion and may explain why some individuals did 
not want to participate in our trial.  
 
Another aspect of psychological treatment that might elicit treatment avoidance is self-
disclosure, the process by which clients divulge private feelings, thoughts and beliefs 
(Leaper, Carson, Baker, Holiday & Myers, 1995). There is variability in the extent to 
which people feel comfortable sharing personal and emotionally charged information 
with others and this has been shown to be a unique predictor of treatment-seeking 
behaviour (Vogel & Wester, 2003; Vogel et al., 2005).  In a cross-sectional study, 
individuals who were uncomfortable discussing personal issues were 5-times less likely 
to seek treatment than individuals who were comfortable (Diala, Muntaner, Walrath, 
Nickerson, LaVeist & Leaf, 2001). It is possible that avoidance of self-disclosure 
deterred enrolment in the present trial. Other factors that have been implicated in 
treatment avoidance are social stigma (Komiya et al., 2000) and anticipated utility and 
risks (Vogel & Wester, 2003), both of which were identified in the Hughes-Morley et al. 
(2014) review as barriers to treatment. Again, these may be important considerations 
with regards to the current research. 
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4.1.5 Treatment rates 
Depression treatment rates are low in the ESRD population and although this is partly 
due to under-diagnosis (Hedayati, Bosworth, Kuchibatla, Kimmel & Szczech, 2006), 
other explanations have been proposed. In a study of peritoneal dialysis patients, 55% 
of those identified as having depression refused further assessment and treatment, 
even when they were informed of the possible advantages (Wuerth, Finkelstein & 
Finkelstein, 2005). The main reasons for treatment refusal were denial that they were 
depressed, unwillingness to take additional medication, refusal to meet with the 
practitioner and the perception that depression was a sign of weakness and a potential 
source of stigmatisation. In another study, only 17% of haemodialysis patients 
identified as being depressed initiated treatment for depression, even after healthcare 
providers were informed of the diagnosis (Weisbord et al., 2013). The authors did not 
determine whether this was due to a lack of intention to treat on the part of the medical 
team, or because patients declined treatment. Furthermore, it is unclear what 
treatments were available to patients. 
 
These findings illustrate that the ESRD population might be especially reluctant to 
engage in treatment for depression and therefore, may be reluctant to participate in a 
trial where they might receive such a treatment. This hypothesis is supported by the 
finding that individuals who declined participation in our trial also declined 
psychological support outside of it. Having said that, other trials of non-self-help 
psychological interventions have successfully recruited ESRD patients (e.g. Cukor et 
al., 2014) indicating that there must be something particular about our recruitment 
methods or intervention that discouraged participation. 
 
4.1.6 A failed trial? 
In light of our recruitment troubles, one might be tempted to describe this as a failed 
trial. However, this does not take into account our aims. We set out to establish the 
feasibility of an RCT examining ACT telephone-supported self-help for depression in 
ESRD, and to that end, the trial addressed our aims – there is clear evidence that a 
full-scale trial adopting the present procedure is not feasible. However, ACT has shown 
effectiveness in other long-term conditions and we were able to demonstrate a 
relationship between the central ACT process – psychological flexibility – and distress 
in our sample. It is important, therefore, to consider how best to approach ACT 
interventions in ESRD while avoiding the recruitment difficulties encountered here. 
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A central consideration is how an ACT self-help intervention is promoted to ESRD 
patients. Evidently, our intervention was not appealing when offered as a treatment for 
low mood or depression, and as discussed, this may have been a factor in our low 
recruitment numbers. However, as briefly mentioned above, ESRD patients may have 
found the intervention more attractive had it been presented in a different way. For 
example, it could be promoted as an approach which helps individuals to do more of 
what is most important to them (i.e. valued living), or as way of improving quality of life. 
It is important to note that we have no data to suggest that this would address 
recruitment (or adherence) difficulties, however, such an approach would be more 
consistent with the ACT model. The ACT approach makes no hypotheses regarding 
distress reduction, in fact the whole model centres on accepting emotional pain in the 
service of values. This is perhaps captured most succinctly by the idea of “growing the 
person” rather than “shrinking the problem”. As such, the intervention would not be a 
treatment for depression but a way of reducing dysfunctional avoidant behaviour and 
encouraging ESRD patients to engage in valued action.  
 
Whether or not this would go some way to resolving recruitment difficulties is 
conjecture. However, without distress reduction as a primary outcome, inclusion criteria 
could be broadened, providing a larger pool of eligible patients from which to recruit. 
This approach has been used in other self-help trials. For example, a study comparing 
two self-help interventions for chronic pain, one based on applied relaxation and the 
other on ACT, successfully recruited 90 individuals from a chronic pain clinic in Sweden 
(Thorsell et al., 2011). Despite having depression and anxiety as outcomes, no distress 
cut-off was used and only two inclusion criteria were stipulated; participants had to be 
accessible during the 7-week intervention period and have sufficient literacy skills. 
Although there are obvious differences when compared to the present trial (e.g. 
population and setting), this study demonstrates the effectiveness of using broader 
inclusion criteria. Unfortunately, the authors do not state how the intervention was 
promoted to potential participants. 
 
In terms of applying this to the present study, one option would be to invite participation 
from all haemodialysis patients receiving treatment at the recruitment sites, regardless 
of their self-reported level of distress. Some eligibility criteria would still be applied, for 
example, participants would still need to be aged 18 years or over, be dialysing for six 
months or longer, have adequate English language speaking and reading ability, and 
an absence of sensory impairments likely to impede engagement in treatment. 
However, no distress cut-off would be applied.  
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Another option would be to use of a lower cut-off on the PHQ-9. Again, this would likely 
produce a larger pool of eligible participants with the possibility that this might increase 
overall recruitment numbers. This is however speculative and more research is needed 
to examine whether individuals with milder symptoms of depression are more 
motivated to participate in supported self-help interventions. The advantage to using a 
lower cut-off is that it is consistent with a stepped-care model of treatment in which 
individuals assessed as experiencing more severe levels of distress receive a more 
intensive intervention (e.g. face-to-face therapy). As such, although it is unclear 
whether this would resolve recruitment difficulties, it would be consistent with NICE 
guidance for the treatment of depression in long-term physical conditions (NICE, 2009). 
Further discussion of the use of a lower PHQ-9 cut-off is provided under the next 
subsection heading. 
 
While recruitment difficulties are common in health research, the review by Matcham et 
al. (2014), examining self-help interventions for psychological distress in patients with 
physical illness, shows that many self-help trials have successfully recruited individuals 
with long-term conditions. They identified 29 trials eligible for inclusion in their 
systematic review, all of which recruited more than our target sample size. Some of 
these studies are not appropriate for comparison with the present study due to 
significant differences in setting, population and intervention, however, examination of 
comparable studies may offer insights into how recruitment in the present trial could be 
improved. For example, in a Dutch trial of CBT-based self-help for people with 
rheumatic disease, Garnefski et al. (2013) recruited 82 individuals through patient 
organisation websites. Interested individuals were referred to a website where they 
could access study information and determine their eligibility. There are several kidney 
patient organisations in the UK, the foremost being the British Kidney Patient 
Association. Use of patient association websites would have broadened our 
recruitment pool to include anyone accessing these websites across the UK, rather 
than being limited to individuals receiving treatment at our recruitment sites. Bearing in 
mind our difficulties, future trials of self-help in ESRD may benefit from combining in-
centre and online recruitment strategies. 
 
An alternative way of widening the pool of potential participants is through a multi-
centre recruitment strategy. In a UK trial evaluating an evidence-based self-help 
guidebook to improve knowledge, anxiety and quality of life in people with ulcerative 
colitis, 240 participants were recruited across six hospital sites (Kennedy, Robinson, 
Hann, Thompson & Wilkin, 2003). There are advantages and disadvantages to this 
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approach. In terms of advantages, multi-centre recruitment provides a more 
representative sample and may allow the target sample size to be reached more 
quickly. However, recruiting from multiple organisations in different geographic regions 
is a time and resource heavy venture and may be beyond the scope of a feasibility trial. 
Once feasibility has been established, multi-centre recruitment may be the optimal 
strategy. 
 
4.2 Feasibility: Assessment 
Interview data indicates that our assessment methods were acceptable and 
appropriate. Completion rates and the extent of missing data are further indicators of 
acceptability. We gained a 36.9% return rate at screening, comparable to the return 
rate in the recent NHS GP Patient Survey, which recorded a national response rate of 
35.7% (Ipsos Mori, 2016). However, our questionnaires were distributed by staff teams 
at dialysis units while the GP Patient Survey was postal. A more fitting comparison is 
with the National Kidney Care Audit Patient Transport Survey which recorded a 67% 
return rate, with questionnaires distributed at renal units (NHS Information Centre, 
2011). In comparison to this, our return rate appears low, however, the Patient 
Transport Survey addressed a highly pertinent and almost daily issue for patients – 
how they get to-and-from their treatment – and revealed a rather negative picture for 
patients reliant on hospital transport. It is plausible that patients would be more 
motivated to respond to a questionnaire when it relates to a highly salient issue over 
which they have high levels of dissatisfaction. However, our response rate is also low 
compared to other hospital-based surveys including the English Cancer Patient 
Experience survey (67%; Macmillan Cancer Research, 2013) and the UK Adult 
Inpatient Survey (49%; Department of Health, 2010).  
 
Our questionnaire was five pages in length and while it is always problematic 
separating the effect of questionnaire content from length, longer questionnaires are 
typically associated with lower response rates (Rolstad, Adler & Ryden, 2011). 
Yammarino, Skinner and Childers (1991) found significantly lower response rates for 
questionnaires longer than 4 pages although this was not replicated in another study 
(Iglesias & Torgerson 2000). Furthermore, both of these studies, as with much of the 
research in this area, are based on postal survey data. Response rates might have 
been boosted if we had reduced the screening questionnaire to the PHQ-9 alone, 
however this would not have allowed us to collect data on psychological flexibility and 
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would have denied us the opportunity to examine which distress measures are most 
acceptable. 
 
Despite our response rates, missing data was minimal. For participants enrolled in the 
trial there was no missing data at all and at screening, there were no missing data 
points for the PHQ-9 and GAD-7. These measures are used widely across the NHS 
and both are recommended in NICE guidelines (NICE, 2011). The present findings 
confirm the acceptability of these measures in this population. There were a small 
number of missing data points on the AAQ-II with more on the problem list and more 
still on the ET. The latter two questionnaires were placed towards the end of the battery 
and patients may have lost interest at this point or not realised that there were 
additional pages. Although it is not entirely clear why the ET in particular had more 
missing data points, it suggests that the PHQ-9 and GAD-7 may be more acceptable 
as distress screening tools in renal services. When taken alongside interview data, the 
shortage of missing data indicates that overall our assessment methods were 
acceptable. Reducing the questionnaire length might serve to increase response rates. 
 
Although largely acceptable to participants, our assessment methods failed to 
effectively identify those for whom self-help might be most suitable. In a stepped-care 
model, the level of intervention is determined by the level of need, with low-intensity 
interventions aimed at individuals in the mild to moderate range of symptom severity. 
The iDiD trial of telephone-supported computerised CBT for distress in haemodialysis 
patients, currently underway in London, proposes the use of baseline PHQ-9 and GAD-
7 scores to identify those individuals for whom their intervention is most appropriate 
(see Hudson et al., 2016 for protocol). Individuals who fall within the mild to moderate 
range on these measures (5-19 on PHQ-9 and 5-14 on GAD-7) are deemed eligible for 
the trial, while those who fall into the sub-clinical or more severe range are not. In the 
present trial, PHQ-9 scores at screening ranged from 0 to 27 with an eligibility cut-off of 
≥10.  
 
Had we used the cut-offs proposed in the iDiD protocol, 31 patients deemed ineligible 
by our cut-off, would have been eligible. Conversely, nine patients who were eligible by 
our cut-off would have been ineligible for being above the mild to moderate range by 
the iDiD criteria. This would have provided a net gain of 22 patients to approach. 
Interestingly, only one of the nine patients who would have been excluded by the iDiD 
criteria consented to participate in the present trial. Furthermore, this individual was the 
only person to formally withdraw from the trial. By adopting the iDiD criteria, we would 
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have broadened the pool of eligible participants, including those with milder depressive 
symptoms for whom self-help might have been more acceptable and more appropriate. 
In addition, those who fell into the severe range (PHQ-9 score >19), who were 
evidently most reluctant to participate in the trial, would have been excluded.  
 
In light of this, it could be argued that our cut-off was too high, excluding individuals 
who may have been best placed to benefit from self-help. However, we had a strong 
justification for using this higher cut-off. As discussed previously, there is considerable 
symptom overlap between depression and ESRD. Several of the items of the PHQ-9 – 
those addressing the cognitive and somatic symptoms of depression – relate to 
symptoms commonly reported by ESRD patients, namely trouble sleeping, lack of 
energy, changes in appetite and trouble concentrating. Individuals with ESRD may 
score highly on these items without meeting diagnostic criteria for depression. As such, 
a cut-off of 5 may lack the specificity to correctly identify depression in ESRD patients.  
 
The Hudson et al. (2016) protocol proposes cut-offs based on a sample of the general 
population recruited through primary care clinics (Kroenke et al., 2001) while our cut-off 
was based on a sample of haemodialysis patients, reporting a 92% specificity and 
sensitivity when using the ≥10 cut-off (Watnick, Wang, Demadura, & Ganzini, 2005). 
Using a lower cut-off may have given a larger pool of participants but it is questionable 
whether all of these individuals would meet diagnostic criteria for a depressive disorder. 
As a feasibility trial, our aim was to determine the parameters of a hypothetical full-
scale trial. If our inclusion criteria fail to identify individuals experiencing the target 
clinical problem, then a full-scale trial would be unable to evaluate the effectiveness of 
our intervention for this problem. While it is worth considering a more liberal cut-off, our 
higher cut-off remains defensible, particularly as it provided a prevalence rate for 
depression that was in the range of estimates identified in previous studies (e.g. Wang 
& Watnick, 2004). Using a cut-off of >5, the prevalence of depression in our screened 
patients would far exceed these estimates. 
 
4.3 Feasibility: Self-Help 
According to Good Practice Guidance on the Use of Self-help materials within IAPT 
Services, an important consideration when designing self-help interventions is the 
readability and cultural appropriateness of the materials (IAPT, 2010). One participant 
in the present study found some of the language in the self-help manual too complex 
and also thought that the material was more relevant to a North American audience. 
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Although this is only one person’s perspective, it is worth considering how the content 
of the self-help book may have effected adherence. It seems likely that participants 
may be deterred from reading a book if it is beyond their level of literacy and if the 
content seems irrelevant to them.  
 
The self-help manual is a general self-help book based on ACT principles. It is not 
specifically written for haemodialysis patients. The trans-theoretical nature of the ACT 
model means that this is less problematic for ACT than it might be for other therapeutic 
approaches (e.g. CBT), but participants might have engaged better if the materials 
seemed more applicable to the haemodialysis patient experience. There is however, no 
data to support this assertion. The original intention had been to design an ACT self-
help manual specifically aimed at haemodialysis patients but this seemed overly 
ambitious in the time-frame available. In hindsight, although this may have improved 
adherence, it is unlikely to have impacted recruitment. 
 
The MRC argue that recruitment and retention are better in trials where potential 
participants value the intervention on offer (Craig et al., 2008). Our interview data on 
participants’ experiences of past psychotherapeutic treatments indicated that only one 
had used a self-help manual. Again, this lacks generalisability due to the small sample 
size but one might hypothesise, given that the proliferation of self-help is relatively 
recent and that the average age of these patients indicates an older group, that the 
ESRD population have little understanding of self-help and the concept of self as a 
mechanism of change. In their review, Khan et al. (2007) found that peoples’ 
understanding of self-help relied on past experiences. It is reasonable to assume that 
individuals who have no past experience of self-help will have a poor understanding of 
it and are unlikely to value it as a prospective intervention. Furthermore, patients in a 
medical setting may be more likely to view their role as a recipient of treatment rather 
than an active agent in it. This lack of understanding could account for our low 
recruitment, although this seems less likely given that patients did not want 
psychological support, regardless of how it would be delivered. 
 
4.4 Strengths 
In addition to our strong mixed methods design, which allowed a triangulation of 
qualitative and quantitative data in order to answer our research aims, there are some 
other notable strengths. Firstly, WV was unaware of the computer-generated random 
number sequence used in the randomisation procedure, reducing the risk of allocation 
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bias. Further risk of bias was removed by allocating people on a participant-by-
participant basis.  
 
The control of concomitant treatments is important in RCTs as this allows any 
improvement in outcomes to be attributed to the intervention under investigation rather 
than other treatments. Concomitant treatments were controlled to the extent that 
individuals were excluded if they were receiving psychological treatment at the time of 
recruitment. Participants were also advised to inform the research team if they started 
treatment. 
 
As a feasibility trial, it is a strength that we were able to evaluate the effectiveness of 
two recruitment strategies, even if this was only due to the ineffectiveness of our initial 
strategy. A strength of our second recruitment strategy is that we actively approached 
everyone who met the PHQ-9 cut-off for depression unless they were already receiving 
psychological treatment within the service. Previous trials of self-help have utilised 
recruitment strategies that require potential participants to actively respond to a study 
information pack (e.g. Woodford et al., 2011). Certain depression specific symptoms, 
such as low motivation, might prevent some participants from responding to invitations 
of this kind, particularly as depressed individuals frequently have low expectations for 
treatment outcomes (Prins, Verhaak, van der Meer, Penninx & Bensing, 2009). By 
actively approaching all patients who met the PHQ-9 cut-off we eliminated this 
problem.  
 
4.5 Limitations 
There are several limitations to our methodology, however the impact of many of these 
limitations is neutralised by the fact that the trial proved unfeasible. As previously 
discussed, low recruitment numbers and poor adherence prevented more in-depth 
analysis into which aspects of the ACT model and delivery format might be most 
helpful for ESRD patients. Indeed, only two participants in the ACT group were 
interviewed and only one of those had read the whole book. This meant very little was 
learnt about the content of the book and in terms of which bits were helpful, acceptable 
and relevant. However, even if we had reached our target recruitment and adherence 
had been high, the design precluded further analysis regarding the active ingredients of 
the intervention.  
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As discussed earlier, some research suggests that self-help is only beneficial when 
therapeutic guidance, such as weekly telephone calls, is provided. It is argued that 
guidance gives added value due to the effects of the therapeutic relationship (Glasman, 
Finlay & Brock, 2004), something that is absent in an unsupported self-help 
intervention. In order to determine whether this was the active ingredient in our 
intervention, an assessment of the therapeutic alliance would be needed with analysis 
focusing on the relationship between alliance and outcomes. Our use of the AAQ-II as 
a process measure instils additional problems in terms of identifying the active 
ingredients. The limitations of the AAQ-II are discussed in more depth above. RCTs are 
useful for identifying which treatments are helpful for which people, but in developing 
new interventions it is important to understand which aspects of the intervention make 
it work. To this end, single-case experimental designs and component studies, in which 
researchers try to isolate the effects of different ingredients by comparing treatments 
with and without them (Ahn & Wampold, 2001), are better suited. For our purposes (i.e. 
determining the feasibility of an evaluative trial), a two-armed RCT design was 
appropriate. Moreover, given our difficulties recruiting enough participants for two arms, 
recruiting enough for a third arm, where participants just receive the self-help book 
without telephone support, seems fanciful. 
 
The factors that might account for our recruitment difficulties have been discussed in 
great detail however much of this speculative. Our design did not allow us to gather 
more detailed information about why people declined participation but it is true that we 
failed to recruit our target sample size. Low recruitment numbers are only a limitation to 
the extent that it precluded further investigation of the ACT model and delivery format. 
It did not prevent us from achieving our primary aim of determining the feasibility of a 
full trial.  
 
An arguable weakness of our design is the use of a treatment as usual control group. 
Öst (2008) argues that the best RCTs compare the active treatment under evaluation 
with another empirically documented active treatment. However, our small sample size 
precluded any between group analysis and was focused more on issues of feasibility 
rather than effectiveness. For these reasons it was not essential to use an active 
comparison group and it seems unlikely that this would have made the trial any more 
appealing to patients.  
 
Under ideal circumstances, frequent recordings of therapy sessions should be checked 
for therapist competence and adherence to the therapeutic model. In the present trial, 
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these checks were not made. Again this did not prove to be overly problematic as 
participants’ poor adherence to the manual meant that they had rarely completed the 
necessary chapters in order to discuss the content.  
 
A final limitation relates to the information given to participants during recruitment. Two 
participants expressed that the randomisation procedure might be unfair, depriving 
patients of the psychological support that they might need. This suggests that a 
proportion of participants, and perhaps potential participants, did not understand the 
rationale for randomisation or the ethical basis of clinical equipoise. There is a 
particularly strong argument for clinical equipoise in this instance as neither ACT nor 
self-help interventions have been evaluated with this population. Although it is clearly 
stated within the participant information sheet that our intervention had not previously 
been evaluated, it is not discussed in relation to the randomisation procedure. More 
work was needed to communicate this information more effectively. An amendment to 
the participant information sheet would be the best way to achieve this but as this is 
highlighted as a specific issue, it might be helpful if the purpose of randomisation and 
the ethical justification for it, is explained verbally when individuals are approached for 
recruitment. 
 
In spite of this, all interviewed participants stated that the information provided was 
clear and we have no data to suggest that a misunderstanding of randomisation and 
clinical equipoise discouraged individuals from enrolling in the trial. All those who met 
the cut-off for depression and declined participation were asked if they would like any 
other support separate to the trial (e.g. referral to psychology). Given that no-one 
accepted this invitation, it suggests that participation was not rejected on the grounds 
that depressed patients were concerned that they would be randomised to the control 
group and therefore not receive psychological treatment. 
 
4.6 Research implications 
We have shown that psychological flexibility is related to psychological distress in 
haemodialysis patients, although this relationship may be overstated given the 
weaknesses of the AAQ-II. However, this finding is consistent with previous studies 
highlighting avoidant coping behaviours as possible factors associated with distress in 
ESRD (e.g. Gillanders et al., 2008). Further research examining the significance of 
ACT processes in ESRD is warranted, as are trials to determine the most effective and 
acceptable formats for delivering ACT interventions.  
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As well as the specific considerations for future research already mentioned in this 
discussion, one possible avenue for prospective studies might lie in chronic pain. More 
than half of the participants in the trial reported that they were troubled by pain, a figure 
consistent with previous research on ESRD pain burden (Davison, 2003; Fainsinger, 
Davison & Brenneis, 2003). Chronic pain remains an inadequately managed, under 
researched and undertreated problem in ESRD and one that impacts almost every 
aspect of health-related quality of life (Davison, 2007). There is now a considerable 
evidence-base for ACT for chronic pain (Hayes et al., 2006) and it has shown 
comparable outcomes to the more established CBT model (Veehof, Oskam, Schreurs 
& Bohlmeijer, 2011). 
 
In light of the high prevalence and inadequate management of chronic pain in ESRD, 
as well as the burgeoning evidence-base for ACT, future research examining the 
acceptability and efficacy of ACT for chronic pain in ESRD is warranted. Careful 
consideration to determine the most appropriate and acceptable formats for delivering 
these interventions is needed. It seems likely that pain, and psychological treatments 
for pain, would not be as stigmatised as depression, particularly in the highly 
medicalised environment of the renal unit. As such, a trial of ACT for pain might not 
experience the same recruitment problems faced by our trial. 
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5. Reflective Section 
This section provides a critical account of my experiences of the research process. My 
perception of the research and its potential merits have changed considerably during 
the course of the research. It is interesting to contrast my perceptions of the research 
at three key points; 1. during the development of the study design; 2. during 
recruitment and data collection; and 3. during the analysis and write-up. At this first 
time point, when the study was in its infancy, I had high expectations about what I 
could achieve. Data on the pervasiveness of depression in ESRD highlighted a highly 
prevalent problem with significant implications for health-related outcomes. 
Furthermore, there was little research on the efficacy of psychological interventions for 
this population and no studies looking at ACT or self-help. I had met with and 
discussed the research with my field supervisor, a Clinical Psychologist working in a 
renal service, and she recognised depression as an unmet need. Indeed, most renal 
services in the UK have access to Clinical Psychology and yet there appeared to be 
very little evidence-base for psychological interventions in this area. It seemed like a 
perfect project with significant clinical and research implications. The number of people 
with ESRD was steadily increasing and depression was a highly prevalent problem with 
virtually no psychotherapeutic evidence-base. There was scope to contribute in a 
meaningful way to the evidence-base and perhaps trigger further research on the ACT 
model in ESRD.  
 
Consideration of the practicalities also seemed promising. I had an enthusiastic field 
supervisor with excellent local knowledge of the patient group and their psychological 
needs. There was a pool of several hundred patients across four dialysis units and if 
prevalence estimates were as high as some research indicated, recruiting the 
designated sample size would not be difficult. As a feasibility trial, I knew that I only 
needed a small sample and that the trial did not need to be fully powered. The design 
was relatively straight forward and would give me experience of both qualitative and 
quantitative methods. 
 
Fast forward to the recruitment phase and things appeared very different. I was 
investing a vast amount of time trying to recruit participants and was struggling to 
muster much enthusiasm for participation from patients. The initial recruitment 
procedure involved a member of unit staff approaching patients and inviting them to 
speak with me about the research. Most were obliging but almost universally they 
denied that they felt low in mood. It was challenging to convince individuals who did not 
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perceive there to be a problem that a self-help manual and phone conversations would 
be of benefit to them. Although it meant considerable delay, it was agreed that an 
alternative recruitment strategy might be the answer and this required a substantial 
ethical amendment. We hypothesised that by screening all patients, we could identify 
those most in need of our intervention and approach them armed with objective data, in 
the form of the completed PHQ-9, demonstrating that they might be struggling with 
their mood. Although ultimately this proved more successful than our initial recruitment 
procedure, I still struggled, recruiting less than a third of the desired sample size.  
 
Not only did many renal patients not want to participate in the trial, they also rejected 
any psychological support outside of the trial. There was a disparity here between my 
perception of clinical need and reality. I had assumed, given the high prevalence of 
depression and limited availability of psychology within the renal service, that there was 
a significant unmet need. Many patients experienced depression and I presumed that 
they would want help to tackle this. Although I could see that self-help might lack 
appeal, the fact that patients did not want psychological support separate to the trial 
suggested that their lack of enthusiasm for the trial was not entirely due to the 
intervention on offer. My perception of the trial at this time was profoundly negative as it 
seemed that I was wasting my time on a failed trial.  
 
It was at this time that I started to question my approach to the research. As a scientist-
practitioner, I considered how I would approach this as a clinician rather than a 
scientist. ACT does not try to target a reduction in psychological distress and makes no 
hypotheses about this. Perhaps ESRD patients would benefit from an ACT intervention 
as a way of improving quality of life or increasing valued action, rather than reducing 
distress. If this had been my approach, inclusion criteria could be much broader as 
specific cut-offs would not need to be met. When seeing patients in clinic, I do not 
expect them to meet a certain cut-off on a distress measure before I agree to help them 
(although this may be true in some stringent services). Indeed, as a clinician, I tend to 
discourage therapy goals around distress reduction and try to focus more on 
behavioural change. In research terms, by ignoring cut-offs it might be difficult to 
demonstrate improvement because scores may already be quite high at baseline 
(where high = better functioning). However, by broadening inclusion criteria, it might 
have allowed us to recruit the target sample size. In doing so, we may have had more 
proof of principle and acceptability data allowing us to draw stronger conclusions about 
the utility of the model and delivery format. 
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Looking back now, I am surprised that I became so tied to depression as a clinical 
problem and depression measures as a way of identifying those most in need of 
psychological help. I have always been critical of diagnostic systems and the 
biomedical model of mental health, avoiding pathologising language in my clinical 
practice and focussing on functional change. Since first being exposed to ACT as an 
Assistant Psychologist, I have been drawn to the ACT principle of destructive normality 
and admired the ACT model for its trans-diagnostic approach. I am attracted to positive 
psychology (Seligman, 2002) and other strengths-based approaches and like the ACT 
concept of growing the person rather than shrinking the problem. As ESRD is a 
predominantly medical problem, many of the papers I read while developing ideas for 
the research were in medical journals. Depression, although widely discussed in the 
ESRD literature, is often described in biomedical terms and I wonder if this primed me 
to think of depression in this way. This may have led me to approach the research in a 
way that was incompatible with the ACT model i.e. identifying individuals who fit into a 
diagnostic category and offering them an intervention to address the experiences that 
situate them in this category. I wonder how recruitment may have differed if patients 
had been offered the same intervention but told that it would help them to grow as an 
individual, do more of what is most important to them and improve their well-being. This 
would have been more compatible with the ACT model and may have been more 
appealing, although it is likely that a different group of individuals would be recruited.  
 
Having previously perceived my research as a failed trial and questioned how I could 
have done things differently, my perception during the analysis and write-up changed 
once more. In all my pessimism about the failed opportunity, I had forgotten what I had 
set out to do. The objective of the trial was to determine the feasibility of a full trial 
examining an ACT self-help intervention for depression in ESRD. To that end, low 
recruitment numbers were no more a weakness than they were a strength. Frustrating 
though it had felt at times, I had achieved my research aims. This was not a failed trial. 
 
I reflected on the ACT model and the research that I had drawn upon to justify its use 
to treat depression in ESRD. These studies had shown a relationship between 
avoidance and distress and this had been replicated in my research. ESRD patients 
who are depressed have a tendency towards avoidant coping. It seems plausible that 
these avoidant tendencies would extend to participation in my research. I was trying to 
recruit the very individuals who were most likely to avoid participating.  
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Overall, I feel satisfied with the project and it has broadened my awareness of the 
challenges of carrying out gold-standard research. It also expanded my understanding 
of the ACT model and gave me the confidence to use it in my clinical practice. I have 
since used ACT in individual therapeutic work with ESRD patients and found it to be a 
well-suited model for a group of patients who are faced with a lifelong, irreversible 
condition, and for whom acceptance of the disease and the associated pain, in the 
service of what is most important to them, may be the most meaningful outcome.  
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Appendix A: Psychotherapy outcome study methodology rating scale 
 
Item Rating and description 
 
i. Clarity of sample description 0 = Vague description of sample (e.g. only mentioned whether patients were 
diagnosed with the disorder). 
1 = Fair description of sample (e.g. mentioned inclusion/exclusion criteria, 
demographics, etc.). 
2 = Good description of sample (e.g. mentioned inclusion/exclusion criteria, 
demographics, and the prevalence of comorbid disorders). 
 
ii. Severity/chronicity of the 
disorder 
0 = Severity/chronicity was not reported and/or sub-syndromal patients were 
included in the sample. 
1 = All patients met the criteria for the disorder. Sample includes acute (<1 year) 
and/or low severity. 
2 = Sample consisted entirely of chronic (>1 year) patients of at least moderate 
severity. 
 
iii. Representativeness of the 
sample 
0 = Sample is very different from patients seeking treatment for the disorder (e.g. 
there are excessively strict exclusion criteria). 
1 = Sample is somewhat representative of patients seeking treatment for the 
disorder (e.g. patients were only excluded if they met criteria for other major 
disorders). 
2 = Sample is very representative of patients seeking treatment for the disorder 
(e.g. authors made efforts to ensure representativeness of sample). 
 
iv. Reliability of the diagnosis 
in question 
0 = The diagnostic process was not reported, or not assessed with structured 
interviews by a trained interviewer. 
1 = The diagnosis was assessed with structured interview by a trained interviewer. 
2 = The diagnosis was assessed with structured interview by a trained interviewer 
and adequate inter-rater reliability was demonstrated (e.g. kappa coefficient). 
 
v. Specificity of outcome 
measures 
0 = Very broad outcome measures, not specific to the disorder (e.g. SCL-90R total 
score). 
1 = Moderately specific outcome measures. 
2 = Specific outcome measures, such as a measure for each symptom cluster. 
 
vi. Reliability and validity of 
outcome measures 
0 = Measures have unknown psychometric properties, or properties that fail to 
meet current standards of acceptability. 
1 = Some, but not all measures have known or adequate psychometric properties. 
2 = All measures have good psychometric properties. The outcome measures are 
the best available for the authors’ purpose. 
 
vii. Use of blind evaluators 0 = Blind assessor was not used (e.g. assessor was the therapist, assessor was 
not blind to treatment condition, or the authors do not specify). 
1 = Blind assessor was used, but no checks were used to assess the blind. 
2 = Blind assessor was used in correct fashion or measures completed online. 
Checks were used to assess whether the assessor was aware of treatment 
condition. 
 
viii. Assessor training 0 = Assessor training and accuracy are not specified, or are unacceptable. 
1 = Minimum criterion for assessor training is specified (e.g. assessor has had 
specific training in the use of the outcome measure), but accuracy is not monitored 
or reported. 
2 = Minimum criterion of assessor training is specified. Inter-rater reliability was 
checked, and/or assessment procedures were calibrated during the study to 
prevent evaluator drift; n/a = if measures completed online. 
 
ix. Assignment to treatment 0 = Biased assignment, e.g. patients selected their own therapy or were assigned 
in another non-random fashion, or there is only one group. 
1 = Random or stratified assignment. There may be some systematic bias but not 
enough to pose a serious threat to internal validity. There may be therapist by 
treatment confounds. N may be too small to protect against bias. 
2 = Random or stratified assignment, and patients are randomly assigned to 
therapists within condition. When theoretically different treatments are used, each 
treatment is provided by a large enough number of different therapists. N is large 
enough to protect against bias. 
 
x. Design 0 = Active treatment vs. wait-list control, or briefly described TAU. 
1 = Active treatment vs. TAU with good description, or placebo condition. 
2 = Active treatment vs. another previously empirically documented active 
treatment. 
 
Continued. 
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Continued. 
 
xi. Power analysis 0 = Biased assignment, e.g. patients selected their own therapy or were assigned 
in another non-random fashion, or there is only one group. 
1 = Random or stratified assignment. There may be some systematic bias but not 
enough to pose a serious threat to internal validity. There may be therapist by 
treatment confounds. N may be too small to protect against bias. 
2 = Random or stratified assignment, and patients are randomly assigned to 
therapists within condition. When theoretically different treatments are used, each 
treatment is provided by a large enough number of different therapists. N is large 
enough to protect against bias. 
 
xii. Assessment points 0 = Only pre- and post-treatment, or pre- and follow-up. 
1 = Pre-, post-, and follow-up <1 year. 
2 = Pre-, post-, and follow-up >1 year. 
 
xiii. Manualised, replicable, 
specific treatment programs 
0 = Description of treatment procedure is unclear, and treatment is not based on a 
publicly available, detailed treatment manual. Patients may be receiving multiple 
forms of treatment at once in an uncontrolled manner. 
1 = Treatment is not designed for the disorder, or description of the treatment is 
generally clear and based on a publicly available, detailed treatment manual, but 
there are some ambiguities about the procedure. Patients may have received 
additional forms of treatment, but this is balanced between groups or otherwise 
controlled. 
2 = Treatment is designed for the disorder. A detailed treatment manual is 
available, and/or treatment is explained in sufficient detail for replication. No 
ambiguities about the treatment procedure. Patients receive only the treatment in 
question. 
 
xiv. Number of therapists 0 = Only one therapist, i.e. complete confounding between therapy and therapist. 
1 = At least two therapists, but the effect of therapist on outcome is not analysed. 
2 = Three, or more therapists, and the effect of therapist on outcome is analysed. 
 
xv. Therapist 
training/experience 
0 = Very limited clinical experience of the treatment and/or disorder (e.g. students). 
1 = Some clinical experience of the treatment and/or disorder. 
2 = Long clinical experience of the treatment and the disorder (e.g. practising 
therapists). 
 
xvi. Checks for treatment 
adherence 
0 = No checks were made to assure that the intervention was consistent with 
protocol. 
1 = Some checks were made (e.g. assessed a proportion of therapy tapes). 
2 = Frequent checks were made (e.g. weekly supervision of each session using a 
detailed rating form). 
 
xvii. Checks for therapist 
competence 
0 = No checks were made to assure that the intervention was delivered 
competently. 
1 = Some checks were made (e.g. assessed a proportion of therapy tapes). 
2 = Frequent checks were made (e.g. weekly supervision of each session using a 
detailed rating form). 
 
xviii. Control of concomitant 
treatments (e.g. medications) 
0 = No attempt to control for concomitant treatments, or no information about 
concomitant treatments provided. Patients may have been receiving other forms of 
treatment in addition to the study treatment. 
1 = Asked patients to keep medications stable and/or to discontinue other 
psychological therapies during the treatment. 
2 = Ensured that patients did not receive any other treatments (medical or 
psychological) during the study. 
 
xix. Handling of attrition 0 = Proportions of attrition are not described, or described but no dropout analysis 
is performed. 
1 = Proportions of attrition are described, and dropout analysis or intent-to-treat 
analysis is performed. 
2 = No attrition, or proportions of attrition are described, dropout analysis is 
performed, and results are presented as intent-to-treat analysis. 
 
xx. Statistical analyses and 
presentation of results 
0 = Inadequate statistical methods are used and/or data are not fully presented. 
1 = Adequate statistical methods are used but data are not fully presented. 
2 = Adequate statistical methods are used and data are presented with M and SD. 
 
xxi. Clinical significance 0 = No presentation of clinical significance was done. 
1 = An arbitrary criterion for clinical significance was used and the conditions were 
compared regarding percent clinically improved. 
2 = Jacobson’s criteria for clinical significance were used and presented for a 
selection (or all) of the outcome measures, and conditions were compared 
regarding percent clinically improved. 
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xxii. Equality of therapy hours 
(for non-wait-list designs only) 
0 = Conditions differ markedly (>20% difference in therapy hours). 
1 = Conditions differ somewhat (10–19% difference in therapy hours). 
2 = Conditions do not differ (<10% difference in therapy hours). 
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Appendix F: Participant Information Sheet 
 
(Final version 1.4: 31/07/15) 
 
Title of study: Acceptance and Commitment Therapy self-help intervention for 
depression in haemodialysis patients: A feasibility randomised controlled trial  
 
Researchers: William Vogt (Chief Investigator), Dr Roshan das Nair, Dr Nima 
Moghaddam, Dr Emma Coyne 
 
Sponsor: Professor Sara Owen, University of Lincoln 
  
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would involve 
for you. One of our team will go through the information sheet with you and answer any 
questions you have. Talk to others about the study if you wish. Ask us if there is 
anything that is not clear. 
 
What is the purpose of the study? 
 
Depression is experienced by 20-40% of people with End-Stage Renal Disease 
(ESRD). Depression not only affects the quality of life of individuals with ESRD but is 
also associated with higher rates of hospitalisation and worse physical health 
outcomes. 
 
Acceptance and Commitment Therapy (ACT) is a talking therapy that has been found 
to be an effective treatment for depression and has been used successfully as a self-
help treatment for other chronic physical health problems. However, no study has 
examined the effectiveness of an ACT self-help treatment for depression in ESRD. We 
want to know whether it is feasible to conduct such a study and will look at the 
suitability of our recruitment, assessment methods and our self-help treatment, and 
help us to calculate the number of people we will need for a larger study.  
 
Do I have to take part? 
 
It is up to you to decide whether you wish to join the study. If you decide to take part 
you are still free to withdraw at any time and without giving a reason. This will not affect 
your legal rights or your medical care. 
 
Can anyone take part? 
 
Only people who have been receiving haemodialysis for more than 3 months and are 
experiencing symptoms of depression can take part.  
 
What will happen to me if I take part? 
 
If you are willing to take part, you will be asked to complete some questionnaires which 
will include some questions about your mood. This will take approximately 10 minutes. 
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If the questionnaires suggest that you are experiencing some distress you will be 
eligible to take part. If your scores do not indicate that you have depression, you will 
not be eligible to take part. 
 
If you agree to take part, you will be asked to fill in some further questionnaires.    
 
After these assessments you will be put into one of two groups. Which group you are 
allocated to will be determined purely by chance (randomly). This is the fairest way to 
ensure that each person has an equal chance of being in either group. 
 
Group 1 
 
Group 1 will be given an ACT self-help workbook. This book contains information about 
ACT as well as some exercises to help develop your skills. This group will be required 
to complete several chapters of the workbook every week for six weeks and will 
continue to receive their usual care. Participants will be given information about which 
chapters to complete each week. Our researcher will provide up to 30 minutes per 
week of telephone support to help complete the chapters. An appropriate time for these 
phone calls will be agreed with each participant. 
 
Once participants have completed the self-help workbook, they will be asked to fill in 
some of the questionnaires again. About two months later they will be asked to 
complete the questionnaires for a final time. It will take about 20 minutes to complete 
the questionnaires each time. 
 
Group 2 
 
Group 2 will not receive the ACT self-help workbook but will continue to receive their 
usual care. As with group 1, participants in group 2 will be asked to complete the 
questionnaires twice more, about 2 and 4 months after being allocated to the group.  
 
Some participants from both groups will be invited to give feedback interviews to find 
out about their experience of being involved in our study.  
 
Will everyone who wants to take part in the feedback interviews be interviewed? 
 
There is an option on the consent form to state whether or not you want to take part in 
the interviews. Not everyone who wants to take part in these interviews will be 
selected. Who takes part in the feedback interviews will be determined purely by 
chance (randomly). This is the fairest way to ensure that each person has an equal 
chance of being interviewed. Anyone who does not want to take part in these 
interviews does not have to do so.  
 
Please be assured that taking part in this study, whichever group you are allocated to, 
will not influence or delay your normal medical care.     
 
 
Continued 
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Expenses and payments 
 
Participants will not be paid to participate in the study. Travel expenses will be offered 
for any visits incurred as a result of participation. 
 
What are the possible disadvantages and risks of taking part?  
 
We appreciate that taking part will use your time and may therefore be inconvenient. If 
you are put into the self-help group, you may talk about your problems during 
telephone conversations with our researcher. Talking about your problems can 
occasionally be upsetting, but our researcher is trained to help make you feel as 
comfortable as possible. The interview and any other aspect of your involvement can 
stop at any time if you do not wish to continue. However, if during the interview or 
telephone conversations you disclose something that raises serious concerns about 
your safety or the safety of others, we may be obliged to break confidentiality and 
contact your GP and/or refer you to the Clinical Psychologist within the renal service. 
You will be told if confidentiality is going to be broken. 
 
What are the possible benefits of taking part? 
 
Taking part in our study means that you may possibly help people with ESRD in the 
future. The information we get from this study will help us decide whether we should 
develop this approach further. 
 
What happens when the research study stops? 
 
When the research stops your usual care will continue. 
 
What if there is a problem?  
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. The researcher’s contact 
details are given at the end of this information sheet. If you remain unhappy and wish 
to complain formally you can do this by contacting NHS Complaints. Details can be 
obtained from your hospital.  
 
Will my taking part in the study be kept confidential? 
 
We will follow ethical and good practice procedures and all information about you will 
be handled in complete confidence. All information which is collected about you during 
the research will be kept strictly confidential, stored in a secure and locked office, 
and on a password protected database. 
 
Your personal data (address, telephone number) will be kept for a year after the end of 
the study so that we are able to contact you about the findings of the study and 
possible follow-up studies, unless you tell us that you do not wish to be contacted. All 
other research data will be kept securely for 7 years.  After this time your data will be 
disposed of securely. During this time all precautions will be taken to maintain your 
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confidentiality. Only members of the research team will have access to your personal 
data. 
 
What will happen if I don’t want to carry on with the study?  
 
Your participation is voluntary and you are free to withdraw at any time, without giving 
any reason, and without your legal rights or medical care being affected. If you 
withdraw then the information collected so far cannot be erased and this information 
may still be used in the project analysis. 
 
Involvement of the General Practitioner/Family doctor (GP) 
 
If you take part in this study, we will write to your GP to notify them of your participation 
in the research. We will explain in the letter that our questionnaire indicates that you 
may be experiencing symptoms of depression. If at any point during the study, there 
are serious concerns regarding your safety we will contact your GP again. 
 
What will happen to the results of the research study? 
 
The information from this study will help us establish the value of this treatment for 
people receiving haemodialysis. The results of the study may be presented to other 
researchers, at meetings and through publication in scientific journals. Although these 
reports may include direct quotes of what you have said, we will ensure that it will not 
be possible for anyone to identify you from them. If you ask the researcher, we would 
be happy to send you a copy of the results when they are available. 
 
Who is organising and funding the research? 
 
This research is being organised and funded by the University of Lincoln. 
 
Who has reviewed the study? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by NRES Committee North West – Preston. 
 
Contact details  
 
If you have any further questions about this study, or wish to contact the study 
sponsors, please contact our researcher  
 
Name of researcher:  William Vogt 
 
Address: School of Psychology (DClinPsy), University of Lincoln, Brayford Pool, 
Lincoln LN6 7TS 
 
Telephone: 07525 219 365  
Email: 13451711@students.lincoln.ac.uk 
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You can also contact the University of Lincoln School of Psychology Ethics Committee 
 
Telephone: 01522 88 6180  
Email: soprec@lincoln.ac.uk 
Address: as above 
 
Complaints 
 
If you have any complaints about this study, please contact the University of Lincoln 
School of Psychology Research Ethics Committee on the contact details above or 
Nottingham University Hospitals NHS Trust Patient Advice and Liaison Service (PALS) 
 
Address: 
Patient Advice and Liaison Service 
Nottingham City Hospital 
Hucknall Rd 
Nottingham 
NG5 1PB 
 
Freephone: 0800 18 30 204 
Email: PALS@nuh.nhs.uk 
 
Thank you for taking the time to read this invitation 
  
 162 
Appendix G: Consent Form 
 
(Final version 1.3: 15/12/14) 
 
Title of study:  Acceptance and Commitment Therapy self-help intervention for 
depression in haemodialysis patients: A feasibility randomised controlled trial 
(Self-help for haemodialysis patients with depression) 
 
REC ref: 14/NW/1463  
 
Name of Researcher: William Vogt 
 
Name of Participant:  
 
1. I confirm that I have read and understand the information sheet version  
 number …………dated...................................... for the above study and  
 have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to  
 withdraw at any time, without giving any reason, and without my medical  
 care or legal rights being affected. I understand that should I withdraw  
 then the information collected so far cannot be erased and that this  
 information may still be used in the project analysis. 
 
3. I understand that relevant sections of my medical notes and data collected 
 in the study may be looked at by authorised individuals from the University 
 of Lincoln, the research group and regulatory authorities where it is relevant 
 to my taking part in this study. I give permission for these individuals to  
 have access to these records and to collect, store, analyse and publish 
 information obtained from my participation in this study. I understand that 
 my personal details will be kept confidential. 
 
4. I would like to be contacted for an interview at a later stage of the study. 
 
 
5. I understand that any telephone conversations or interviews which take  
 place as part of the study may be recorded. 
 
6. I understand that if I take part in the interview, anonymised quotes from 
the interview and phone conversations may be used in publications that 
arise from this study  
 
7. I agree to my GP being informed of my participation in this study. 
 
 
8. I agree to take part in the above study. 
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________________________ ______________     __________________ 
Name of Participant   Date          Signature 
 
 
________________________ ______________     __________________ 
 Name of Person taking consent Date          Signature 
 (if different from Chief Investigator) 
________________________ ______________     __________________ 
Name of Chief Investigator  Date      Signature 
 
3 copies: 1 for participant, 1 for the project notes and 1 for the medical notes 
 
  
 164 
Appendix H: Interview Schedule 
 
Questions for all interviewees: 
 
1. How did you find the recruitment process? What was it like be recruited at the 
dialysis unit? Did you find it intrusive? Was the information that you were given 
clear? 
 
2. After signing up for the study, you were randomly allocated to the group who 
received the self-help book / to the group who didn’t receive the self-help book. 
How did you find the allocation procedure? Did you understand this well? Did 
you think it was a fair way of allocating people to groups? If not, what would be 
a better way? 
 
3. How did you find completing the questionnaires? Were the questions clear? Did 
they capture the right information? Were you happy with how long they took to 
complete? 
 
4. Since been diagnosed with chronic kidney disease, have you ever received any 
psychological treatment? When was this? How long was this for? (e.g. number 
of sessions and length in time). What type of psychological treatment? What 
was the treatment for? 
 
5. Since your diagnosis, have you ever been prescribed any medication for 
depression? When was this? How long was this for? What medication? 
 
6. Have you read any other self-help books? What were they? What aspects of 
them were helpful? 
 
7. Have you been to any mindfulness, meditation or therapeutic groups? 
 
8. Have there been any significant changes to your medical care since taking part 
in the study? (e.g. kidney transplant, change to home haemodialysis). 
 
9. What changes to the study (if any) would you recommend? You might want to 
think about the recruitment process, the intervention length or intensity, the 
telephone call length, intensity or regularity, the questionnaires. This could be 
something you have mentioned before or something new, it should help with 
future research. 
 
Questions for intervention group only: 
 
11. What did you think of the self-help manual? You might want to think about the 
style, content, language, length and interactivity. 
 
12. What aspects of the intervention (self-help manual with telephone support) do 
you think might be difficult for people who receive dialysis? 
 
13. What would make this treatment more appropriate or helpful for people who 
receive dialysis? (e.g. different format, length, more support) 
 
14. Which aspects of the manual did you find most helpful? 
 
15. Which aspects of the manual did you find least helpful? 
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16. Where did you usually read the book? (e.g. while on dialysis, at home) 
 
17. What barriers made it difficult to read the book or complete the exercises? (e.g. 
life events, living situation, health) 
 
18. Do you have any thoughts about self-help provided in a different format (e.g. 
computerised, audio)? 
 
19. Do you think other dialysis patients would benefit from a self-help treatment with 
telephone support? Why? 
 
20. What did you think of the telephone support? (e.g. length, regularity, intensity) 
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7. Poster 
 
Acceptance & Commitment Therapy Self-Help for Depression in 
Haemodialysis: A Feasibility Randomised Controlled Trial
Will Vogt1 Roshan das Nair1, Nima G Moghaddam1, Barnaby Proctor1, Emma Coyne2
1Trent Doctorate in Clinical Psychology; 2Renal Unit, Nottingham University Hospitals NHS Trust
Contact: emma.coyne@nuh.nhs.uk
Research Aims
• To assess the feasibility of a full trial of
a telephone-supported self-help
intervention based on ACT.
• To generate data about the potential
efficacy of the intervention by
conducting individual level analysis.
• To examine the relationship between
psychological flexibility and distress.
Participants were 
given a copy of 
Get Out of Your 
Mind and Into 
Your Life11 - a 
general self-help 
text based on 
ACT.
Method
Participants were recruited from four
outpatient haemodialysis units across
Nottinghamshire, UK. The Patient Health
Questionnaire7 (PHQ-9), EuroQol8 (EQ-5D-
5L) health-related quality of life measure,
Acceptance and Action Questionnaire II9
(AAQ-II) and Valued Living Questionnaire10
(VLQ) were completed at baseline and 2-
and 4-months post-randomisation.
Participants in the intervention arm were
asked to complete an ACT self-help manual
over six weeks with weekly telephone
support. Following completion of the trial, six
participants were interviewed to examine the
acceptability of the trial procedure and
intervention. Interview data was analysed
using framework analysis. Leeds Reliable
Change Indicator was used to conduct
individual level analysis.
References: 1Kimmel, P.L. (2001). Psychosocial factors in dialysis patients. Kidney International, 59(4), 1599-1613. 2Chilcot, J., Wellsted, D., & Farrington, K. (2010). Depression in end-stage renal disease: current advances and research. Seminars in Dialysis, 23(1), 74-82. 3Ibrahaim, N., Chiew-Thong, N.K., Desa,A., & Razali, R. (2013). 
Depression and coping in adults undergoing dialysis for end-stage renal disease. Asia Pacific Psychiatry, 5(1), 35-40. 4Gillanders, S., Wild, M., Deigham, C., & Gillanders, D. (2008). Emotion regulation, affect, psychosocial functioning, and well-being in hemodialysis patients. American Journal of Kidney Diseases, 51(4), 651-652. 5Hayes, S.C., 
Strosahl, K., Wilson, K.G. (1999). Acceptance and Commitment Therapy: An experiential approach to behavior change. New York: Guilford Press. A-6Tjak, J.G., Davis, M.L., Morina, N., Powers, M.B., Smits, J.A., & Emmelkamp, P.M. (2015). A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and 
physical health problems. Psychotherapy and Psychosomatics, 84(1), 30-36. 7Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ‐9. Journal of General Internal Medicine, 16(9), 606-613. EuroQol Group. (1990). 8EuroQol--a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199-208. 9Bond, F. W., 
Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K. et al (2011). Preliminary psychometric properties of the acceptance and action Questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy, 42(4), 676-688. 10Wilson, K. G., Sandoz, E. K., Kitchens, J., & Roberts, M. (2010). 
The valued living questionnaire: Defining and measuring valued action within a behavioral framework. Psychological Record, 60(2), 249-272. 11Hayes, S. C., & Smith, S. (2005). Get out of your mind and into your life: The new acceptance and commitment therapy. Oakland, CA: New Harbinger Publications. 
Introduction
People with end-stage renal disease (ESRD)
experience rates of depression ranging from
20 to 40%1. Depression is associated with a
range of negative health-related outcomes2
and may be related to avoidant coping
behaviours including behavioural
disengagement3 and the suppression of
negative emotions4.
Acceptance and Commitment Therapy (ACT)
centres on interventions aimed at reducing
experiential avoidance, encouraging
acceptance as a means of fostering value-
guided action5.
It has shown promising results in a number
of long-term conditions6 and has been
translated into a variety of self-help formats.
ACT has never been tested as a treatment
for depression in ESRD.
Results
In total, 99 (36.87%) of 276 screening questionnaires were returned.
Of these, 30 (30.3%) met the cut-off for depression on the PHQ-9 with
nine enrolling in the trial.
AAQ-II scores of screened participants were positively associated with
scores on the PHQ-9 indicating a positive relationship between
psychological inflexibility and depression.
Interview data indicated that the recruitment process, randomisation
procedure, and assessment methods were acceptable.
Only one in four of the participants in the ACT arm of the trial
completed all chapters of the book with health problems the main
barrier to completion. Individual level analysis revealed that one
participant in each condition experienced clinically significant change
in PHQ-9 scores.
Conclusion
Our findings indicate that a definitive trial examining the effectiveness
of a telephone-supported ACT self-help intervention would not be
feasible. Many aspects of the trial were acceptable to participants,
including the main recruitment strategy, randomisation procedure and
data collection methods. However, low recruitment numbers and poor
adherence to the self-help manual indicate that a full-scale trial would
not be viable.
Health problems may make it difficult for ESRD patients to engage in,
and commit to, self-help interventions. Given the relationship between
psychological flexibility and distress in ESRD, ACT interventions may
have a utility. Research is needed to identify how best to approach
ACT interventions with this population.
Quotes
“I struggled to catch up with the book. I had a stroke two years ago so I’m a bit
slower reading. I don’t tend to read much.”
“I’d been waiting for a parathyroidectomy for a while and then the op came up, so I
tried getting to read it, but I couldn’t, I couldn’t concentrate.”
“A lot of people… wouldn’t want to do the self-help book, and there’s also a lot that
probably wouldn’t want the phone calls either.”
Figure 1. Flow of participants
